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Dairy farming in the Netherlands
Dairy farming is an important and highly efficient industry in the Netherlands. The growth 
in dairy farming was initiated after the Second World War when the government decided 
to subsidise farmers in order to produce food for low prices and boost the rebuilding of 
the country. Large efficiency steps were made due to increased knowledge on genetics 
and diet regimes, but also technology such as stables and milking machines, which made 
it possible to manage more cows per person. The number of farms decreased, but the 
number of dairy cows and the production per cow increased strongly [1]. The last 20 
years the number of dairy farms halved from 37,465 in 1995 to 18,300 farms in 2015. In 
the same period, the number of cows per farm almost doubled from 45.6 to 88.9 and the 
lifetime milk yield per cow increased with nearly 30% from 23,950 kg to 30,686 kg. These 
improvements on milk production also have their drawbacks as it is accompanied with 
increased health problems and their associated costs [2, 3]. The major health problems in 
dairy farming are mastitis, lameness and reduced fertility and these are important reasons 
for culling of dairy cows [4]. 
Mastitis
Mastitis is an inflammation of the udder caused by a microbial agent, which is accompanied 
with a decreased animal welfare, production loss and high costs [5-7]. Based on worldwide 
estimations, clinical mastitis costs about €61 - €97 per cow annually [8]. Mastitis is a 
multifactorial disease dependent on (mostly) bacterial exposure and the immune status of 
the cow, which is influenced by factors such as energy balance and milk production [9]. 
Since mastitis and (high) somatic cell counts (SCC) are strongly related, SSC is used as 
an indicator for mastitis in routine screening programmes. Major pathogens in mastitis are 
E. coli and the Streptococcus species [10]. Mastitis causing agents can be distinguished 
in environmental (e.g. E. coli) and contagious (e.g. Staphylococcus aureus) bacteria [9], 
which have their origin in the cows environment or are transmitted via infected quarters, 
respectively. Mastitis can be subdivided in clinical mastitis and subclinical mastitis. 
Clinical mastitis includes an inflammatory reaction in the udder with elevated SCC and 
changes in milk composition and occurs in either an acute or chronic form. Subclinical 
mastitis is asymptomatic and is indicated by SCC > 250,000 cells per ml in multiparous 
cows and SCC > 150,000 cells per ml in primiparous cows [11]. The risk of clinical mastitis 
is highest early in lactation [12], while the risk of subclinical mastitis increases during 
lactation [13]. The risk of both clinical and subclinical mastitis increases with age and 
are associated with an increased risk of culling [10]. Clinical mastitis incidence on Dutch 
conventional farms is about 33 cases per 100 cows per year [14], while others reported 
47 cases per 100 cows per year in the UK [15]. The same group observed a subclinical 
mastitis incidence of 71 cases 100 cows per year in the UK, illustrating that mastitis is a 
major health problem in dairy farming.
Lameness
Lameness is the impairment of the cows` locomotion, which is caused by several leg and 
claw disorders. The most abundant causes of lameness are sole ulcers, white line defects 
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(lesions in the junction between the foot sole and wall), digital dermatitis (Mortellaro 
disease) and foot rot [16-18]. The incidence of lameness is highly variable between farms 
and studies; one study reported an annual incidence of lameness per 100 cows ranging from 
31.6 to 111.5 cases [16], in another study 10.7 to 170.1 cases were observed [19]. Claw 
problems are classified as infectious e.g. digital dermatitis and non-infectious e.g. trauma 
or white line defects and therefore have a different aetiology [20]. Infectious claw problems 
are often associated with a disbalance in the diet or energy balance and depression of the 
immune system [21]. Lameness does not only affect the cows` locomotion and welfare, 
but has also indirect consequences such as a reduced feed intake, milk production, fertility 
and energy balance and an increased risk of culling [21-25]. Risk factors for lameness are 
high milk production, acidosis (diet), season, animal housing, low body condition score 
(BCS) and (improper) management [17, 18, 26, 27]. 
Fertility 
To initiate and maintain milk production in dairy cows, it is important that cows give birth 
to a calf about once a year. From the 1950s a steady decline in fertility is observed in dairy 
cattle worldwide [28]. Cows fail to ovulate or lose their foetus early in pregnancy. The 
moment of insemination coincidences with peak lactation, when high milk production 
affects the nutritional need and energy balance of dairy cows and thereby impairs fertility 
[29]. Whether infertility is a direct consequence of high milk production or only inadequate 
management remains to be established [30]. Main factors contributing to impaired fertility 
are a too high or low body condition score (BCS <2.5 or >3.5 on a 5-point scale), disbalance 
in feed macrominerals (e.g. Ca2+ and Mg+) and hormones, heat stress and diseases such as 
endometritis, mastitis, lameness and metabolic diseases [29, 31-34].
Energy balance, diet and health problems
The development of mastitis, lameness and fertility are all associated with a high milk 
yield, (negative) energy balance and diet of dairy cows [35]. This is also reflected by 
the main breeding goals in dairy farming across countries: production (59.5%), durability 
(28%) and health and reproduction (12.5%), where production has much more interest 
than bovine health [36]. Modern dairy farming focusses on the diet and energy balance of 
cows, especially in the transition period, to prevent disease [37]. Still, after calving, high 
producing cows will come into a negative energy balance (NEB) as their feed intake does 
not meet their requirements and impairs the bovine immune system [35, 38]. Also the 
periparturient period itself is accompanied by immune suppression [39]. As a consequence, 
about 75% of the health problems in dairy cows occur the first month after calving [40]. 
Immune system
As in humans, the bovine immune system is divided in an innate and adaptive immune 
system. The innate immune system is characterised by fast responses based on recognition 
of conserved microbial structures by preformed receptors or immune proteins. Important 
players are different types of immune cells, and humoral factors like antimicrobial 
peptides and the complement system. Immune cells such as macrophages and neutrophils 
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recognize and phagocytise microbes and produce cytokines in order to attract other 
immune cells and to induce an adaptive immune reaction. Antimicrobial peptides, such 
as lactoferrin, are amphipathic molecules of < 100 amino acids long with antimicrobial 
and immunomodulatory functions [41]. They are produced by immune and epithelial cells 
and can kill among others by direct interaction and disruption of the bacterial membrane. 
The complement system involves a large set of proteins that can recognise microbes via 
three different pathways: the classical, the mannose-binding lectin and the alternative 
pathway. These pathways differ in the way of activation, but they all lead to the activation 
of key player C3b and subsequently opsonisation or lysing of microbes.   
The adaptive immune system includes B- and T-cells, which are responsible for humoral 
(antibodies) and cell-mediated immunity, respectively. The B- and T-cell compartments 
include several cells with their own functions. Conventional B-cells (B-2 cells or 
follicular B-cells) are derived from the bone marrow. Upon interaction of the B-cell 
with a specific antigen and costimulation by T-cells, the B-cell becomes activated, starts 
proliferating and develops into plasma cells that secrete specific antibodies (SpAbs), 
mostly IgM (Figure 1). In addition, memory B-cells are formed which initiate a rapid 
antibody response upon a next encounter with the same antigen. In this secondary 
response B-cells undergo somatic hypermutation and class-switching to e.g. IgG1 and 
IgG2 subclasses leading to highly specific antibodies. T-cells are generally subdivided 
in CD4+ T-helper cells and CD8+ cytotoxic T-cells. CD4+ T-cells are involved in B-cells 
activation and co-stimulation by the production of cytokines and cell-cell interactions. 
CD8+ T-cells perform direct killing of virus-infected and tumour cells.   
At the interplay of the innate and adaptive immune system are the γδ-T-cells, NKT-cells, 
marginal zone B-cells and B-1 cells [42]. These more innate-like cell types recognise a 
limited and more conserved repertoire of antigens than the conventional B- and T-cells. In 
addition, B-1 cells and γδ-T-cells recognise self-antigens [43], while conventional B- and 
T-cells are negatively selected for self-antigens. B-1 and γδ-T-cells are both relatively 
more abundant in young individuals, particularly the γδ-T-cells that represent up to 60% 
of the peripheral blood mononuclear cells (PBMCs) in newborn calves [44].
B-1 cells
B-1 cells are well defined in mice, but sporadically described in cows. B-1 cells in cows 
were defined by the originally used murine markers CD5 and CD11b and subdivided 
in CD5+CD11b- B1a cells, CD5-CD11b+ B1b cells and CD5-CD11b- conventional B-2 
cells [45]. According to this classification, the total B-1 cell population would represent 
about 30 to 40% of the PBMCs and would increase up to 80% during a Trypanosoma 
congolense infection. Using these markers in humans, the B-1 cell population would 
represent about 10 to 30% of the PBMC. In contrast, murine B-1 cells are nearly absent in 
blood, but are enriched in the peritoneal and pleural cavities. These findings and additional 
research showed that the markers CD5 and CD11b are not suitable to identify B-1 cells 
only (Reviewed in chapter 2). B-1 cell identification in mice requires the following 
markers: CD5+/-, CD11b+, IgMhigh, IgDlow, B220low, CD23- and CD43+ [46, 47].  
Despite the fact that B-1 cells produce antibodies, they are more innate-like cells and 
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from an evolutionary perspective, B-1 cells were present earlier than the conventional 
B-2 cells [48]. The major function of B-1 cells is the spontaneous production of Natural 
Antibodies (NAbs), while B-2 cells produce Specific Antibodies (SpAbs) upon interaction 
with a specific antigen and costimulatory signals. Additional functions of B-1 cells are 
the production of IL-10, (partial) production of intestinal IgA, phagocytosis and killing of 
microbes and subsequent induction of CD4+ T-cell responses [48-51]. 
Figure 1: Antibody production by B-1 and B-2 cells
The conventional B-2 cells are activated by the interaction with a specific antigen (microbe) and costimulatory 
signalling. Activated B-2 cells start proliferating and produce specific antibodies (SpAbs) which bind to the 
antigen the B-2 interacted with and no other microbes. B-1 cells do not need the interaction with a specific 
antigen, but spontaneously produce natural antibodies (NAbs). These NAbs are mostly IgMs which bind to 
common microbial structures and auto-antigens.
B-1 cell regulation
B-1 cells are primarily formed before birth and maintained through life, while B-2 cells 
mainly develop around birth and strongly increase afterwards by clonal expansion [52]. In 
contrast to B-2 cells which proliferate upon B-cell receptor (BCR) stimulation, B-1 cells 
are hypo-responsive to BCR engagement showing no or little proliferation and increased 
apoptosis [53]. This BCR unresponsiveness maintains B-1 cell numbers since mutations in 
negative regulators of BCR signalling result in increased B-1 cell numbers and mutations 
in positive regulators lead to decreased B-1 cell numbers [47]. Because of their hyper-
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expression of the regulator gene c-myc, which encodes a transcription factor that induces 
cell cycle progression, B-1 cells show autonomous proliferation, unlike B-2 cells [54]. 
In addition, B-1 cells are able to spontaneously produce antibodies, which is different 
from antibody production in B-2 cells that requires BCR stimulation [55]. Antibody 
production in B-2 cells depends on several transcription factors such as B lymphocyte 
inducer of maturation program 1 (BLIMP-1) and paired box gene PAX-5 under control 
of key regulator interferon response factor 4 (IRF4). Peritoneal and splenic B-1 cells can 
produce low levels of NAbs independent of IRF4, however, high production of NAbs by 
splenic B-1 cells is IRF4-dependent. In addition, recent research suggests that B-1 cells 
from different sources have different functions [56]. Peritoneal B-1 cells are involved in 
inflammatory responses, while splenic (and bone marrow-derived) B-1 cells are the main 
producers of NAbs. They are also differently regulated since the number of peritoneal B-1 
cells (and conventional B-2 cells) strongly decreased in the absence of secreted (natural) 
IgM, while splenic B-1 cells are unaffected and MZ cells even increased [57]. The absence 
of natural IgM resulted in antibody-mediated autoimmunity, implying an important role 
for B-1 cells in preventing autoimmunity. Furthermore, serum IgM levels were shown to 
control B-1 and MZ B-cell numbers at steady state [58].
Natural antibodies
Natural antibodies (NAbs) are defined as polyreactive antibodies, which are produced 
without prior antigenic stimulation [59]. These antibodies are often directed to 
common microbial structures (e.g. lipopolysaccharides (LPS), lipoteichoic acid (LTA), 
peptidoglycans (PGN)), auto-antigens (e.g. DNA, phosphatidylcholine (PtC)) and 
neo-antigens (e.g. keyhole limpet hemocyanin (KLH)) [60, 61]. The NAb repertoire is 
germline-like due to limited use of V-genes, somatic hypermutation and incorporation of 
N-additions and is not further modified because of their lack of memory formation [59, 62]. 
Studies in mice and human showed that auto-reactive IgM and IgG (natural) antibodies are 
already present in newborns and individuals recognize a conserved collection of antigens 
[63]. The auto-reactive NAb repertoire develops and matures during early life, leading 
to some diversity, which is maintained during life. NAbs directed to common microbial 
structures were also shown to be conserved between species, since cross-reactivity was 
observed between mice, humans and rats [59]. The NAb repertoire consists of IgM, IgA, 
IgG1, and IgG2 antibodies, which are present in different amounts in species and body 
fluids. In mammalian blood, IgM is the most dominant NAb [64]. Due to its pentameric 
structure, natural IgM antibodies bind their target with low affinity, but high avidity. About 
90% of total IgM levels in germ-free mice are natural antibodies [62]. In addition, NAbs in 
germ-free mice represent about 50% and 10% of the total IgA and IgG levels, respectively. 
Function NAbs
Natural antibodies have different roles in the immune system and can act in similar ways 
as specific antibodies [65]. They are not able to eliminate pathogens by themselves [66], 
but cooperate with other cells and factors of the innate immune system to do so. However, 
NAbs can be considered part of the innate immune defence and are especially important in 
the initial phases of an immune response. Binding of NAbs to pathogens such as bacteria 
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and viruses has different consequences. Firstly, NAbs result in neutralisation of the 
pathogen thereby preventing that the pathogen enters host cells or tissues. Agglutination of 
pathogens by NAbs provides a rapid reduction of infectious agents by creating antibody-
antigen immune complexes with improved recognition by e.g. DCs via Fc receptors. 
Binding, or opsonisation, by NAbs also marks pathogens, leading to pathogen capture in 
the spleen or lymph nodes. When trapped in these secondary lymphoid organs, pathogens 
are unable to injure other organs [64]. Additionally, this antibody-antigen immune complex 
can be taken up by neutrophils, resident macrophages and dendritic cells, resulting in 
pathogen clearance and the induction of an immune response against the pathogen. The 
antibody-antigen immune complexes are also recognised by the complement system, 
mediating opsonisation, phagocytosis or direct killing by lysing the pathogen [65, 66]. 
Especially IgM is a strong activator of the classical complement pathway by the binding of 
the constant region of IgM to complement factor C1q [64, 67]. Next to their role in innate 
and adaptive immunity, NAbs have some housekeeping functions as they contribute to the 
removal of oxidized lipids and apoptotic cells, and maintain intestinal homeostasis [68]. 
NAbs and survival
NAbs have a non-redundant role in the (humoral) innate immune system and are essential 
in the protection against viral and bacterial infections [66, 67, 69]. Mice suffering from 
an acute peritoneal infection had much higher mortality rates in the absence of NAbs; 
about 70% of the mice lacking secreted immunoglobulin type M (sIgM) died versus 
20% of the wild-type mice [69]. Without NAbs, the mice were insufficiently protected 
during the first phases of the bacterial infection. Furthermore, NAbs were shown to have 
a predictive value for the risk of dying in laying hens [70]. The NAb titers to KLH and 
LPS in 20-weeks old laying hens were indicative for their survival; chickens having low 
NAb titres against KLH were more prone to die early. Also in Soay sheep, there was a 
positive correlation between autoreactive antibodies (NAbs) and survival [71]. The female 
Soay sheep with high anti-nuclear antibody levels were shown to be able to survive 
better during harsh winters than the ewes with low anti-nuclear antibody levels.  
The effects of NAbs in mice, chicken, and sheep studies make it reasonable that NAbs have 
an important role in bovine immunity too. Indeed, this is strongly supported by the work of 
Ploegaert et al. [72]. She showed that the natural antibodies (type IgM and IgA) appear 
to have a considerable impact on the resistance to clinical mastitis in heifers with a good 
udder health history. Heifers with low NAb titres tend to have a higher risk to develop 
clinical mastitis than heifers with high NAb titres. In clinically healthy multiparous cows, 
the susceptibility for developing clinical mastitis significantly decreases by increasing 
IgG1 levels against KLH [72]. These findings indicate that NAbs might have a predictive 
value for the ability of a cow to resist certain infectious diseases. In addition, lactating 
cows with a negative energy balance were shown to have low NAb levels against KLH 
[38]. Based on these results, NAbs are a candidate biomarker for natural resistance in cows.
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Resilient Cattle (“Weerbaar Vee”)
Dutch dairy farming is changing and, after years of focussing on milk yield, the 
animal welfare becomes of increasing importance. Dairy cows in the Netherlands live 
about 3.5 lactations [1], which means an average age of 5.5 years. This is relatively 
young since cows are able to reach an age of about 20 years. The main reasons for 
involuntary culling are health problems such as mastitis, lameness and fertility as 
mentioned before. Another concern in dairy farming is the use of antibiotics, and 
thereby the associated risk of emerging antibiotics resistance. The government urges to 
reduce the use of antibiotics in the whole livestock industry and decided to restrict the 
use of certain antibiotics for human diseases only. To increase the age and welfare of 
the Dutch dairy cows, projects are initiated such as Resilient Cattle. This project aims 
to answer the question whether the resilience of cows can be measured, to what extend 
this is hereditary and whether this resilience can be positively influenced.  
The Resilient Cattle project is a cooperation between companies (GD and CRV), the 
University of Wageningen and initially 30 conventional dairy farmers spread over the 
Netherlands. Together they aim at increasing the health and age of dairy cows by decreasing 
the health problems. Different approaches were chosen to reach this goal. Previous 
research showed that Natural Antibodies (NAbs) are a suitable candidate biomarker 
for disease resistance in dairy cows. NAbs were represented as IgM antibodies binding 
to KLH. In the Resilient Cattle project, the potency of NAbs is further investigated on 
different levels. NAbs were determined in the bovine serum and milk samples and related 
to the development of periparturient diseases to establish the prognostic value of NAbs. 
In addition, to be able to use NAbs as a biomarker in practice, the relation between NAbs 
in blood and milk was determined since milk is much more feasible for routine screening. 
Also the heritability of NAb levels was calculated to test if selective breeding can influence 
NAbs. A field study was conducted on the 29 dairy farms involved in the project. Under 
supervision of a veterinarian, the health problems on each farm were investigated and 
approached with farm-specific management tools. The ultimate read-outs were a decrease 
in health problems, particularly in the periparturient period, and a change in NAb levels. In 
parallel, a lab-based approach was used to increase knowledge about the NAbs itself and 
their source, the B-1 cells. Additionally, a Proteomics approach was used to identify new 
potential biomarkers for disease resistance in milk.
Resilient Cattle biobank
During the Resilient Cattle project, a large biobank was created containing blood, serum 
and milk samples from the cows present on 29 of the 30 dairy farms involved. In 2011, 
2012 and 2014 blood and serum samples were collected from the dairy cows and some of 
the calves. Also milk samples were collected: one in 2011, four in 2012/2013 and every 
6-8 weeks in the period of December 2013 until March 2015. From each cow, 5 to 14 milk 
samples are stored in the Resilient Cattle biobank. Next to the biological samples, also milk 
production and registration data (MPR) are collected and thorough disease registration 
data were recorded. The MPR data are determined for each farm at a 6 to 8 week interval 
containing information about among others milk yield, somatic cell counts, percentage fat 
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and protein. The disease registration data concerns all diseases and treatments the cows 
received including the moment and duration of disease. Diseases were categorised in: 
mastitis, other udder-related problems (e.g. trauma), metritis (all uterus-related problems), 
retained placenta (retention of the embryonic tissues for more than 24 hours after calving), 
respiratory diseases, lameness (includes all leg and claw problems), metabolic diseases 
(diseases such as milk fever and ketosis, which occur due an imbalance in macrominerals 
and a negative energy balance) and “other” (all diseases that did not fit the previous 
categories). During the project a special interest into the so-called production diseases 
emerged, which occur in the periparturient or transition period (about 3 weeks before and 
after calving) [73]. These production diseases include: metritis, retained placenta and the 
metabolic diseases.
This thesis
This thesis concerns biomarkers and mechanisms of natural disease resistance in dairy 
cows. Natural antibodies were implied to have a protective role in the bovine immune 
system as they were shown to be negatively associated to the risk of clinical mastitis 
in dairy cows. However, it remains to be established whether higher NAb levels are 
associated with an increased disease resistance in dairy cows and can be used as a 
biomarker for health. In addition, the underlying mechanism i.e. the functional and 
regulatory role of NAbs in the bovine immune system and how they contribute to disease 
resistance is currently not known. Studying NAbs in the bovine immune system is not 
straight forward, since both natural and specific antibodies are present in the cow and 
they are hard to distinguish from each other (Figure 1). Knockout models, as used for 
NAb research in mice, are not available for cows. An alternative way to study NAbs is to 
determine antibody binding to a naïve antigen. A naïve antigen, such as keyhole limpet 
hemocyanin (KLH), is not encountered before and specific antibodies against KLH will 
be lacking in the cow. Antibodies binding to KLH should therefore, principally, be NAbs. 
Another approach is to study the cells that produce NAbs: the B-1 cells. In conjunction 
with NAbs, these B-1 cells may be a suitable biomarker. These cells also enable to study 
the regulation of NAb production as B-1 and (conventional) B-2 cells can be distinguished 
based on their phenotypes. Another advantage of B-1 cells is that B-1 cells can be used 
as a selection tool for calves at young age. Calves need to be selected at 2 to 3 weeks of 
age if they are suitable for rearing to become a dairy cow (replacement heifer) or to be 
sold as veal calf. Rearing of a calf costs about €1700, so it would be beneficial to be able 
to select a high-resistant dairy cow at young age. Measuring NAbs at this young age is 
not informative, since the serum antibodies mainly consist of maternal-derived antibodies 
and not NAbs produced by the calf. B-1 cells are most likely not transferred from cow to 
calf and might be a better reflection of the immune competence of the calf. The B-1 cells 
are well described in mice, but less studied in veterinary species. The B-1 cell phenotype 
described for veterinary species is mainly based on murine markers, which were shown to 
be not suitable. A better identification of bovine B-1 cells is therefore needed.   
Since the potency of NAbs and B-1 cells as biomarker for disease resistance remains 
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to be determined, also additional biomarkers for disease resistance are desired. Current 
biomarkers, such as SCC for mastitis, are disease-specific and can only be determined 
when the disease is already there. A predictive marker for disease resistance would be more 
valuable since it offers the opportunity to manage the cow at risk and thereby hopefully 
prevent disease. To monitor the disease resistance, a biomarker should be suitable for 
routine screening and therefore a milk protein marker is preferred. 
In short, the main aims in this thesis are:
• Determining the role of NAbs in the bovine immune system
• Identification of bovine B-1 cells and their relevance to NAb production
• Identification of alternative biomarkers for disease resistance in bovine milk using  
 Proteomics
These aims are addressed in the following chapters of this thesis. Chapter 2 encloses 
a review about the identification of B-1 cells in veterinary species. B-1 cells are well 
described in mice and humans. However, the phenotype of B-1 cells is shown to be 
variable between tissues in mice and the B-1 cell phenotype is still under debate in 
humans. In veterinary species, such as cows, B-1 cells are poorly described and their 
identification is based on markers, which were shown to be not suitable. The review 
gives an overview of the literature describing the B-1 cell phenotype, development and 
the existence of natural antibodies in veterinary species. Furthermore, this review is an 
introduction to the next chapter, since chapter 3 shows the identification of putative B-1 
cells in cows. B-1 cells in cows might be a more clear marker for disease resistance in 
dairy cows than NAbs. In addition, B-1 cells can be determined at young age and are 
therefore suitable as a screening tool for young calves. Putative B-1 cells are identified 
using flow cytometry based on known markers described for mice and humans as far as 
possible since tools like monoclonal antibodies for cows are limited. These putative B-1 
cells were quantified in blood of young calves before and after they received colostrum. 
Young animals have relatively more B-1 cells since B-2 cells enormously expand after 
birth while B-1 cell numbers are just maintained by self-renewal. The kinetics of B-1 cells 
during the first three weeks of life were correlated with the development of IgM antibodies 
binding to phosphatidylcholine (PtC), which is used as a marker for NAbs. In chapter 4 we 
investigated the role of NAbs in the bovine immune system i.e. their ability to recognise 
and kill bacteria. NAbs, were represented by IgM antibodies binding to KLH. Cows were 
selected from the Resilient Cattle biobank for having high and low NAbs in serum. Both 
groups were tested in ELISA for their IgM and IgG antibodies binding to common microbial 
structures (LPS, LTA and PGN) and intact, fixed bacteria (E. coli and S. typhimurium). 
The cows with high and low NAb levels were also compared for their ability to kill live 
E. coli and S. typhimurium bacteria via antibody-mediated complement killing in a newly 
developed serum bactericidal test. Additionally, the performance in the serum bactericidal 
test was related to the development of mastitis within one or five years after testing to 
  1
General Introduction
Page | 12
determine the prognostic value of the serum bactericidal test. Chapter 5 addresses the 
search for new biomarkers for natural disease resistance of dairy cows. The proteins 
in milk of cows with recurrent diseases (low-resistant cows) and cows without health 
problems (high-resistant cows) were compared using Proteomics. Potential biomarkers 
obtained by Proteomics were validated with ELISA in a larger group of high- and low-
resistant cows based on disease registration data. Moreover, the potential biomarker levels 
in milk were related to diseases the cows had suffered from and, finally, to culling in order 
to determine the association with specific diseases and to test the prognostic value. At the 
end of this thesis, limitations and future perspectives will be summarised and placed in the 
context of available literature in the general discussion (Chapter 6).
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Abstract
Text B-1 cells are well-established in mice in terms of their development, phenotype and 
functions. They have a unique role in the immune system and are responsible for the 
production of natural antibodies. The existence of B-1 cells in veterinary species is often 
discussed, but the true homologues of murine B-1 cells are not determined yet. Differences 
in surface marker expression and the lack of antibodies to detect cell markers in veterinary 
species challenges the identification of B-1 cells. However, similarities in foetal B-cell 
and antibody development between veterinary species and mice are consistent with 
the existence of both B-1 and the conventional B-2 cell populations. In this review, the 
existence of B-1 cells in veterinary species is discussed.
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B-cell subsets
Naïve B-cells from mice and humans can be divided in three major subsets: B-1, follicular 
and marginal zone (MZ) B-cells, based on their phenotype, localization and function [1, 
2]. Follicular B-cells, or B-2 cells, are the conventional B-cells originating from the foetal 
liver and are maintained through life in the bone marrow. Peripheral B-2 cells are mainly 
located in the spleen and lymph nodes. B-2 cells produce specific antibodies upon antigen 
exposure and show somatic hypermutation and class-switching. B-1 and MZ B-cells are 
more innate-like B-cells, which share a distinct common progenitor [3] and emerge from 
foetal progenitors in the liver. B-1 cells are mainly located in the peritoneal cavity and 
marginal zone cells are located in the spleen. B-1 B-cells are maintained through life by 
self-renewal, while MZ B cells are long-lived. B-1 and MZ B cells rapidly respond to 
T-cell independent antigens and are able to produce natural antibodies [4]. Marginal zone 
B-cells can also perform T-cell dependent immune responses [5]. As the focus of this paper 
is B-1 cells, the follicular (B-2 cells) and MZ B-cells will no longer be discussed.
B-1 cells
B-1 cells were first described in mice as Ly-1 (CD5) positive cells involved in autoimmunity 
[6]. Nowadays, murine and human B-1 cells are well described in terms of development, 
regulation and their role in immunity, however, the B-1 cell phenotype is still highly 
debated in humans [7-11]. B-1 cells were mainly found in the mouse pleural and peritoneal 
cavity, intestine and in small numbers in the spleen, lymph nodes and peripheral blood [12-
14]. B-1 cells are the main producers of natural antibodies: polyreactive antibodies which 
are produced without prior stimulation by foreign antigens. These antibodies are mostly 
germ-line encoded IgMs and have an important role in the first phases of an immune 
response as they are present before the specifically-induced B-2 derived antibodies [15, 
16]. Natural antibodies have a homeostatic role as they recognize self-antigens and 
mediate the clearance of apoptotic cells, but are therefore also related to auto-immunity 
[17, 18]. B-1 cells are able to phagocytose and kill bacteria and induce CD4+ T-cell 
responses [19]. Furthermore, B-1 cells are potent producers of Il-10 upon TLR stimulation 
implying a regulatory role [20]. B-1 cells are considered to be an important link between 
the innate and adaptive immune system. From an evolutionary perspective, B-1 cells share 
characteristics, like phagocytosis and antimicrobial activity, with the “primitive” B-cells 
found in fish [19]. Unlike mice and humans, B-1 cells are hardly described in cows or 
other veterinary species.
Identification B-1 cells based on marker expression
Initially, B-1 cells were identified in mice by the expression of CD5 and CD11b or IgMhigh 
and IgDlow, thereby discriminating the B1a (CD5+CD11b+) and B1b (CD5-CD11b+) B-cell 
subtypes [21]. B1a cells are the main producers of natural antibodies [11] and B1b cells 
are involved in the rapid induction of antibody responses to T-cell independent antigens 
that turned out to be long-lasting [22]. Several studies aimed to identify B-1 cells in non-
mouse species based on the expression of CD5 and CD11b as described for murine B-1 
cells [23-26]. The following species will be reviewed: sheep, pig and cow.   
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In sheep, two different IgM positive cell populations with diverse characteristics could 
be identified in blood using CD5 and CD11b [24]. The ovine CD5+/-CD11b+ B-cells were 
suggested to be B-1 cells as these cells under unstimulated conditions are larger in size, 
have a higher cell-cycle activity and a higher surface IgM expression than the CD5-CD11b- 
B-cells. On the other hand, and contrary to the situation in mice, the CD5+/-CD11b+ B cells 
were most abundant in blood and proliferated upon surface IgM stimulation, indicating a 
B-2 cell phenotype. Consequently, these CD5+/-CD11b+ B-cells were not considered true 
homologues of the murine B-1 cells. Another study proposed the ovine CD11b+/CD21- 
and CD11b-/CD21+ cells populations as being B-1 and B-2 cells, respectively [27]. The 
CD11b+/CD21- cells expressed high levels of IgM, like B-1 cells. On the other hand, the 
CD11b+/CD21-  cells were scarcely present in neonates and increased with age, which 
better reflect B-2 cells than B-1 cells.       
Porcine B-1 and B-2 cells were suggested to be discriminated by CD5+ and CD5- B-cells 
[25]. Though, this statement was rejected by the same group a decade later, because the 
CD5+ and CD5- B-cell populations did not differ in, among others, antibody isotypes and 
antibody repertoires, while B-1 derived antibodies are expected to be more germline-
like than B-2 derived antibodies [26].       
In cows, CD5+CD11b+ B-cells were shown to be present in blood and were suggested 
to resemble murine and human B-1 cells. During Trypanosoma congolense infections, 
increased levels of serum auto-antibodies were determined which were associated with 
a rise in CD5+CD11b+ cells [23, 28] and production of IgM against non-Trypanosoma 
antigens by CD5+ B-cells [29]. Though the expansion of the CD5+ B-cell population mainly 
occurred 7 to 10 days after the parasites were present in blood, which is more in favour of 
B-2 cells. Bovine leukaemia virus (BLV) induced B-cell lymphomas were also categorized 
in B-1 and B-2 cell-derived tumours based on the murine CD5 and CD11b expression [30-
32]. However, in contrast to what would be expected, one study reported higher surface IgM 
expression levels on the B-2 cell-derived lymphoma than on the B-1 cell-derived lymphoma 
[31]. Different B-cell populations can be distinguished in cows based on CD5 and CD11b, 
however, it is not if these are the true homologues of murine B-1 and B-2 cells.   
In mice and humans it was shown that the combination of CD5 and CD11b was actually 
too limited to identify B-1 cells. CD5, an activation marker and negative regulator of 
BCR signalling, is also expressed on activated and anergic B-2 cells and thereby not 
a unique marker for B-1 cells [7, 14, 33-35]. In line with this, in pigs and cows CD5 
expression is also upregulated on B-cells upon activation, indicating a B-2 cell phenotype 
[25, 36]. Moreover, CD5+ B-cells were absent in blood and the spleen of foetal calves 
[28] and represent only 1-2% of the splenic B-cell population in foetal lambs [37], while 
B-1 cells in mice were shown to originate primarily during foetal development [38]. In 
addition, neonatal calves have low percentages of CD5 positive B-cells, which more than 
doubled at 7 months of life [39]. Taken into account that the number of B-cells per mL 
blood increased about 7-fold [40], this indicates a large increase in CD5+ B-cells in cows 
after birth, indicative for B-2 cell expansion. In particular, the upregulation of CD5 on 
CD5- cells upon B-cell receptor crosslinking [36] makes CD5 as marker for B-1 cells 
in cows controversial [39, 41]. Likewise, in humans CD5 is not a very discriminative 
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marker as only 34±3% of the CD5 positive B-cells are B-1 cells [7].  
Taken together, CD5 is not a very specific marker for B-1 cells in mice or in other species. 
The same is true for CD11b. Only half of the murine peritoneal B-1 cells express CD11b 
[42] and CD11b expression on B-1 cells declines after they leave the peritoneal cavity 
[43], implying that CD11b is not a stable B-1 cell marker. In contrast to mice, sheep 
and cows have very variable and high percentages of CD11b positive B-cells in blood 
[23, 24]. Furthermore, the number of CD11b positive B-cells was shown to increase after 
birth since CD11b+ B-cells were rare in neonates [27], while B-1 cells should be present 
after birth already. The previous results implies that the markers CD5 and CD11b+ are 
therefore not reliable markers for identifying B-1 cells in different species.  
Alternative indicators for B-1 cells in mice are high IgM expression in combination with 
low IgD expression. In contrast, conventional B-2 cells express low levels of IgM and 
high levels of IgD. The existence of IgD was questioned for pigs, cows and sheep for 
a long time as the delta gene or surface IgD could not be detected [28, 44]. Since IgD 
appeared to be lacking, some studies suggest that the whole B-cell population of cows 
and rabbits consists of B-1 cells [28, 45]. A decade later, the delta genes were found and 
shown to be transcriptionally active in pigs, cows and sheep [46]. Recently, Xu et al. 
(2012) showed very low percentages of IgD positive B-cells (1.2% of the peripheral 
blood lymphocytes) by surface staining with an IgD-specific antibody. Although, IgD 
positive B-cells were enriched in the bovine spleen, about 93% of the splenic B-cells 
were IgD negative [47], implying an unrealistic high percentage of B-1 cells in cows. This 
questions the use of IgM and IgD to distinguish B-1 and B-2 cells in cows.  
In summary, the most useful markers to indicate B-1 cells in veterinary species, including 
cows, are still unknown. In summary, increasing evidence suggests that the commonly 
used B-1 marker CD5, alone or in combination with CD11b, is not unique nor suitable for 
B-1 cell identification, not even in mice and humans. Additional or alternative markers 
are described for mice and humans, but these are not applicable for veterinary species 
since the commercial antibody repertoire is limited. Although murine B-1 cells are well-
defined, B-1 cells were not observed in the peritoneal cavity of many in- and outbred 
mouse strains except in the commonly used laboratory strains [48], supporting why it 
is hard to identify the true homologs of murine B-1 cells in other species.   
B-cell development with notes on B-1 cells
Though the existence of B-1 cells in pigs is not established [49, 50], the foetal B-cell 
development during gestation (114 days) is well described and shows large similarities with 
mice (gestation 20 days). B-cell development in foetal mice was shown to occur in three 
different waves [38], where the first wave starts in the yolk sac and para aortic splanchopleural 
region at 9 days of gestation (dg) and consists of B-1 cell progenitors only [3]. These B-1 
cells originate from hemogenic epithelial cells [51]. The second wave of B-cell development 
originates from the foetal liver and mainly results in B-1 cells, while the production of B-2 
cells has just started [38]. The B-1 cell progenitors in the foetal liver were derived from 
resident hematopoietic stem cells and hemogenic epithelial cells, which were migrated from 
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the yolk sac and para aortic splanchopleural region, and develop in parallel to mature B-1 
cells [51]. Around birth, the third wave in B-cell development occurs from the bone marrow 
and gives rise to mainly B-2 cells. After birth, the number of B-2 cells strongly increases 
due to clonal expansion, while B-1 cells are maintained by self-renewal.   
Also in pigs, the first indications for B-cell lymphopoiesis were found in the yolk sac 
from day 20 of gestation [50]. The yolk sac involutes around day 24 to 27, which is 
accompanied by the emergence of B-cell development in the foetal liver around day 30. 
Later in gestation, the bone marrow develops, resulting in a strong increase in B-cell 
lymphopoiesis and the presence of B-cells in the periphery from day 40. From day 55, 
a CD5 positive B-cell population develops in the porcine thymus and is maintained 
after birth [50, 52]. These B-cells are able to perform class-switching and produce IgG 
and IgA positive cells without exogenous stimulation [52, 53]. However, this B-cell 
population is unlikely to represent B-1 cells since they could be reconstituted by cells 
from the foetal liver as well as adult bone marrow, while in mice peritoneal B-1 cells can 
only be reconstituted from the foetal liver [54]. Like mice, B-cell lymphogenesis in pigs 
is maintained in the bone marrow throughout life [55].    
Foetal B-cell development in cows (gestation 280 days) and sheep (gestation 150 days) 
appears to be comparable [56], although it is less studied than in mice and pigs. Unlike 
mice, gut associated lymphoid tissue (GALT) in the ileal Peyer`s patches is the main 
location for B-cell development in cows and sheep and therefore often indicated as a 
primary lymphoid organ in these species [56, 57]. Foetal B-cells development in cows was 
hypothesized to occur in two waves [58]. During the first wave, bovine B-cells originate 
from progenitors in the bone marrow. The second wave of B-cell development is localised 
in the GALT and is characterized by a large expansion of the pre-immune B-cell pool. 
However, immature B-cells were already observed in the foetal spleen and lymph nodes 
(60 - 85 dg) well before they were determined in the foetal bone marrow (190 – 238 dg) 
[58], suggesting an earlier wave of B-cell development derived from the spleen [59]. B-cell 
lymphopoiesis is maintained in the foetal bone marrow, but is declined in adult bone marrow 
as shown by decreased recombination-activating genes (RAG) activity [60].   
Comparable to cows, sheep IgM+ cells were first observed in the foetal spleen at 48 dg 
[61]. At 63 dg IgM+ cells were present in the foetal spleen and lymph nodes and were 
expanding until 98 dg [62]. The first IgM+ cells in the ileal Peyer`s patches were observed 
from 70 dg and significantly expand around 100 dg [61]. Splenectomy at 56 dg impaired 
B-cell development, although, it does not prevent total B-cell development [63], indicating 
that B-cells in sheep were not derived from the spleen only. Unlike mice, IgM+ B-cells 
were scarce (< 1%) in the liver of foetal lambs at different stages of gestation [37, 62]. 
Most likely, the first stages of B-cell development occur in the foetal spleen and other 
lymphoid tissues [64]. B-cell development is greatly reduced in foetal lambs by injecting 
anti-IgM at 63 dg [65] and resulted in strongly diminished B-cell numbers in the secondary 
lymphoid tissues and B-cell absence in the ileal Peyer`s patches. As B-cell development 
is seriously impaired with a single injection of anti-IgM, in contrast to repeated injections 
in mice, B-cell progenitors might originate in a small time-frame only or the ileal Peyer`s 
patches can be seeded in a small time-frame [64]. Immature B-cells migrate from the 
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spleen and seed the ileal Peyer`s patches where they proliferate and the pre-immune 
B-cell repertoire is formed [66]. In the foetal spleen and ileal Peyer`s patches, but not 
the foetal bone marrow, somatic hypermutation occurs in the absence of exogenous 
antigens and contributes to the diversity of the naive B cell repertoire [67].   
Foetal B-cell development in pigs shows similarity to that of mice. Both mice and porcine 
B-cells originate from the same locations and in the same order, which might be an indication 
for the existence of B-1 cells in pigs. However, B-cell development in the less-studied cows and 
sheep does not indicate two distinct B-1 and B-2 cell populations during foetal development. 
B-cell lymphopoiesis continues through life in mice, humans and pigs, but stops early in 
life in chickens, rabbits, sheep and cows [60, 68, 69]. This kinetics is consistent with B-1 
development in mice and is suggestive for the presence of bovine B-1 cells [60].  
Natural antibodies
As natural antibodies are produced without prior stimulation with foreign antigens, they 
are already present in newborns. Pre-suckled calves and piglets have low amounts of 
serum antibodies [53], consistent with the early presence of B-1 B-cells in utero. Both 
cows and pigs have epitheliochorial placentas, and as a consequence, no antibodies are 
transferred from mother to foetus during pregnancy [49]. The young animals are mainly 
dependent on antibodies derived from colostrum that are taken up during the first 24 to 
36 hours after birth to provide passive immunity [70]. The prenatal antibody repertoire 
produced in the foetal pig are derived from B-cells originating from different locations, 
like the yolk sac and foetal liver [50]. Antibodies derived from the yolk sac and foetal 
liver were shown to have 100% and >90% in-frame VDJ rearrangements, respectively, 
indicating germline-like antibodies as produced by B-1 cells [71]. However, the 
percentage in-frame rearrangements decreased to 71% after lymphopoiesis had started 
in the bone marrow, indicating the production of B-2 cell-derived antibodies. In line, 
antibody diversity due to N-additions was determined in different organs of foetal calves 
by the expression of terminal deoxynucleotidyl transferase (TdT) [72]. About 41±13% 
of the bone marrow-derived B-cells in foetal calves express TdT, while only less than 
0.05% of the B-cells express TdT in the foetal spleen, liver and ilial Peyer`s patches. 
This indicates the production of different antibody repertoires in different locations in 
the foetal calf, suggesting the presence of B-2 cells in the foetal bone marrow and B-1 
cells in the foetal liver and spleen, like mice and probably in pigs. Collectively, these data 
indicate that both B-1 and B-2 cell populations are present in the bovine system.  
B-1 cells: implications for cows
Bovine B-1 cells were initially identified by CD5 and CD11b expression. As 
discussed in this review, these markers might not be the most useful markers for B-1 
cell identification in cows since CD5 positive B-cells are scarce in the bovine foetus 
and CD5 expression is strongly increased after birth and upon B-cell stimulation both 
characteristic for B-2 cells. Some studies suggested that all bovine B-cells belong 
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to the B-1 population due to the very low IgD expression on bovine B-cells and the 
cessation of B-cell lymphopoiesis in adults. This hypothesis seems unlikely as this 
would imply that all antibodies in cows are natural antibodies and antigen-specific 
reactions or vaccination are not possible, which is not the case. Future studies are needed 
to elucidate the existence and precise phenotyping of bovine B-1 cells.      
In conclusion
The existence of B-1 cells in farm animals is often discussed, however, clear evidence 
is still lacking. Though the prenatal production of antibodies and the class-switching of 
a minority of B-cells without antigenic stimulation is in favour of the presence of B-1 
cells. Differences between species in terms of marker expression and B-cell development 
hampers the identification of distinct B-1 and B-2 cell populations in species of veterinary 
interest. 
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Abstract
B-1 cells are well-described in mice, but not in veterinary species such as cows. Currently, 
the bovine B-1 phenotype is still based on the cell surface markers CD5 and CD11b, which 
in mice and humans were shown to be not unique for B-1 cells. In this study, we identified 
B-1 cells in cows using a combination of the B-1 markers IgM++ and pSYK++ (a marker 
for constitutive intracellular signalling). Flow cytometric analysis showed a distinct cell 
population of IgM++pSYK++ cells, indicating B-1 cells. This cell population has, similar to 
murine B-1 cells, a higher expression of CD80 compared to B-2 cells which are indicated 
by IgM+pSYK-. In addition, the postnatal development of the IgM++pSYK++ cell correlates 
with the postnatal appearance of natural antibodies (NAbs) in serum, which are represented 
by IgM antibodies binding to phosphatidylcholine (PtC). Based on phenotypic markers 
(IgM and CD80) and functional markers (pSYK and production of NAbs), we identified 
B-1 cells in cows. 
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Introduction
B-1 cells were first identified in mice as Ly-1+ (or CD5+) cells which were involved 
in autoimmunity [1]. Nowadays, B-1 cells are well-characterised in mice and humans 
and were shown to be an important link between innate and adaptive immunity [2]. 
The main characteristic of B-1 cells is the production of so-called natural antibodies 
(NAbs): polyreactive antibodies, mostly IgM, which are produced without prior 
antigenic stimulation [3]. Natural antibodies are germ-line encoded antibodies that 
are often directed to conserved microbial components and that are therefore important 
in the initial phases of an immune response [4]. They also have a homeostatic role as 
they can recognize self-antigens, such as phosphatidylcholine (PtC), which represents 
a cryptic determinant on senescent red blood cells [5]. In addition, NAbs mediate 
the clearance of apoptotic cells [6]. Other functions of B-1 cells are the ability to 
phagocytose bacteria and process and present bacterial antigens in the context of MHC 
class II to induce CD4+ T-cell responses [7] and the production of IL-10 [8].   
As described for humans and mice, B-1 cells differ from conventional B-2 cells as 
B-1 cells spontaneously produce NAbs, while B-2 cells need antigenic stimulation and 
costimulation in order to produce specific antibodies. In addition, B-1 cells originate 
primarily before birth from the foetal liver and are maintained through life by self-renewal 
[9]. B-1 cell show constitutive intracellular signalling caused by active phosphorylation 
and dephosphorylation cycles of intracellular mediators such as spleen tyrosine kinase 
(SYK), and have increased CD80 (B7-1) and CD86 (B7-2) surface expression [10]. In 
contrast, B-2 cells originate from the (foetal) bone marrow and B-2 cell numbers strongly 
increase after birth due to clonal expansion after antigenic stimulation. Intracellular 
signalling in B-2 cells is only induced upon B-cell receptor stimulation and additionally, 
naïve B-2 cells have lower CD80 and CD86 surface expression levels than B-1 cells 
[10]. Furthermore, B-1 and B-2 cells also have distinct gene expression patterns of 
lineage specific transcription factors and regulators of B-cell function [11].  
B-1 cells are well-characterised in mice and different markers are described to identify 
B-1 cells in different tissues [12]. Murine B-1 cells are mainly located in the peritoneal 
cavity and to a lesser extent in the spleen and can be discriminated from other cells using 
the following markers: CD5+/-, CD11b+, IgMhigh, IgDlow, B220low, CD23- and CD43+ [13, 
14]. In humans, B-1 cells are identified in blood as: CD20+CD27+CD43+CD70- [15]. In 
less studied animals such as farm animals, B-1 cells are poorly described. Bovine B-1 
cells were identified in blood based on the murine B-1 cell markers CD5 and CD11b 
(Naessens, EJI (1992)). However, using CD5 and CD11b does not solely identify B-1 cells 
in mice and might therefore not the best markers to identify B-1 cells in other animals. 
CD5 is expressed on the B1a subtype of B-1 cells, but also present on anergic B-2 cells 
and upregulated on activated B-2 cells in mice [15-19]. In calves, CD5+ B-cells strongly 
increase after birth, which is more indicative for a B-2 cell expansion than a B-1 cell 
population maintained by self-renewal [20, 21]. CD11b is shown to be expressed on only 
half of the peritoneal B-1 cell population and CD11b expression is lost upon extravasation 
of the peritoneal cavity in mice [22, 23]. In contrast, bovine B-cells in blood express high 
and variable levels of CD11b [24, 25]. 
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In this paper, we aimed to identify bovine B-1 cells based on (available) markers described 
for murine and human B-1 cells using flow cytometry. In addition to the phenotypic 
characteristics, we tested the B-1 cells for functional features such as constitutive 
intracellular signalling. Furthermore, we determined the relation between the development 
of B-1 cells and IgM antibodies binding to phosphatidylcholine in young calves. Lastly, 
we compared the CD5+/-CD11b+ cell population with the B-1 cell population identified by 
our new B-1 cell markers in cows.
Materials and Methods  
Animals 
Blood and serum from four Holstein-Friesian calves were collected before (day 0) 
and after (day 4, 10 and 20) colostrum intake. These calves were housed at the dairy 
herd of Wageningen University and Research Centre (WUR) in Wageningen. Blood 
collection was approved by the Institutional Animal Care and Use Committee of 
Wageningen University and Research Centre (DEC2014005b). The adult dairy cows 
described in this paper were housed at the same facility (DEC2016001a).  
Additionally, serum samples were collected from 28 calves before colostrum intake (day 
0) and at 2, 6, 10, 18 and 26 weeks of age. These calves were housed at the Farm Animal 
Health department of the Faculty of Veterinary Medicine, Utrecht University, in Utrecht. 
Blood collection was approved by the Institutional Animal Care and Use Committee of 
Utrecht University (DEC0202080601).  
PBMC isolation  
Blood samples were collected in Vacutainer Sodium Heparin tubes (BD, Plymouth, UK). 
Peripheral blood mononuclear cells (PBMCs) were isolated from blood using Ficoll (GE 
Healthcare Bio Sciences, Uppsala, SE). In short, blood was diluted 1:1 in Phosphate-
Buffered Saline (PBS) (Lonza, Walkersville Inc, USA) and loaded on Ficoll (GE Healthcare 
Bio Sciences, Uppsala, SE). Tubes were centrifuged for 25 minutes at 450 G at room 
temperature (RT). PBMCs were isolated and washed with PBS. The Ficoll separation was 
less clear in the youngest calves, therefore red blood cell (RBC) lysis was performed on all 
samples using ammonium chloride lysing buffer (Per litre: 8.3g NH4Cl, 1g KHCO3, 0.04g 
Na2EDTA·H2O, 2.5g bovine serum albumin. All chemicals were obtained from Sigma, St. 
Louis, USA). 
Flow cytometry  
PBMCs were stained for extracellular markers using sheep anti-bovine IgM FITC, 
mouse anti-bovine CD80 PE (AbD Serotec, Raleigh, USA), mouse anti-human CD69 
APC-Cy7 (BD, New Jersey, USA) and mouse anti-human CD14 Brilliant Violet 421 
(eBioscience, San Diego, USA). Afterwards, dead PBMCs were gated out based on 
staining with Fixable Viability Dye eFluor 506 (Affymetrix eBiosciences, San Diego, 
USA) according to instructions provided. Constitutive intracellular signalling was assayed 
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by the accumulation of phosphorylated spleen tyrosine kinase (pSYK) after phosphatase 
inhibition with pervanadate. Adapted from [10, 26] as follows. PBMCs were incubated 
with 6.25µM pervanadate/H2O2 per 1x10
6 cells in RPMI without supplementation (Lonza, 
Walkersville Inc, USA) for 8 minutes at 37˚C. Spontaneous increase of pSYK was 
measured by incubating PBMCs in RPMI without supplementation or pervanadate for 
8 minutes at 37˚C. Afterwards, the PBMCs were kept on ice for one minute and then 
immediately fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich, Missouri, USA) 
for 10 minutes at 37˚C. PBMCs were permeabilised with FoxP3 / Transcription Factor 
Staining Buffer Set (Affymetrix eBioscience) for 30 minutes at RT. Intracellular pSYK 
was stained with mouse anti-human ZAP70 (PY319) / SYK (PY352) Alexa Fluor 647 or 
PE (BD Phosflow, New Jersey, USA) according to instructions provided.  
Table 1: Flow cytometry antibodies
Antibody Clone Dilution Company
IgM Polyclonal 1:1250 Serotec
CD14 M5E2 1:100 eBiosciences
CD69 FN50 1:20 BD
CD80 Il-A159 1:10 Serotec
pSYK 17A/P-ZAP70 1:10 BD
 
ELISA  
The number of B-1 cells (IgM++pSYK+) in cows was related to the binding of IgM to 
phosphatidylcholine (PtC), a NAb antigen. PtC (Sigma-Aldrich) was coated on flat-
bottom, high-binding ELISA plates (Greiner Bio-One, Frickenhausen, Germany) at 50µg/
ml in 100% ethanol and the ethanol was allowed to evaporate at RT. After evaporation 
was completed the plates were blocked with Casein Universal Diluent/Blocker (SDT, 
Baesweiler, Germany) for one hour at RT. Plates were washed three times with 0.05% 
Tween-20 (Thermo-Scientific, Waltham, USA) in PBS. Serum samples were 1:5 diluted 
in 1:3 Casein/PBS, incubated for one hour at RT and the plates were washed four times 
with 0.05% PBST. IgM antibodies binding PtC were detected using a mouse anti-
bovine IgM Horse Radish Peroxidase (HRP) conjugated antibody (Bethyl Laboratories, 
Inc. Montgomery, USA) 1:5,000 times diluted in 1:3 Casein/PBS and incubated for 
one hour at RT. Afterwards, the wells were washed five times with 0.05% PBST and 
incubated with 3,3’,5,5’-Tetramethylbenzidine (TMB) (SDT, Baesweiler, Germany) for 
20 minutes at RT in the dark. The reaction was stopped using 2% hydrogen chloride 
(HCl). Plates were measured with the Filtermax F5 Multimode ELISA plate reader 
(Molecular devices, Sunnyvale, USA) at 450nm and corrected at 620nm.  
Total IgM levels were determined using the Bovine IgM ELISA Quantitation Set following 
the manufacturers` instructions (Bethyl Laboratories). 
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Results  
B-1 cell surface IgM expression   
We tested several markers that were described for these human and murine B-1 cells 
on bovine PBMCs (Supplementary table 1). Unfortunately, several markers were not 
available for cows, consequently, it was hard to combine a complete set of markers, such 
as CD20+CD27+CD43+CD70- which was described for human B-1 cells. Instead we started 
from another marker described for B-1 cells in mice and humans: IgM++ [10, 15, 16]. 
Young individuals have relatively more B-1 cells as most B-1 cells originate before birth 
and the B-2 cell population is not fully expanded yet [9]. Comparing the IgM expression 
between young calves and adult cows showed a distinct IgM positive population in calves 
enriched for IgM++ cells (Figure 1a). In contrast, IgM expression on adult B-cells showed 
a more continuous IgM expression, with more IgM+ cells than young calves.   
 
IgM and pSYK markers for bovine B-1 cells  
The IgM++ population in calves might identify a population enriched for B-1 cells, but it is 
not a distinctive marker. Another important B-1 cell feature is the continuous intracellular 
signalling caused by the constitutively active phosphorylation and dephosphorylation of, 
among others, spleen tyrosine kinase (SYK) [10]. In non-activated B-2 cells this cycling 
is not active and pervanadate-induced inhibition will result in no or low accumulation 
of phosphorylated SYK (pSYK). However, activated B-2 cells will also show pSYK 
accumulation. Therefore activated B-2 cells were discriminated from B-1 cells using the 
activation marker CD69 [27, 28]. Additionally is stained for CD14 and a fixable viability 
dye to exclude monocytes and dead cells, respectively. Combining the markers IgM and 
pSYK resulted in a distinct population of IgM++ and pSYK++ cells of B-1 cells. B-2 cells 
are represented by IgM+ and pSYK- expression (Figure 1b). Intracellular staining for 
pSYK often results in a bimodal distribution of positive T-cells and highly positive B-cells.
Higher CD80 expression on IgM++pSYK++ cells  
To support that bovine B-1 and B-2 cells could be discriminated using IgM and pSYK, 
these cell populations were additionally tested for CD80 expression as B-1 cells have a 
higher gene and surface expression of CD80 than B-2 cells [10, 11]. Figure 1c shows the 
expression of CD80 on B-1 cells (IgM++pSYK++) and B-2 cells (IgM+pSYK-). The  bovine 
B-1 cells displayed a higher CD80 expression than B-2 cells.
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Figure 1: Combining IgM and pSYK results in a distinct cell population with increased CD80 expression
The expression of IgM was determined in calves and cows. A representative picture is shown figure 1a where 
calves have a separate IgM++ population, while adult cows show a more continuous IgM expression. Figure 
1b shows the gating strategy to identify bovine B-1 cells. Combing IgM with pSYK, which represents the 
continuous intracellular signalling in B-1 cells, results in a distinct IgM++pSYK++ cell population which are the 
B-1 cells. The B-2 cells are indicated by IgM+pSYK- cells. Gating strategy: PBMCs  Single cells  viable cells 
 CD14- cells  CD69- cells  IgM versus pSYK. Figure 1c shows a higher CD80 expression in the bovine 
B-1 cells (IgM++pSYK++) than the B-2 cells (IgM+pSYK-).
A
B
C
Calf
Cow
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IgM++pSYK++ cells associated with anti-PtC IgM antibodies
The further confirmation of this B-1 cell population is technically hampered by the 
inability to link the phenotypic characterisation to functional read-outs, like spontaneous 
IgM production, due to the chemical fixation of the cells required for the intracellular 
pSYK staining. Instead we determined natural antibody (NAb) levels in bovine sera and 
related these to the percentage of B-1 cells to validate our findings. Serum NAb levels 
were indicated by the levels of IgM binding to phosphatidylcholine (PtC), a well-known 
NAb antigen [5, 29]. Blood samples were collected from 4 calves before colostrum intake 
(day 0) and at 4, 10 and 20 days afterwards to determine the percentage of B-1 cells (of 
total PBMCs) and anti-PtC IgM levels. During the first 20 days of life, the percentage of 
B-1 cells increased gradually from on average 0.25% to 1.0% of total PBMCs (Figure 2a). 
The same kinetics was observed for the anti-PtC IgM levels with low anti-PtC IgM levels 
before colostrum intake and a gradual increase afterwards (Figure 2b). The percentage of 
B-1 cells and the levels of anti-PtC IgM showed a strong correlation (Pearson r = 0.768, p 
= 0.0008) (Figure 2c). 
A B
C D
Figure 2: B-1 cells and NAbs before and after colostrum intake
The percentage of B-1 cells (IgM++pSYK++) and NAbs (IgM binding phosphatidylcholine (PtC), OD 450nm – 
620nm) were measured in 4 calves before colostrum intake (day 0) and at 4, 10 and 20 days afterwards (Figure 2 
a and b). Both B-1 cells and NAbs increase after colostrum intake and stabilise afterwards. One calf is missing at 
time-point 4 days as the B-1 cell identification failed due to technical problems. Figure 2c shows the correlation 
between presence of B-1 cells and NAbs (Pearson r = 0.768, p = 0.0008). Figure 2d shows the total IgM levels 
in the calf serum samples in mg/ml. 
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Since most antibodies in young calves are maternally-derived, we also determined the 
total IgM levels (Figure 2d) and related their kinetics to that of B-1 cells and anti-PtC 
IgM levels. As expected, the total IgM levels showed a sharp increase after colostrum 
intake and subsequently decreased. This kinetics was different from the gradual increase 
as observed for B-1 cells and anti-PtC IgM levels.
Development PtC-binding IgM in calves  
The kinetics of B-1 cells, total IgM and PtC binding IgM levels were determined in four 
calves only in a period of three weeks. During this period, maternally derived antibodies 
are present in calf serum and represent the majority of all antibodies. Therefore, the IgM 
kinetics was also determined in a larger group of calves for a longer period. Total IgM 
levels and PtC-binding IgM levels were measured in a complete set of 15 calves sampled 
before colostrum intake (day 0) and at 2, 6 10, 18 and 26 weeks afterwards. Precolostral 
total IgM levels were low (76 µg/ml ± 160 µg/ml) and rose sharply after colostrum intake 
(0.98 mg/ml ± 0.42 mg/ml at 2 weeks of age) (Figure 3a). The total IgM levels tended to 
decrease from 2 to 6 weeks of age, increased again from 6 to 18 weeks and stabilised from 
18 weeks on to approximately 1.7 mg/ml. In contrast, PtC-binding IgM levels increased 
from birth until 6 weeks of age and then stabilised (Figure 3b). 
Figure 3: Total IgM levels and NAbs in serum before and after colostrum intake.
Figure 3 shows the total IgM levels (mg/ml) and NAbs (IgM anti PtC, OD 450nm – 620nm) in serum of 15 calves 
which were sampled before colostrum intake (day 0) and at 2, 6, 10, 18 and 26 weeks afterwards (Figure 3a + b). 
Results are represented as averages with bars indicating the standard deviations.
 
IgM++pSYK++ versus CD5+/-CD11b+ cells  
Bovine B-1 cells were previously indicated by CD5+/-CD11b+ and could be subdivided in 
CD5+CD11b+ B1a and CD5-CD11b+ B1b cells [24]. The overlap between our IgM++pSYK++ 
and the former CD5+/-CD11b+ B-1 cell populations was determined in 7 adult dairy cows. 
Within the IgM++pSYK++ cell population, 42% CD5+CD11b+ B1a and 24% CD5-CD11b+ 
B1b cells were observed (Figure 4a), which results in a proportion of approximately 2:1 B1a 
versus B1b cells. About 34% of the B-1 cells indicated by IgM++pSYK++ were not identified 
A B
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by CD5+/-CD11b+. The other way around, within the CD5+/-CD11b+ cell population only 
23% of the cells was also indicated by IgM++pSYK++ (Figure 4b).   
The total percentage of B-1 cells in bovine blood indicated by IgM++pSYK++ and CD5+/-
CD11b+ were 6% and 35% of the PBMCs, respectively. 
Figure 4: Comparison CD5+/-CD11b- versus IgM++pSYK++ cell populations
B-1 cells were formerly indicated using CD5 and CD11b and subdivided into B1a CD5+CD11b+ and B1b CD5-
CD11b+ cells. We identified B-1 cells using IgM++pSYK++. Figure 4a indicates the overlap between the B-1 cell 
populations as specified by IgM++pSYK++. Figure 4b shows the overlap between the B-1 cell populations as 
specified by CD5+/-CD11b+. (Pictures based on the average percentage of B-1 cells in 7 adult cows.)
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Discussion
In this paper, we aimed to identify bovine B-1 cells based on their phenotypic and 
functional characteristics. Combining the markers IgM and pSYK resulted in a distinct 
IgM++pSYK++ cell population, which was consistent with murine B-1 markers and 
appeared to be B-1 cells in cows. Like murine and human B-1 cells, these B-1 cells in 
cows have a higher CD80 surface expression than the B-2 cells (IgM+pSYK-). In addition, 
the development of B-1 cells in first three weeks of life was strongly correlated with the 
development of NAbs (anti-PtC IgM levels), but not to total IgM levels, since total IgM 
levels are mainly determined by maternal antibodies in these young calves. This difference 
in kinetics was maintained in calves up to an age of half a year. The NAbs increased 
until 6 weeks after birth and then stabilised. In contrast, the total IgM levels clearly 
showed the uptake and breakdown of maternally derived antibodies with subsequent 
endogenous IgM production, which increased up to 18 weeks of age. Comparing the B-1 
cell populations identified by the formerly described CD5+/-CD11b+ and our IgM++pSYK++ 
markers showed a low overlap between these B-1 cell populations.  
These B-1 cells in cows were identified starting from known markers described in 
mice and humans [13-15]. However, the required bovine-specific antibodies were 
only scarcely available and impeded the identification of bovine B-1 cells. Using 
a similar set of antibodies and antigens like in mice and humans was therefore not 
possible. Though, high expression of IgM and CD80 and the constitutive intracellular 
signalling reflected by pSYK were also described for murine and human B-1 cells 
[10, 15]. Murine B-1 cells are mainly located in the peritoneal cavity, in lesser extent 
in the spleen and intestine and nearly absent in the peripheral blood [16, 30, 31]. 
However, similar to the situation in humans, we identified B-1 cells in peripheral blood, 
indicating that the distribution of B-1 cells is different for different species [15].   
The human B-1 cells were debated, among others, due to their similarity with pre-
plasmablasts [32, 33]. In addition, our B-1 cells show tonic signalling and express high 
levels of IgM, like transitional B-cells in mice and humans [34]. Pre-plasmablasts and 
transitional B-cells are not described in the bovine system yet, so we cannot compare 
these cell populations to our B-1 cells. However, human and murine pre-plasmablasts and 
transitional B-cells express AA4.1 (CD93 or C1qR) [35] and this might therefore also be 
true for cows. Combining the IgM and pSYK staining with AA44.1 showed that this marker 
is lacking on our B-1 cells (data not shown). In humans, the development of transitional 
B-cells strictly depends on the signalling function of the B-cell receptor, a typical feature 
of B-2 cells. Furthermore, transitional B-cells do not produce PtC antibodies unless 
stimulated [5, 36], which is contradictive with the strong correlation observed in our study 
between IgM++pSYK++ cells and IgM antibodies binding to PtC. This makes it unlikely 
that IgM++pSYK++ cells represent pre-plasmablasts or transitional B-cells.  
The B-1 cells and NAbs were shown to increase and stabilise simultaneously during the 
first 20 days of life. The larger group of 15 calves showed an increase in NAbs up to 6 
weeks of age with a subsequent stabilisation. This prolonged rise in NAbs might be caused 
by individual differences between calves as indicated by the large standard deviations at 
2, 6 and 10 weeks of age. However, the NAb kinetics fit the observation that murine B-1 
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cell development continues during the first weeks after birth and is repressed by feedback 
inhibition at 4 to 8 weeks of age [37]. The total percentage of B-cells in calves strongly 
increased from birth up to 5 months of age and was mainly represented by B-2 cells [38]. 
In addition, the NAb kinetics did not correlate with the total IgM levels, which are mainly 
determined by maternally derived antibodies in combination with endogenous production 
by B-2 cells. Calves are born hypogammaglobulinaemic and mainly rely on colostrum-
derived antibodies for their immune defence and survival. These colostrum-derived 
antibodies are taken up in the first 24 to 36 hours of life [39] resulting in a peak IgM level 
at half a day of age. Total IgM levels subsequently decline with a half-life of 4 days and the 
lowest IgM levels occur around one month of age [40]. Meanwhile, the endogenous IgM 
production is initiated at approximately 8 to 16 days of age. Although, we did not monitor 
the IgM levels at such short intervals, we observed an overall similar kinetic of IgM levels. 
The overlap between the B-1 cell populations indicated by our IgM++pSYK++ and the 
former CD5+/-CD11b+ B-1 cell markers was low since 66% of the B-1 cells indicated by 
our IgM++pSYK++ were also indicated using the CD5+/-CD11b+ markers. The other way 
around, the overlap was 23% only. Most B-1 cells are IgM positive, but using IgM as a 
marker limits the identification of B-1 cells that are IgA or IgG positive [41] and could 
be a reason for the incomplete overlap between the B-1 populations. More importantly, 
using the CD5+/-CD11b+ markers revealed a much higher percentage of B-1 cells in 
bovine blood than using IgM++pSYK++ (35% versus 6%) and will therefore negatively 
influence the percentage of overlap as they have at least a 29% difference.  
The percentage of bovine B-1 cells identified by IgM++pSYK++ was similar to the 
percentage of human B-1 cells in blood [15], but much higher than in mice [16]. The 
proportion of CD5+ B1a versus CD5- B1b cells within the bovine IgM++pSYK++ population 
is comparable to the proportion B1a and B1b cells in mice, namely 2:1 [42].  
Taken together, our findings demonstrate a novel identification of bovine B-1 cell population 
based on the combined surface expression of IgM and CD80, constitutive intracellular 
signalling as reflected by pSYK and the observed age-related relation between B-1 cells 
and occurrence of NAbs represented by IgM anti PtC in calves.
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Supplementary table 1: Markers for B-1 cell identification using flow cytometry  
Marker Expression Suitable for cow Clone Supplier Notes
Mouse
CD5 + or - + CC17 Serotec Discriminates B1a and 
B1b cells
CD11b + + ICRF44 Serotec Tested
IgM High + PC Serotec Tested
IgD Low N/A - - Described by [43]
Not tested
CD23 - ? 9P25 - Cross-reactive ab [44]. 
Not tested
CD43 + - CO.44B8 Serotec Cross-reactive ab, but 
not discriminative
Human
CD20 + - PC Bioss Not working, N/A
CD27 + ? M-T271 
or PC
Bioss / BD Cross-reactive ab [44]
Not in our hands
CD43 + - CO.44B8 Serotec Cross-reactive ab, but 
not discriminative
CD70 - N/A - - Activation marker
Additionally described*
CD69 - + FN50 BD Activation marker
Cross-reactive ab 
pSYK + + 17A/P-
ZAP70
BD / eBioscience Cross-reactive ab
CD24 - - ML5 BD Marker transitional 
B-cells
Human ab not  
cross-reactive
CD93 - + PC Bioss Marker transitional 
B-cells
CD80 High + IL-A159 Serotec Tested
CD86 High ? IL-A190 Serotec Not tested
Il-10 + ? CC318 Serotec Not tested
* These are additional markers which have been described. We tested these markers on bovine PBMCs as 
indicated. More markers have been described in literature, but were not tested in this study as indicated. N/A = 
not available. PC = polyclonal antibody.
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Abstract
Natural antibodies (NAbs) are mostly IgM antibodies produced without antigenic 
stimulation and serve as a first line of defence of the immune system. As both natural 
and specific antibodies are present in animals, NAbs are studied by determining the IgM 
response to naïve antigens like keyhole limpet hemocyanin (KLH). In this study, we selected 
cows based on high and low anti-KLH IgM titers, reflecting high and low NAb titers, and 
determined if the anti-KLH IgM titers were indicative for the recognition of common 
microbial structures (lipopolysaccharide, lipoteichoic acid and peptidoglycan) and intact 
bacteria (Escherichia coli and Salmonella Typhimurium). Sera with high NAbs titers 
showed more IgM and IgG binding to common microbial structures and S. Typhimurium 
bacteria than sera with low NAbs titers. The same association was observed for IgM 
binding to E. coli, but not for IgG binding to E. coli. Antibody-mediated complement 
killing of E. coli and S. Typhimurium in a newly developed bactericidal test was equal 
between high and low NAb cows. However, relating the outcome of the bactericidal test 
to the development of mastitis within one and even four years after sampling showed a 
significant negative correlation implying cows that were less potent in bacterial killing 
had a higher chance on developing mastitis. In conclusion, sera with high NAbs titers had 
more antibodies binding to common microbial structures and intact bacteria. Furthermore, 
the bactericidal test might provide a useful prognostic tool for the development of mastitis.
Key words: Antibody-mediated complement killing, Natural antibodies, Dairy cattle
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Introduction
Natural antibodies (NAbs) are polyreactive antibodies that are produced without prior 
antigenic stimulation and mostly directed to auto-antigens and common microbial 
structures like Pathogen-Associated Molecular Patterns (PAMP) [1]. In mammals, 
NAbs are mostly IgM [2] and are produced by B1 B-cells [2, 3], performing a first line 
of defence against invading pathogens [4]. In contrast, specific antibodies (SpAbs) are 
produced by B2 B-cells in response to antigen exposure, and by consequence, are far 
more restricted in their epitope recognition compared to NAbs. Mouse studies showed that 
NAbs have a unique role in the immune system. NAbs can act in similar ways as SpAbs 
by initial recognition and opsonisation of pathogens, resulting in subsequent complement-
dependent killing or phagocytosis [5, 6]. Moreover, NAbs play a homeostatic role e.g. by 
clearing apoptotic cells and neo-epitopes [7, 8]. High serum NAb levels were associated 
with increased survival of laying hens [9] and sheep [10] and NAbs were essential in the 
survival of mice suffering from an induced acute peritonitis [11]. In cows, NAb levels in 
milk were suggested to be positively related with resistance to mastitis [12].   
Binding of bovine serum antibodies to PAMP makes it hard to discriminate the role of 
NAbs from that of SpAbs. In other species, NAbs binding the naïve antigen Keyhole 
Limpet Hemocyanin (KLH) were studied. Dairy cows unlikely will have SpAbs to KLH, 
since KLH is derived from the Californian Pacific coast sea mollusc Megathura crenulata 
[13], but dairy cow do have NAbs binding KLH in milk and serum [14, 15].   
The aim of the present study was threefold. First, it was studied whether NAbs in bovine 
serum, represented by anti-KLH IgM antibodies, were related with the levels of IgM 
and IgG serum antibodies binding lipopolysaccharide (LPS), lipoteichoic acid (LTA) 
and peptidoglycan (PGN) representing PAMP from Gram negative and Gram positive 
bacteria, and intact Escherichia coli (E. coli) and Salmonella enterica subspecies enterica 
serovar Typhimurium bacteria (S. Typhimurium). These bacteria were chosen, as E. coli is 
a major pathogen in bovine infectious diseases in the udder [16, 17] and S. Typhimurium 
is an opportunistic bacterium that emerges when a cows` health status is compromised. 
The level of antibodies binding to S. Typhimurium is chosen as an indicator for natural 
immune competence. Such antibody-based indicator of natural immune competence was 
previously described in chickens [18, 19]. Second, it was determined if high serum NAb 
titers resulted in higher microbial killing via antibody-mediated complement killing in a 
newly developed bactericidal test. Third, NAb titers and bactericidal activity of bovine 
serum were related with the future development of mastitis. 
Materials and methods  
Animal selection
Bovine serum samples were selected from the “Resilient Cattle” (Weerbaar Vee) 
biobank containing serum, blood and milk samples collected on 29 conventional, 
Dutch farms between 2011 and 2015. In total, 2032 and 3109 serum samples were 
collected during winter 2011 and spring 2012, respectively. Disease registration and 
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milk recording data were collected. The disease registration data cover the type and 
numbers of disease, the date when disease occurred and treatments per cow.   
Serum samples were tested for IgM and IgG antibodies binding to Keyhole Limpet 
Hemocyanin (KLH). Since the majority of NAbs are IgM antibodies [2], cows were 
selected on anti-KLH IgM titers and the following criteria: exclusion of cows with parity 
0, cows between 0 and 30 days in lactation and cows with elevated somatic cell counts 
(SCC) at the moment of sampling. Maximum SSC were <150,000 cells/mL for primiparous 
cows and <250,000 cells/mL for multiparous cows, respectively. Exclusion of cows by the 
aforementioned criteria resulted in 1494 and 2384 cows in winter 2011 and spring 2012, 
respectively (Fig. 1A and B). 
IgM and IgG antibodies binding KLH
IgM and IgG antibody titers to KLH were determined using an enzyme-linked 
immunosorbent assay (ELISA) as described [20]. IgM and IgG levels binding to KLH 
were expressed as titer where the titer represented the log2 value of the dilution closest to 
50% of Emax. Emax is the highest value of the standard curve [21].
IgM and IgG antibodies binding LPS, LTA and PGN
IgM and IgG antibodies in serum binding to LPS, LTA and PGN were determined by 
ELISA. High-binding 96-wells plates were coated overnight at 4˚C with 4 µg/mL LPS 
(from Escherichia coli O55:B5, Sigma-Aldrich Inc, Missouri, US), LTA or PGN (from 
Staphylococcus aureus, Sigma) in PBS. Plates were blocked using Casein (Casein Diluent, 
Stereospecific Detection Technologies, Baesweiler, Germany) for 1.5 hours (h) at room 
temperature (RT). Serum samples were diluted 10x, 25x and 1000x in 1:3 diluted Casein 
in PBS for PGN, LPS and LTA, respectively. Diluted sera were incubated for 1 h at RT. 
Plates were washed with PBS containing 0.05% Tween-20 and incubated with either 
sheep-anti-bovine IgM HRP or IgG HRP (Bethyl Laboratories Inc., Montgomery, US) 
1:5000 diluted in 1:3 Casein/PBS for 1 h at RT. After washing, plates were incubated with 
3,3’,5,5’-tetramethylbenzidine (TMB) (SDT, Germany) for 20 minutes at RT and stopped 
using 2% hydrogen chloride (HCl). OD-values were measured at 450 nm and blanc 
corrected using the Filtermax F5 plate reader (Molecular Devices, Sunnyvale, California).
IgM and IgG antibodies binding Escherichia coli and Salmonella Typhimurium
E. coli (JM109) and S. Typhimurium (SL3261) bacteria were grown overnight at 
37˚C in LB medium. The next day, bacteria were transferred to fresh LB medium and 
grown to log-phase (OD600nm = 0.6 - 0.8). Bacteria were washed three times in 0.1 
M Na2CO3/NaHCO3 buffer (pH 9.6).      
Medium-binding plates were coated with 2x108 bacteria/mL in 0.1 M Na2CO3/
NaHCO3 buffer (pH 9.6) and incubated overnight at 4˚C. Bacteria were fixed using 4% 
paraformaldehyde for 2 h at RT. Plates were blocked using Casein for 1 h at RT. Serum 
samples were diluted 100 times in 1:3 Casein/PBS and incubated for 1 h at RT. After 
washing with PBS containing 0.05% Tween-20, IgM and IgG antibodies binding to E. coli 
or S. Typhimurium were detected as previously described (See IgM and IgG antibodies 
binding to LPS, LTA and PGN).
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Bactericidal activity of bovine serum
Serum samples containing high or low NAb titers were selected and tested for antibody-
mediated complement killing. Bacterial killing was expressed as the minimal inhibitory 
dose (MID), the highest serum dilution that inhibited bacterial growth (Supplementary 
Fig. 1), and was measured in a newly developed bactericidal test based on [22]. Bacteria 
(E. coli JM109 or S. Typhimurium SL3261) were inoculated in LB medium and grown 
to log-phase. Serum samples were heat-inactivated (HI) for 30 minutes at 56˚C. The HI 
sera were diluted with PBS and titrated with two-step dilutions starting at 1:10 in 80 µL/
well in flat-bottom 96-wells culture plates (Greiner Bio-One, Frickenhausen, Germany). 
Next, 20 µL/well untreated foetal calf serum (FCS, Thermo Fischer Scientific, MA) was 
added as fixed source for complement with low levels of endogenous antibodies. Bacteria 
were diluted to 4x106 bacteria/mL in LB medium and 100 µL bacteria were added to the 
diluted sera. Plates were measured at 595 nm using the Filtermax F5 microplate reader 
before and after overnight incubation at 37˚C while shaking at 250 rpm.   
The majority of NAbs in mice were shown to be IgM antibodies and only a minor part 
was IgG [2]. To minimize the influence of specific IgG antibodies in the test, cows were 
selected with low IgG levels to E. coli or S. Typhimurium in combination with high or low 
IgM antibody levels against these bacteria. This selection resulted in 20 high and 20 low 
cows for E. coli and for S. Typhimurium, which were compared in the bactericidal test.
Statistical analysis
Differences in IgM and IgG levels between cows with high- and low anti-KLH IgM titers 
were determined using the Mann-Whitney U test since the samples were not normally  
distributed (GraphPad Prism 5). Normality was tested using the Shapiro-Wilk normality test. 
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Results
High or low serum IgM titers against the naïve antigen KLH were defined as high or low 
NAb titers. In order to increase the contrast, cows were selected that had consistently 
the 15-20% highest or lowest NAb titers in two serum samples taken in successive 
years (Fig. 1A (2011) and B (2012)). Cows that were clinically ill around the moment of 
sampling were also excluded. This selection resulted in 79 serum samples high and 77 
serum samples low in NAbs, as about 35% of the cows remained high or low NAb titers 
in two successive years. This selection was thus reflected in the serum anti-KLH IgM 
levels (Fig. 1C) and also in the total IgM antibody levels (Fig. 1D). The next experiments 
were performed with the serum samples obtained in the first winter of this study (2011) 
.
Figure 1: Frequency distribution and serum IgM anti KLH titers to determine high and low NAbs cows. 
(A) Frequency distribution of serum IgM anti KLH titers measured in 1494 cows obtained in Winter 2011. IgM 
anti KLH is a measure for natural antibodies (NAbs). The bars indicate the selection of cows with the 15% lowest 
and 15% highest NAb titers. (B) Frequency distribution of serum NAb titers measured in 2384 cows obtained 
in Spring 2012. The bars indicate the selection of cows with the 20% lowest and 20% highest NAb titers. Cows 
having the 15-20% highest and lowest NAb titers in both serum samples were selected, resulting in 79 high 
NAb and 77 low NAb cows. (C) Statistical analysis of the NAb titers in the high and low NAbs cows showed 
significant higher NAb titers in the high NAbs cows. (Mann-Whitney U test, p < 0.0001) (D) Total serum IgM 
levels (mg/mL) measured in cows high and low in NAb titers. Serum IgM levels (mg/mL) were significantly 
higher in the cows with high NAb titers. (Mann-Whitney U test, p < 0.0001) 
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Binding of serum antibodies to common microbial structures
Sera with high and low NAb titers were tested for IgM and IgG binding to LPS, LTA and 
PGN, respectively (Fig. 2). As NAbs are often directed to common microbial structures, it 
was hypothesised that cows with higher NAb titers showed more binding to PAMPs (Fig. 
2) and whole microbes (Fig. 3). Cows with high NAb titers had indeed higher IgM and IgG 
binding LPS, LTA and PGN than cows with low NAb titers (Fig. 2). Comparing the levels 
of IgM and IgG binding LPS of cows high and low in NAb titers showed significantly 
higher binding (p < 0.0001) in high NAb cows (Fig. 2A). This large difference (p < 0.0001) 
was also found for IgM and IgG binding LTA (Fig. 2B) and PGN (Fig. 2C). 
Figure 2: IgM and IgG response against LPS, LTA and PGN of cows high and low in NAbs
The IgM and IgG response against the PAMPs LPS (A), LTA (B) and PGN (C) were determined in bovine serum 
samples high and low in NAb titers, 79 and 77 samples respectively. IgM and IgG responses are represented 
as OD-values (OD450nm – OD620nm). The OD-values are blanc-corrected. The IgM and IgG responses against the 
different PAMPs differed significantly between cows with high and low NAb titers (Mann-Whitney U test, p < 
0.0001).
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Binding of serum antibodies to E. coli and S. Typhimurium 
Levels of IgM and IgG binding E. coli and S. Typhimurium bacteria were significantly 
higher (p < 0.0001) in bovine sera with high NAb titers compared to sera with low NAb 
titers except for the levels of IgG binding E. coli (Fig. 3A and B). The level of IgG binding 
E. coli was not significantly different between the cows with high or low NAb titers. This 
was reflected by the Spearman correlation for IgM and IgG antibodies binding to E. coli 
or S. Typhimurium, which was lower for E. coli, 0.430 and 0.685, respectively (Fig. 3C 
and D). 
Figure 3: IgM and IgG responses to E. coli and S. Typhimurium in bovine sera with high and low NAb titers.
Cows with high (n = 79) and low (n = 77) NAb titers were tested for their serum IgM and IgG responses to whole, 
fixed E.coli (A) and S. Typhimurium (B) bacteria in ELISA. One cow tested highly positive for S. Typhimurium 
and is removed from this selection, resulting in 78 high NAb cows and 77 low NAb cows in Fig. 3B and D. 
Reactivities are represented as OD-values (OD450nm-OD620nm) and were corrected for the background signal. High 
NAb cows had significantly higher IgM responses against E. coli and S. Typhimurium than low NAb cows. 
(Mann-Whitney U test, p < 0.0001) A similar relation was observed for the IgG response to S. Typhimurium 
(Mann-Whitney U test, p < 0.0001), but not for E. coli. Spearman correlations were determined for IgM and IgG 
binding to E. coli (0.430) and S. Typhimurium (0.6848) and were highly significant (p < 0.0001) (Fig. 3C and D). 
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Bactericidal activity of bovine serum
The MID for E. coli and S. Typhimurium was determined via bactericidal activity in sera 
from the selected cows. Cows with high NAb titers were expected to have a higher MID 
than cows with low NAb titers. The frequency of serum dilutions indicating the MID were 
shown in Fig. 4A and B. These dilutions varied from 0 to 160 for E. coli and 20 to 80 for 
S. Typhimurium, respectively. No statistical differences were found between high and low 
NAb cows and killing of E. coli or S. Typhimurium (Fig. 4C and D). Besides, no relation 
was found for IgG and killing in the bactericidal test (data not shown).
Figure 4: Minimal inhibitory dose for E. coli and S. Typhimurium in bovine sera with high and low NAb 
titers
The minimal inhibitory dose (MID) of different bovine sera is determined for 20 vs. 20 cows high vs. low in 
IgM against E. coli (A) or S. Typhimurium (B). The MID is determined as the highest serum dilution that still 
inhibits bacterial growth after 24 hours incubation and is represented as frequencies of cows with a specific 
MID. Open bars: cows high in IgM anti E. coli or S. Typhimurium, black bars: cows low in IgM anti E. coli 
or S. Typhimurium. Figure C and D show the average MID for cows high or low in IgM anti E. coli (C) or S. 
Typhimurium (D) with standard deviations.
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Prognostic role of bactericidal test activity in serum
Next, the bactericidal activity was related to the available disease registration data. 
Since E. coli and S. Typhimurium are important infectious agents in dairy cattle, we 
focussed on the occurrence of mastitis, independent of the NAb status of the cows. 
Cases of mastitis were recorded within a period of one (2012) and four (2015) years 
after sampling. It was hypothesised that cows developed mastitis were less able to kill 
bacteria i.e. had a lower MID.        
Cows that did develop mastitis within one year after sampling had a lower MID in the 
E. coli and S. Typhimurium bactericidal tests (Fig. 5A and B). For the S. Typhimurium 
bactericidal test this relation still remained for a period up to four years after sampling, 
indicative of a true prognostic value of the outcome in the bactericidal test (Fig. 5C and D). 
A similar trend was found when the NAb status was taken into account, a lower MID for 
cows that developed mastitis within one year (Supplementary data Fig. 2).
 
Figure 5: Predictive value bactericidal test for the development of mastitis
The performances in the E. coli and S. Typhimurium bactericidal test were represented by the MID and related 
to the development of mastitis one year after sampling (A and C) and on the long term i.e. after 4 years (B and 
D). The bar graphs represent the average MID with standard deviations for cows that did develop mastitis (open 
bars) and those that did not develop mastitis (black bars) independent of their NAb status. Cows that developed 
mastitis within one year had a significantly lower MID in the E. coli (A) and S. Typhimurium (B) bactericidal 
test, Mann-Whitney U test p = 0.0282 and p = 0.0115 respectively. On the long term, this relation still persists for 
the S. Typhimurium bactericidal test (p = 0.0267), but not for the E. coli bactericidal test. 
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Discussion
The present study showed that cows selected for high NAb titers in serum binding KLH, 
especially, represented by anti-KLH IgM antibodies, have a high binding capacity to 
PAMPs like LPS, LTA and PGN, respectively, as well as intact E. coli and S. Typhimurium 
bacteria. However, as determined in the bactericidal test, the higher binding capacity 
of cows with high NAb titers did not correspond with a higher antibody-mediated 
complement killing, which was shown to be equal between cows with high and low 
NAb titers. The MID determined in the E. coli and S. Typhimurium bactericidal tests 
was related mastitis incidence, independent of NAb-status. A lower MID was observed 
in cows that developed mastitis in one to even four years after sampling.   
Anti-KLH IgM and IgG titers were used as indicator for NAbs in poultry [9] and dairy 
cattle [14], and were proposed to be a tool to determine the innate disease resistance of 
dairy cattle [15]. In this study, positive relations were found between serum anti-KLH 
IgM titers and the levels of antibodies in serum binding various PAMPs. NAbs have been 
shown to bind to conserved microbial structures and auto-antigens [1, 21]. In accordance, 
cows with high NAb titers also showed higher levels of IgM and IgG binding to whole E. 
coli and S. Typhimurium bacteria. Levels of IgG in serum binding to E. coli bacteria were 
equal between cows having high or low NAb titers. With respect to the different levels of 
IgG binding either E. coli or S. Typhimurium, it was suggested that the differences in LPS 
expression on the E. coli and S. Typhimurium strains used in the present study may have 
diminished the chance of cross-reactive antibodies between these bacteria [23]. E. coli 
expressed rough LPS, while S. Typhimurium expressed smooth LPS, which may have elicited 
an antibody response to both the rough core and smooth O-antigen [24].    
NAbs were earlier shown to have an essential role in antibody-mediated complement 
killing [25, 26]. This killing is mainly performed by (pentameric) IgM antibodies 
because of higher avidity with complement than (monomeric) IgG [27]. Despite 
higher levels of IgM binding to E. coli and S. Typhimurium whole bacteria in cows 
with high NAb titers, there was no difference between these cows and cows with low 
NAb titers in bactericidal activity. This suggested that bacterial killing was not only 
the results of antibody-mediated (classical) complement killing, but also by activation 
of the alternative or mannan-binding lectin complement pathways [28, 29] or, more 
importantly, anti-microbial proteins and peptides in serum [30]. Since the endogenous 
complement system was replaced by FCS-derived complement, which likely has lower 
complement levels [31], the killing potential of NAbs might be underestimated. NAbs 
were shown to be involved in various components of the immune system such as antigen 
neutralisation, opsonisation and trapping in secondary lymphoid tissues and thereby 
cooperating with immune cells to elicit an immune response [5, 6, 32]. Thus, a direct 
beneficial role for enhanced NAb titers in cows remains to be elucidated.   
The bactericidal activity in sera showed relations with the occurrence of mastitis. Cows 
that developed mastitis within one or even four years after sampling, performed less in 
the bactericidal activity test i.e. they inhibited bacterial growth at lower serum dilutions. 
This suggested a prognostic value for the bactericidal test indicating those cows that are 
less powerful in combating microbes. Future studies should establish the actual prognostic 
value of this bactericidal test for the development of major diseases related to cow’s health. 
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Conclusion
Selected dairy cows with higher levels of IgM (natural) antibodies to KLH have higher 
levels of (natural) IgG antibodies to KLH, and higher levels of antibodies binding 
PAMP from Gram negative and Gram positive bacteria. In addition, also higher levels 
of antibodies binding to whole E. coli and S. Typhimurium bacteria were found in these 
cows. Bactericidal activity in serum to E. coli and S. Typhimurium were, however, not 
different in these cows suggesting that the NAb titers to KLH and antibodies to PAMPs 
measured were not involved in classical complement mediated killing. On the other 
hand, cows with a higher bactericidal activity in serum had a reduced chance to develop 
mastitis in the years after sampling. The developed bactericidal test could therefore be a 
promising tool to select dairy cows with increased resistance to mastitis.  
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Supplementary data figure 1: Overview bactericidal test 
Overview of bactericidal test. The different components, heat-inactivated serum, foetal calf serum and bacteria 
in LB-medium, are added in consecutive order. Serum samples are titrated in PBS to be able to determine the 
minimal inhibitory dose (MID). The MID is the highest serum dilution that still inhibits bacterial growth, here 
indicated by blue squares. 
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Supplementary data figure 2: MID and prognosis for disease development
Bactericidal tests with E. coli and S. Typhimurium were performed to determine the minimal inhibitory dose 
(MID) for bovine serum samples high and low in NAb titers. NAbs are defined as the IgM response to KLH. The 
average MIDs were related to the development of mastitis in the year after sampling. The bar graphs represent 
the average MID with standard deviations for cows high or low in NAb titers with and without mastitis (2A and 
B). Significant differences were found for cows high in NAb titers and the development of mastitis (p = 0.0237) 
in the E. coli bactericidal test. A similar trend was found S. Typhimurium. Significance was determined using 
the Mann-Whitney U test. 
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Abstract
The objective of this study was to identify and characterize potential biomarkers for disease 
resistance in bovine milk that can be used to indicate dairy cows at risk to develop future 
health problems. We selected high- and low-resistant cows i.e. cows that were less or 
more prone to develop diseases according to farmers` experience and notifications in the 
disease registration data. The protein composition of milk serum samples of these high- 
and low-resistant cows were compared using NanoLC-MS/MS. In total 78 proteins were 
identified and quantified of which 13 were significantly more abundant in low-resistant 
cows than high-resistant cows. Quantification of one of these proteins, lactoferrin (LF), by 
ELISA in a new and much larger set of full fat milk samples confirmed higher LF levels in 
low- versus high-resistant cows. These high- and low-resistant cows were selected based 
on comprehensive disease registration and milk recording data, and absence of disease 
for at least 4 weeks. Relating the experienced diseases to LF levels in milk showed that 
lameness was associated with higher LF levels in milk. Analysis of the prognostic value of 
LF showed that low-resistant cows with higher LF levels in milk had a higher risk of being 
culled within one year after testing than high-resistant cows. In conclusion, LF in milk 
are higher in low-resistant cows, are associated with lameness and may be a prognostic 
marker for risk of premature culling. 
Key words: dairy cattle, biomarker, lactoferrin, milk 
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Introduction
The objective of this study was to identify biomarkers for disease resistance in bovine milk, 
thereby providing a prognostic tool to indicate dairy cows at risk to develop future health 
problems. The last decades dairy farming in the Netherlands has changed enormously and 
the number of cows per farm increased with 40% during the last 10 years [1]. Clinical 
mastitis, one of the major health problems in dairy farming, has an incidence of about 33 
cases per 100 cows annually [2] with associated annual costs of approximately €61 to €97 
per cow based on worldwide estimations [3]. Also fertility problems and lameness are 
important issues in dairy farming [4, 5]. About 75% of the diseases in dairy cows occur in 
the first month after calving [6]. Around parturition, the immune system is compromised 
and the feed intake does not meet the energy requirements of the cow resulting in a negative 
energy balance (NEB), which makes the cow susceptible for diseases [6-8].  
To monitor the health status of cows, several studies were performed to obtain specific 
biomarkers. For example the energy balance, and thereby the risk of developing 
disease, can be measured by the levels of not-esterified fatty acids (NEFA) and beta-
hydroxybutyrate (BHBA) in blood [9]. Pre-partum NEFA serum levels were shown to 
be positively correlated with the risk of mastitis after parturition [10, 11]. High post-
partum NEFA levels are also a predictor for clinical ketosis, retained placenta, metritis 
and displaced abomasum [9]. Acute phase proteins (APP) in cows, like haptoglobin 
and serum amyloid, are common markers for infection and inflammation [12-14]. 
Haptoglobin and mammary-associated serum amyloid A (M-SAA3) were consistently 
increased in milk and subsequently in blood after a Staphylococcus aureus-induced 
subclinical mastitis [12, 15]. In milk, an increase in somatic cell counts (SCC) or lactate 
dehydrogenase (LDH) are markers for mastitis [16, 17] and are now routinely tested. 
Furthermore, ketosis can also be determined in milk by the rise in BHBA levels.  
The risk for development of important diseases in dairy cattle can thus be monitored by 
the levels of some of these markers, which are used for regular screening in dairy farming 
already. A regularly used marker like SCC is specifically related to detection of mastitis, 
but does not indicate other diseases. Therefore, we are aiming for prognostic markers 
in bovine milk that are related to diseases different than mastitis. Markers in milk are 
preferred since milk samples are already collected regularly for routine screening, in 
contrast to blood samples. Nowadays, hundreds of unique proteins can be identified in 
different fractions of bovine milk by mass spectrometry [18, 19]. This makes a proteomics 
approach a valuable tool for discovery of novel biomarkers [20, 21]. Here, we use shotgun 
proteomics (NanoLC-MS/MS) to compare milk samples of cows with a good health 
history (high-resistant cows) to milk samples of cows with a poorer health history (low-
resistant cows). To exclude the detection of acute disease related markers, all samples 
were taken from cows that had not experienced health problems in the preceding 4 weeks. 
With this approach, we aimed to identify novel candidate biomarkers in milk for disease 
incidence in dairy cows, which were then evaluated in a larger number of milk samples 
from high- and low-resistant cows, selected on basis of comprehensive disease registration 
data collected during this study. 
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Materials and methods  
Samples
Milk samples were obtained from the Resilient Cattle (“Weerbaar Vee”) biobank established 
in the Netherlands from 2010 until 2015. Cows from 29 conventional Dutch dairy farms 
were sampled multiple times during this period with the highest sampling frequency in 
2014. In 2014, all full fat milk samples tested in the general milk recording and monitoring 
program were also stored in Resilient Cattle biobank at -80˚C (5 to 14 samples per cow). 
From 2010 until 2015 comprehensive disease registration data of these cows were collected. 
The disease registration data were carefully documented as instructed and supervised by 
one veterinarian and contained information about the diseases, applied treatments and 
medications the cows received including data about the duration of disease and treatment, 
vaccinations and hoof trimming. Diseases were categorized by the same veterinarian 
into: mastitis, other udder problems, lameness, retained placenta, metritis (uterus-related 
problems), respiratory diseases, metabolic diseases (e.g. ketosis) and “other” (diseases 
different than the previous categories for example trauma due to accidents).   
First, milk serum samples used for proteomics analysis were selected based on the farmer`s 
opinion on perceived disease resistance of the cows in combination with disease registration 
data. Farmers were asked to identify their five highest and five lowest performing cows 
in terms of health problems, which are henceforward called high- and low-resistant cows. 
These cows were checked for health problems using the recorded disease registration 
data and milk recording data. Cows with somatic cell counts above 250,000 cells/ml were 
excluded to reduce the chance on including cows with an ongoing mammary infection 
[22]. In addition, cows were excluded with annotations in the disease registration data 
within one month before or after the moment of sampling. High-resistant cows had no or 
only minor health problems, while low-resistant cows had recurrent health problems. Four 
high-resistant and four low-resistant cows were selected for proteomics analysis. These 
two group of cows were matched for age, parity, milk production, somatic cell counts 
(SCC), fat percentage, protein percentage and days in milk (DIM). At the moment of milk 
sampling all cows in both groups were clinically healthy based on disease registration 
and milk recording data. The individual milk serum samples were compared to a pooled 
of milk serum sample derived from 26 cows. This randomly chosen “average group” is 
matched to both groups of low-resistant and high-resistant individual samples in terms of 
age, parity, milk production, SCC, fat percentage, protein percentage and DIM.  
The second and larger group of 43 high- and 36 low-resistant cows were selected based 
on the disease registration data obtained from the beginning of 2010 until summer 2014. 
Cows in the high- and low-resistant groups were matched for farm (n = 9), age, parity, milk 
production, SCC, fat percentage, protein percentage and DIM. Other inclusion criteria 
for the cows were: raised on the selected farms, born between 2008 and 2011, more than 
30 days in lactation, production above the average production per farm and somatic cell 
count at sampling below 250,000 cells/ml. High-resistant cows had no annotations in the 
comprehensive disease registration data except for vaccinations. Farmers were carefully 
instructed and coached by the same veterinarian in keeping the disease registration accurate 
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and up to date. Low-resistant cows had at least two annotations in the disease registration 
data (excepting regular vaccinations).
NanoLC-MS/MS
Milk serum samples were prepared by centrifugation at 1,500 g for 10 minutes at 10˚C. 
The supernatant was collected (without fat layer) and diluted 1:1 in 0.05 M ammonium 
bicarbonate buffer pH = 8.0 (ABC buffer, NH4HCO3 in water), then ultra-centrifuged at 
100,000 g for 90 minutes at 30˚C. The clear supernatant (milk serum) was collected and 
prepared for proteomics analysis as described by [23]. Milk serum samples were treated 
using the filter-aided sample preparation (FASP) method [24] to clean the samples and 
perform trypsin digestion. After trypsin digestion, the resulting peptides were labelled 
by dimethyl labelling [25]. The amine-group of each peptide reacts with formaldehyde 
(for light label) or deuterated formaldehyde (for heavy label) forming a so called Schiff 
base, which is subsequently reduced by cyanoborohydride resulting in a light or heavy 
label attached to each peptide [26]. The milk serum samples from high- and low-resistant 
cows were individually labelled with a light label and compared to a pool of milk serum 
from 26 cows containing a heavy label. Protein quantity is expressed as a log2 ratio of 
the individual milk serum samples to the pooled milk serum sample. All eight individual 
samples can be compared with each other due to this labelling approach.  
NanoLC-MS/MS analysis was performed as described by [27]. Full scan positive 
mode FTMS spectra were measured between m/z 380 and 1400 on a LTQ-Orbitrap 
XL (Thermo electron, San Jose, CA, USA) in the Orbitrap at high resolution (60000). 
CID fragmented MSMS scans of the four most abundant 2+ and 3+ charged peaks in 
the FTMS scan were recorded in data dependent mode in the linear trap (MSMS 
threshold = 5.000, 45s exclusion duration for the selected m/z +/- 25 ppm).   
LCMS runs with all MSMS spectra obtained were analysed with MaxQuant 1.3.0.5 
[28] using default settings for the Andromeda search engine [29] except that extra 
variable modifications were set for de-amidation of N and Q.    
A bovine database downloaded from Uniprot (http://www.uniprot.org) was used together 
with a contaminants database that contains sequences of common contaminants as for 
instance: BSA (P02769, bovine serum albumin precursor), Trypsin (P00760, bovine), 
Trypsin (P00761, porcine), Keratin K22E (P35908, human), Keratin K1C9 (P35527, 
human), Keratin K2C1 (P04264, human) and Keratin K1CI (P35527, human).   
In the MaxQuant analysis, only peptides and proteins with a false discovery rate (FDR) 
of less than 1% were accepted. Reversed hits were deleted from the MaxQuant protein 
groups result table. The protein groups result was filtered further to keep only proteins 
with at least 2 identified peptides of which at least one should be unique and at least one 
should be unmodified. 
Lactoferrin ELISA
The bovine lactoferrin ELISA was performed according to manufacturer instructions 
(Bovine Lactoferrin ELISA Quantitation Set, Bethyl Laboratories Inc., Montgomery 
USA). Milk samples were diluted 500, 1000 or 4000 times in Blocking Reagent (Roche 
Applied Science, Mannheim, Germany). All samples and standards were prepared and 
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measured in duplicate at 450nm using a Filtermax F5 Plate Reader (Molecular Devices, 
Sunnyvale, California). 
Statistical analysis
Groups of high- and low-resistant cows were matched for age, parity, milk production,  SCC, 
fat percentage, protein percentage and DIM. The association of disease status or condition 
with LF levels were analysed with PROC MIXED in SAS 9.3 (SAS Inst. Inc. Cary, NC). 
To approximate normality, the natural logarithm (ln) of LF levels were calculated and 
analysed. Preliminary analyses indicated that the fixed continuous effect of a 305 days milk 
production in kg, age of the cows in years, DIM, the interaction between age and DIM, and 
the random class effect of farms (farm 1 to 9) significantly affected LF levels. These effects 
were, therefore, maintained as correction factors within the models (base model). Inspection 
of the distribution of the residuals and the Q-Q plot indicated 2 possible outliers which 
were LF levels below the detection limit. These observations were, therefore, removed 
from the dataset, resulting in 43 high-resistant and 34 low-resistant cows.   
To assess whether disease status or condition status was associated with LF levels, disease 
and condition variables were categorized into a limited set of different classes as some 
categories only had 1 observation. For mastitis, lameness, metabolic diseases and retained 
placenta the data were converted to a binary trait consisting of either having a condition 
(1) or not having a condition (0). For metritis the data was categorized in three classes 
consisting of having metritis once (1), having metritis more than once (2) or not having 
metritis (0). The fixed class effect of disease status or condition status was then individually 
added to the base model in separate analyses. To assess whether significant differences 
exist between cows that are not ill and cows that are ill with or without a certain condition, 
cows were categorized for each individual condition as either not ill, ill with a condition, 
or ill without a condition. These categories were individually added to the base model in 
separate analyses. Results are displayed in vertical scatter plots as the original individual 
observation (uncorrected LF level in µg/ml) for each disease status and/or condition.
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Results  
Comparison of Milk Serum Samples of High- and Low-Resistant Cows by Proteomics
To characterize potential biomarkers for disease resistance in dairy cows, differences 
in milk serum proteins between 4 high- and 4 low-resistant cows were determined by 
NanoLC-MS/MS. In total, 78 proteins were identified and quantified in these samples 
(Supplementary Table 1). Each protein is represented in Fig. 1 as a log2 ratio of the protein 
abundance in high-resistant versus low-resistant cows. Log2 protein ratios between -1 and 
1 were considered as natural variation, which may be caused by, for example, differences 
in cow genetics and individual farms. The proteins outside these limits may indicate 
true variation between high- and low-resistant cows. The expression of 10 proteins was 
significantly (p < 0.05) different between the high- and low-resistant cows (open squares 
in Fig. 1). All 10 proteins were 2.3 to 6 times more abundant in milk serum of low-resistant 
than high-resistant cows (Table 1). To reduce the chance of missing potential biomarkers, 
while testing only a small number of cows, initially also proteins with 0.05 < p < 0.07 were 
included, which resulted in the inclusion of 3 additional proteins (open triangles in Fig. 1) 
and a total of 13 proteins. The cut-off at p < 0.07 was chosen to include potential biomarkers, 
but still outside the natural variation between cows (log2 protein ratios between -1 and 1). 
The proteins that were selected were detected in at least 3 out of 4 cows per group. 
 
Figure 1: Ratio of milk serum proteins of high- to low-resistant cows
The diamonds, triangles and squares indicate the proteins found in milk serum samples from 4 high- and 4 low-
resistant cows (n = 78). Proteins are represented as a log2 ratio of (ratio protein expression in high-resistant cows 
/ protein expression in pooled milk sample) divided by (ratio protein expression in low-resistant cows / protein 
expression in pooled milk sample). Log2 protein ratios between -1 and 1 are considered as natural variation. 
Open squares: proteins that differ between high-and low-resistant cows (p < 0.05). Open triangles: proteins that 
differ between high- and low-resistant cows (0.05 < p < 0.07). The abbreviations correspond to the proteins listed 
in Table 1.
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Selection Potential Biomarkers
The 13 proteins that differed between high- and low-resistant cows (p < 0.07) were judged 
for their potential as a biomarker for bovine health. Most proteins were membrane-
bound and were therefore less suitable as a biomarker since sample preparation and 
protein quantification with a high-throughput technique like ELISA is more difficult 
(Table 1). We therefore selected two soluble proteins for further investigation: gamma-
glutamyltranspeptidase 1 (gGT1) and lactoferrin (LF). Gamma-GT1 is an enzyme involved 
in the Meister glutamyl cycle and is responsible for the transfer of glutathione across the 
cell membrane to maintain homeostasis [30]. Furthermore, gGT1 levels in blood are related 
to liver performance and intoxication [31]. Gamma GT1 levels measured in urine can be 
an indicator for renal damage [32]. The association with disease and damage makes gGT1 
in milk an interesting candidate marker for disease resistance. Lactoferrin is a glycoprotein 
produced by glandular epithelial cells and neutrophils and is present in all body fluids. 
It is part of the innate immune system and has antimicrobial, antiviral, antifungal, anti-
inflammatory and anti-oxidative properties, among others by iron sequestering [33, 34] 
and can also act as an acute phase protein [35]. 
LF Levels in Milk of High- and Low-Resistant Cows, Selected on Disease Registration 
Data
New, full fat milk samples were selected from the “Resilient cattle” biobank to determine if 
LF and gGT1 were suitable markers for health-related problems in cows. Milk samples of 
43 high-resistant cows and 34 low-resistant cows were collected based on comprehensive 
disease registration data and milk recording data from January 2010 until July 2015. These 
cows did not have annotations the disease registration data in the month before and after 
sampling. LF and gGT1 levels were determined using commercially available ELISAs. 
The gGT1 levels in full fat milk samples were below the detection limit (data not shown) 
and were therefore not further investigated. Lactoferrin levels were detectable using 
ELISA and were expressed in µg per ml (Fig. 2). For statistical analysis, the LF levels 
were ln transformed and corrected for milk production, days in milk (DIM), age, farm 
and the interaction between DIM and age as these variables significantly influenced LF 
levels in milk. No association was found for LF levels and somatic cell counts (data not 
shown). The least squares means (corrected mean) for LF levels in full fat milk were 244 
µg/ml and 311 µg/ml for high- and low-resistant cows, respectively, and were significantly 
higher in low-resistant cows (p = 0.047) (Fig. 2). This is consistent with the previous 
results obtained by NanoLC-MS/MS for the 8 milk serum samples. This implies that being 
high- or low-resistant is significantly associated with LF levels in full fat milk, even after 
correction for milk production, DIM, age, farm and the interaction between DIM and age.
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Figure 2: LF levels in full fat milk samples of high- versus low-resistant cows
LF levels were measured in full fat milk samples from 43 high- and 34 low-resistant cows using ELISA. LF 
levels were expressed as the original LF concentration in µg/ml. The horizontal line indicates the mean. Statistics 
were performed on the ln transformed and corrected data. (Correction for farm, 305 days production, age, days in 
milk (DIM) and the interaction between age and DIM.) LF levels were significantly higher in low-resistant cows 
than high-resistant cows (p = 0.047).
Association of LF Levels in Milk and Specific Diseases
Next, we determined if the LF levels in full fat milk were associated with specific classes 
of diseases, independent of the resistance status of the cows. Cow performance was 
monitored by disease registration data and milk recording data. Diseases were categorised 
in: mastitis, other udder problems, lameness, retained placenta, metritis, respiratory 
diseases, metabolic diseases and “other” (diseases different than the previous categories 
or e.g. trauma). Cows with high disease resistance had none of the aforementioned health 
problems, while the low-resistant cows had at least two times an annotation in the disease 
registration data. Based on disease incidence, the association with LF levels in milk 
was determined for the following health-related problems in cows: mastitis, metabolic 
diseases, lameness, metritis and retained placenta (Supplementary Fig. 1).   
We did not observe a significant difference in LF levels in milk between cows that had 
mastitis, metabolic diseases, metritis or a retained placenta in the past and cows without 
these particular diseases (Supplementary Fig. 1a-d). Nevertheless, cows that had suffered 
from lameness (n = 14) were significantly different from cows without lameness (p = 
0.024) as cows with lameness had higher LF levels in their milk (Supplementary Fig. 1e).
Association of LF levels in Milk with Mastitis and Lameness in High- and Low-
Resistant Cows
Independent of being high- or low-resistant, LF levels were determined with respect to 
the different diseases. When the high- and low-resistance status was taken into account, 
the low-resistant cows that had suffered from mastitis showed similar LF levels in milk as 
the low-resistant cows without mastitis (Fig. 3a). Low-resistant cows with lameness had 
significantly higher LF levels in milk compared to high-resistant cows without lameness (p 
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= 0.014) (Fig. 3b). LF levels appeared to be higher in low-resistant cows that had suffered 
from lameness compared to low-resistant cows without lameness, although, this difference 
was not significant (p = 0.13) (Fig. 3b). 
Figure 3: LF levels in full fat milk related to mastitis and lameness
LF levels were determined in full fat milk samples and related to disease thereby comparing high-resistant cows, 
low-resistant cows which had suffered from a specific disease and low-resistant cows without that particular 
disease. Individual LF levels were expressed in µg/ml. Statistics were performed on the ln transformed and 
corrected data. 3A. High resistant cows, low-resistant cows which had suffered from mastitis and low-resistant 
cows which had suffered from other diseases than mastitis had similar LF levels in milk. 3B. Low-resistant cows 
which had suffered from lameness had significantly higher LF levels in milk compared to high-resistant cows 
(p = 0.014).
Prognostic Value Lactoferrin
The LF levels were measured in milk samples collected during the summer of 2014. One 
year later, summer 2015, we investigated which of the high-and low-resistant cows were 
culled or not as an indicator for cow performance. Figure 4 shows the LF levels in full fat 
milk of high- and low-resistant cows that were still alive and those that were culled within 
one year. The low-resistant cows that were culled within one year after sampling had on 
average higher LF levels (least squares means = 394.0 µg/ml) than high-resistant cows 
that were alive (265.2 µg/ml), high-resistant cows that were culled (166.1 µg/ml) and low-
resistant cows that were still alive (288.6 µg/ml). This difference was significant between 
high-resistant cows that were still on the farm and low-resistant cows that were culled 
within one year (p = 0.035) and between high- and low-resistant cows that were culled (p 
= 0.0017) (Fig. 4). A similar trend was observed for low-resistant cows that were still alive 
and those that were culled (p = 0.10). In addition, high-resistant cows that were culled 
had lower LF levels in milk compared to high-resistant cows that were still alive (p = 
0.041) and low-resistant cows that were still alive (p = 0.017). Taken together, these results 
indicate that low-resistant cows with higher LF levels had a higher chance of being culled.
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Figure 4: LF levels in full fat milk and culling
To determine the prognostic role of LF, LF levels in milk were related to culling. LF levels in milk were 
determined in high- and low-resistant cows that were culled or alive one year after sampling. Individual LF 
levels were expressed in µg/ml. Statistics were performed on the ln transformed and corrected data. LF levels 
were lower in high-resistant cows which were culled compared to high-resistant cows that were still alive (p = 
0.041) or low-resistant cows that were still alive (p = 0.017). Low-resistant cows that were culled had higher LF 
levels in milk than high-resistant cows which were still alive (p = 0.035) or culled (p = 0.0017).
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Discussion
In this study we identified LF as a putative marker for lameness with prognostic value 
for early culling. Potential biomarkers were characterised in milk to indicate cows that 
are at risk to develop disease using a proteomics-based approach. The initial comparison 
of milk serum samples from 4 high- versus 4 low- disease-resistant cows revealed 13 
proteins that were differentially expressed between both groups (ten p < 0.05 and three p 
< 0.07). These proteins were all more abundantly detected by proteomics in milk serum 
of low-resistant cows compared to high-resistant cows. Using ELISA we confirmed in a 
much larger set of full fat milk samples that the levels of one of these proteins, LF, were 
significantly increased in low-resistant cows. A positive association was observed between 
LF levels in milk and cows that had suffered from lameness. No significant associations 
were found for LF levels and metabolic disease, metritis, retained placenta or mastitis. The 
LF levels were also associated with culling and had a prognostic value for culling as low-
resistant cows that were culled within one year had higher LF levels in milk.  
The two potential biomarkers, gGT1 and LF, were selected from the proteins that were 
significantly different between high- and low-resistant cows, because these were soluble 
proteins which were related to disease in practice and literature. Elevated gGT1 levels 
in blood is an indicator for cholestasis and liver failure and is already used in practice. 
In literature, enhanced gGT1 activity in serum of Rathi cattle is a marker for stress and 
metabolic dysfunction [36]. Increased gGT1 levels in urine were related with renal 
injury [32]. Additionally, gGT1 levels were used as an indicator for colostrum uptake 
in young calves and lambs [37]. Unfortunately, the gGT1 levels in milk were below the 
detection limit of the available capture ELISA, therefore the relevance of gGT1 levels 
in milk for bovine health could not be determined in this study. LF levels were shown 
to be significantly higher in low-resistant cows. Lactoferrin has different functions [33-
35] and plays e.g. an important role in the induction of innate immunity by sequestering 
iron and thereby limiting the availability of free iron, which is essential for bacterial 
growth. Therefore, it might appear counterintuitive that a protective agent like LF 
is increased in low-resistant cows, since higher LF levels imply a better protection 
against disease. However, a similar situation is seen for SCC. A higher SCC is usually 
caused by an influx of neutrophils in the udder to fight a (starting) bacterial infection 
[38]. Similar to LF, the higher SCC level helps to control the infection, which is 
favourable for the cow. At the same time the higher SCC level is an indication of a recent 
or ongoing infection, which will occur more often in low-resistant cows.   
Lactoferrin levels were significantly associated with lameness i.e. cows that had suffered 
from lameness in the past had higher LF levels in milk. Other studies showed relations 
between lameness and elevated levels of the acute phase proteins serum amyloid A, 
haptoglobin and fibrinogen in serum [39, 40]. However, in our milk samples these proteins 
were not significantly different in high- and low-resistant cows or were not detected at all 
by NanoLC-MS/MS (Supplementary data 1), suggesting that LF was not produced due to 
an acute phase response. As we excluded cows with annotations in the months before and 
after sampling, this implies that LF could indicate lameness on a long term in contrast to 
e.g. serum amyloid A which indicates an ongoing infection. 
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Lactoferrin in milk is released by neutrophils and epithelial cells and its production is 
positively related with the influx of neutrophils and SCC [41]. Since SCC were on average 
equal between high- and low-resistant cows (data not shown), it is less likely that LF levels 
were increased due to neutrophil infiltration in the udder.  Lactoferrin and haptoglobin levels 
in milk were also associated with the energy status of cows [42]. Cows with higher serum 
NEFAs levels around parturition, an indicator for increased fat mobilisation and a negative 
energy balance (NEB), had significantly higher LF and haptoglobin levels in milk for several 
weeks afterwards. Moreover, cows with more metabolic stress after calving had more 
health disorders [43]ular, like lameness [44]. In line with this, the low-resistant cows in our 
study had higher LF levels in milk, suffered at least two times from periparturient diseases, 
and showed a significant association between LF levels and lameness. Unfortunately, data 
on the cows` energy status was lacking in our study and a significant association between 
LF levels in milk and periparturient diseases was not observed (data not shown).  
In contrast to other studies, no association was observed between LF levels in milk and SCC 
[45-47]. However, we selected for cows with SCC below 250.000 cells/ml and excluded cows 
with annotations in the disease registration data in the month before and after sampling, thereby 
excluding an association with mastitis. In addition, we found an increase in CD36, BTN1A1, 
IDH1 and kappa-casein in milk of low-resistant cows, while others showed these proteins 
to be decreased in milk from cows with ongoing mastitis [48, 49]. This supports the notion 
that the increased LF levels observed in this study were not caused by mastitis.    
Initially, we found an association between LF levels and disease-resistance in cows in 
retrospect, but a prognostic marker for disease-resistance would be more valuable. The 
prognostic value of LF was studied based on culling rates one year after our analysis. LF 
levels were significantly higher in low-resistant cows that were culled within one year 
compared to high-resistant cows. A similar trend was observed comparing low-resistant 
cows which were culled or still alive. This suggest that LF is an indicator for culling 
risk and might be a result of repeated health problems. High-resistant cows that were 
culled within one year surprisingly had significantly lower LF levels compared to the 
high-resistant cows that were still alive, suggesting that these cows were culled for other 
reasons than low-resistant cows. Although, it should be taken into account that the number 
of high-resistant that were culled were low (n = 6). Despite the variability in basal LF levels 
between cows [50] and the short half-life of LF in milk [51], we did show an association 
between LF levels in milk and lameness and culling. These results warrant larger studies 
to validate LF as a (prognostic) biomarker for the health status of dairy cattle and the risk 
of premature culling. 
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Conclusion
In conclusion, using a proteomics approach, we have established a potential biomarker 
for cows with health problems. Low-resistant cows have higher lactoferrin levels in milk 
even though these cows were clinically healthy at the moment of sampling. The LF levels 
were positively associated with lameness and may be a long term indicator for this disease. 
Moreover, cows with high LF levels were more likely to have been culled one year after 
sampling, indicating that LF has potential as a prognostic biomarker for premature culling. 
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Supplementary figure 1: LF levels in full fat milk and associations with disease
The relevance of individual diseases on LF levels in full fat milk was determined by comparing the LF levels in 
cows with a particular disease versus all other cows. (High- and low-resistance classification was not taken into 
account.) Individual LF levels in milk were expressed in µg/ml. The horizontal line indicates the mean. Statistics 
were performed on the ln transformed and corrected data. Diseases were classified into: A. mastitis, B. metabolic 
diseases (met. dis.), C. metritis, D. retained placenta (ret sec) and E. lameness. Cows which had suffered from 
mastitis, metabolic diseases, metritis or retained placenta were not significantly different from the other cows. 
However, cows which had suffered from lameness had significant higher LF levels in milk (p = 0.024). 
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Table
Table 1: Milk serum proteins that differ between high- and low-resistant cows
Protein Full name Uniprot ID Subcellular location
Fold 
change p-value
CD9 CD9 antigen P30932 M 6.0 0.037
GGT1 Uncharacterised protein; 
Gamma-glutamyl transpeptidase 1, gamma-
glutamyltransferase 1
G3N2D8 M, S 5.4 0.024
SLC34A2 Solute carrier family 34 (sodium-dependent 
phosphate transport protein 2B) member 2
F1N6D4 M 5.1 0.039
CSN3 Casein kappa P02668 E 4.6 0.011
BTN1A1 Butyrophilin subfamily 1 member A1 P18892 M 3.6 0.026
LTF Lactotransferrin P24627 E, S 3.3 0.069
GP2 Uncharacterised protein; Glycoprotein 2, 
zymogen granule membrane, pancreatic 
secretory granule membrane major 
glycoprotein
F1N726 E, S 3.1 0.063
PLIN2 / 
ADFP
Perilipin 2, adipophilin, adipose 
differentiation-related protein
F1N1N6 M 3.1 0.021
CD36 CD36 molecule, platelet glycoprotein IV, 
thrombospondin receptor
P26201 M 3.1 0.034
XDH Xanthine dehydrogenase/oxidase F1MUT3 C, E 3.0 0.006
IDH1 Isocitrate dehydrogenase 1 (NADP+) Q9XSG3 C 2.5 0.011
ACTB Actin, cytoplasmic 1 P60712 C 2.4 0.060
UBC Polyubiquitin P0CH28 C 2.3 0.037
C = cytosol, E = extra-cellular space, M = membrane, S = secreted
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Table 1: Proteins identified in milk serum samples from 4 high- and 4 low-resistant cows using 
NanoLC-MS/MS
Uniprot ID Protein name Gene name
P80195 Glycosylation-dependent cell adhesion molecule 1 GLYCAM1
Q3SZR3 Alpha-1-acid glycoprotein ORM-like
G5E5H7 Uncharacterized protein PAEP
E1BGW1 Mucin-15 MUC15
Q3ZCH5 Zinc-alpha-2-glycoprotein AZGP1 
F1N3Q7 Apolipoprotein A-IV APOA4
Q2KJF1 Alpha-1B-glycoprotein A1BG
O46375 Transthyretin TTR
Q0IIA2 Odorant-binding protein-like MGC151921
Q03247 Apolipoprotein E APOE
P02754 Beta-lactoglobulin LGB 
Q0IIH5 Nucleobindin 2 NUCB2
E1BH06 Uncharacterized protein LOC617696
P50448 Factor XIIa inhibitor N/A
F1MXP8 Proactivator polypeptide PSAP
P31096 Osteopontin SPP1
F1MSZ6 Antithrombin-III SERPINC1
Q3ZBZ1 45 kDa calcium-binding protein SDF4
F1MH40 Uncharacterized protein Bt.57604
Q32KV6 Nucleotide exchange factor SIL1 SIL1
P00711 Alpha-lactalbumin LALBA
Q3MHN2 Complement component C9 C9
P15497 Apolipoprotein A-I APOA1
P81187 Complement factor B CFB
G8JKW7 Uncharacterized protein SERPINA3
A8YXY3 15 kDa selenoprotein SEP15
P12763 Alpha-2-HS-glycoprotein AHSG
Q0P569 Nucleobindin-1 NUCB1
A6QR11 Protein kinase C-binding protein NELL2
F1MPE1 Uncharacterized protein CD109
P17690 Beta-2-glycoprotein 1 APOH
F1N5M2 Vitamin D-binding protein GC
P10790 Fatty acid-binding protein, heart FABP3
P08037 Beta-1,4-galactosyltransferase 1 B4GALT1
F1MBN5 Folate receptor alpha FOLR1
P02666 Beta-casein CSN2
Q9MZ06 Fibroblast growth factor-binding protein 1 FGFBP1
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P80025 Lactoperoxidase LPO
Q29443 Serotransferrin TF
Q2KIS7 Tetranectin CLEC3B
A6QNL0 Monocyte differentiation antigen CD14 CD14
P34955 Alpha-1-antiproteinase SERPINA1
E1BND5 Uncharacterized protein NCOA6 
P01044 Kininogen-1 KNG1
P12799 Fibrinogen gamma-B chain FGG
F1N045 Complement component C7 C7 
A1L528 RAB1A, member RAS oncogene family RAB1A
P17697 Clusterin CLU
F1MLW7 Uncharacterized protein IGLL1
P79345 Epididymal secretory protein E1 NPC2
A5PJE3 Fibrinogen alpha chain FGA
G3X7A5 Complement C3b alpha chain C3
P02662 Alpha-S1-casein CSN1S1
F1MAV0 Fibrinogen beta chain FGB
P81265 Polymeric immunoglobulin receptor PIGR
P11151 Lipoprotein lipase LPL
P02663 Alpha-S2-casein CSN1S2
F6R3I5 Uncharacterized protein CRISP3
P19120 Heat shock cognate 71 kDa protein HSPA8
P0CH28 Polyubiquitin-C UBC
P60712 Actin, cytoplasmic 1 ACTB
F1MXX6 Lactadherin MFGE8
Q9XSG3 Isocitrate dehydrogenase [NADP] cytoplasmic IDH1
G5E5V1 Uncharacterized protein N/A
Q05927 5-nucleotidase NT5E
P61823 Ribonuclease pancreatic RNASE1
F1MUT3 Xanthine dehydrogenase/oxidase XDH
P26201 Platelet glycoprotein 4 CD36
F1N1N6 Perilipin-2 PLIN2
F1N726 Uncharacterized protein GP2
P24627 Lactotransferrin LTF
Q2KJ93 Cell division control protein 42 homolog CDC42
P18892 Butyrophilin subfamily 1 member A1 BTN1A1
P02668 Kappa-casein CSN3
F1N6D4 Sodium-dependent phosphate transport protein 2B SLC34A2
G3N2D8 Uncharacterized protein GGT1
P30932 CD9 antigen CD9
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General discussion
The aim of this thesis was to study biomarkers and mechanisms of disease resistance in 
dairy cows. The milk production on dairy farms is strongly increased and is associated 
with an increase in health problems in dairy cows. As the use of antibiotics is restricted, it 
is important to improve disease resistance as an alternative to prevent cows from falling 
ill. In this thesis, we studied known and identified new (candidate) biomarkers for disease 
resistance. A true prognostic biomarker indicates cows at risk for disease and offers the 
opportunity to adapt the management of these cows at risk for disease and prevent them 
from developing disease. Such biomarkers can additionally be used as an early selection 
tool to rear calves with a better disease resistance that eventually become high disease 
resistant dairy cows. One such a candidate biomarker that is used in our research are 
Natural Antibodies (NAbs). In chapter 4, we studied the role of NAbs in the bovine 
immune system in terms of bacterial recognition and killing. These NAbs are produced 
by B-1 cells, a B-cell subset. Basic immunological aspects of these B-1 cells are reviewed 
in chapter 2. We identified these bovine B-1 cells and their functional capacity in chapter 
3. We also performed initial studies to the potential of these B-1 cells to be used as an 
alternative marker for disease resistance, which might be implemented at a young age. 
An alternative approach to identify new biomarkers for disease resistance in milk is based 
on proteomics and this is described in chapter 5. In chapter 6 (General Discussion), we 
elaborate on the potential biomarkers that were described in this thesis with a focus on 
NAbs as indicated by IgM antibodies binding to KLH. Furthermore, the IgM++pSYK++ 
B-1 cells are compared to the previously described CD5+/-CD11b+ cells and their role in the 
bovine immune system is discussed. Lastly, the difference between high and low disease 
resistance cows is investigated based on the differences in the milk proteome.
Biomarkers
In this thesis, we studied existing and newly selected biomarkers associated with disease 
in dairy cows. A biomarker is defined as a biological characteristic that can be objectively 
measured as an indicator of normal biologic processes, or a response to a therapeutic 
or husbandry and diet-based intervention. Biomarkers are used for diagnosis and staging 
of disease, and as indicators of disease prognosis. Most diseases in dairy cows occur in 
the periparturient period and are also called production diseases as they have a strong 
association with high milk production and energy balance of the cows [1]. Such potential 
biomarkers are studied in this thesis, including: 
• B-1 cells and serum NAb levels to indicate general disease resistance
• Serum bactericidal test as a prognostic test for presence of (sub)clinical mastitis 
• Lactoferrin levels in milk as indicator for lameness and risk of culling in the near future
These potential biomarkers are not yet recognised to be useful in daily management of dairy 
cows. A biomarker should display the following characteristics: specific, be measurable in 
an easy, consistent and robust manner, variable between cows and over time, and repeatable 
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within cows [2, 3]. Here I discuss to what extent the candidate biomarkers studied in this 
thesis meet the criteria of a biomarker for disease resistance.
Serum Natural Antibody levels as indicator for general disease resistance
Two types of antibodies derived from different subsets of B-cells exist: natural antibodies 
(NAbs) produced by B-1 cells, which is present in an organism without prior antigenic 
contact and is part of the first-line innate defence; and specific antibodies (SpAbs) produced 
by B-2 cells, which develops after antigenic challenge. NAbs have a significant function 
in maintaining tissue homeostasis, promoting phagocytic clearance of apoptotic cells and 
preventing infectious and autoimmune diseases, and in recognizing and removing cancer 
cells [4]. Natural Antibodies, represented by anti-KLH IgM antibodies, were suggested 
to be a candidate biomarker for disease resistance in dairy cows before [2]. The author 
showed that NAbs can be conveniently measured in serum and in milk using ELISA, 
underscoring that NAb levels are variable between cows and repeatable within cows 
[5]. Additionally, NAbs were suggested to be related with the risk of developing clinical 
mastitis in heifers with a good udder health history, whereby higher NAb levels in milk 
appear to be protective against the development of clinical mastitis [2]. However, when 
studying heifers this association was only a trend and not a significant correlation, and thus 
the association between NAbs and natural disease resistance still had to be established. The 
observed trend was, however, in line with studies in mice and chicken and underscored a 
protective role for NAbs [6, 7]. In a small dataset consisting of cows with high (n = 20) 
or low (n = 20) serum NAbs levels (Chapter 4), the measured KLH-binding NAb levels 
were associated with mastitis, lameness and periparturient diseases using PCA statistical 
analysis. In this group of cows, periparturient diseases covered metritis, placenta retention 
and metabolic diseases. From our results it is clear that having high or low serum NAbs 
was not associated with diseases the cows had suffered from in the past period. However, 
analysis on the whole “Resilient Cattle” biobank (by I. den Uijl) showed that NAb levels 
measured in one milk sample before calving was indicative for the risk of periparturient 
diseases after calving. In this case, higher NAb levels were associated with a higher risk 
of future health problems (data not published). In line with these results, milk NAb levels 
were positively correlated with plasma levels of non-esterified fatty acids (NEFA), which 
is an indicator for lipolysis and a negative energy balance (NEB) [8]. In contrast, plasma 
NAb levels were negatively correlated with plasma NEFA levels [9]. All together, these 
data show ambiguous relations between NAbs and several aspects of disease resistance 
and it cannot be concluded that NAbs are a true biomarker for disease resistance under all 
conditions. It appears that different factors, such as disease history, presence in plasma or 
milk, influence the relationship of NAb levels with disease resistance which impacts on 
their use as single marker in practical management of dairy cows.
B-1 cells as indicator for general disease resistance
Subsequently, B-1 cells, being responsible for NAb production, were studied as an 
alternative marker for disease resistance in cows. Also in cows it is not easy to clearly 
distinguish NAbs and SpAbs, but B-1 and B-2 cells have distinct phenotypes and could 
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therefore be related to different immune parameters. In addition, serum NAbs measured 
in young calves (< one month) mainly represent maternally-derived NAbs instead of 
endogenously produced NAbs. Therefore, measuring NAbs in young calves does not 
accurately indicate the immune competence of the calf itself. In contrast, B-1 cells are of 
endogenous origin since they are produced mainly before and around birth [10]. For these 
reasons, numbers and activity of B-1 cells might be a more reliable marker for immune 
competence than the presence of NAbs per se, which partly consist of maternal antibodies. 
We identified the B-1 cells in cows (chapter 3) and observed that the percentage of B-1 
cells is variable between cows (personal observations). In chapter 3 is shown that B-1 cells 
in calves appear to increase after colostrum intake (day 4) and stabilise afterwards (day 4 
to day 20). Though, the percentages B-1 cells slightly increase in older calves (personal 
observations). The stability of B-1 cell numbers in adult cows and their value as biomarker 
for disease resistance is not determined yet. However, B-1 cells can have an added value 
for selecting young calves as replacement heifers or for the veal industry. It is costly to 
rear calves to replacement heifers and therefore a suitable test at a young age, in this case 
< 2 weeks, would be economically beneficial. B-1 cells could be determined at a young 
age, though, it is too early to implement B-1 cells as biomarker for disease resistance as 
prospective cohort studies should first be performed. 
Serum bactericidal test as a prognostic test for presence of (sub)clinical mastitis 
Chapter 4 describes the serum bactericidal test for its prognostic value predicting the 
development of mastitis. This serum bactericidal test is based upon antibody-mediated 
complement killing. Cows that performed less in the serum bactericidal test, i.e. the serum 
could only stop bacterial growth at lower dilutions, were more likely to develop mastitis 
afterwards. This relation was significant for those cows that developed mastitis within 
one year after blood collection when using E. coli in the bactericidal test. When using 
S. Typhimurium, this relation was significant for even up to 4 years after sampling. As 
shown in chapter 4 differences between cows were observed and the test has a prognostic 
value for the development of mastitis. The relation between bacterial killing and mastitis 
was specific; no or ambiguous relations were found with lameness, production diseases 
or culling (data not shown). In addition, having high or low serum NAbs as such was not 
related to bacterial killing. Since we used the same batch of foetal calf serum (FCS) to 
replace the complement system in each individual serum sample, the relation between 
bacterial killing and development of mastitis appears to be based on microbial recognition 
by (total) serum antibodies. Antibody-mediated complement killing is most likely the 
mechanisms underlying this bacterial killing as heat-inactivated serum was unable to kill 
bacteria in the absence of complement. In addition, FCS was unable to kill bacteria by 
itself in the dilution (1:10) that was used in the bactericidal test. Interestingly, the antibody 
repertoire in serum and milk is not exactly the same due to selective receptor-mediated 
transport of antibodies from blood to the udder and local production of antibodies in 
the udder [11]. Still, the serum bactericidal test does show a predictive value for udder 
health. The application of this serum bactericidal test in routine screening, however, is 
still far away due to technical and practical limitations. These issues should be resolved 
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as the test is potentially of great value since it is prognostic for up to 4 years. The test 
needs further standardisation as a constant source of FCS is needed. Furthermore, the 
effect of age, stage of lactation and other cow-related factors are currently not known and 
for practical implementation of the serum bactericidal test also cut-off values need to be 
established. Specifically, it would also be interesting to determine the applicability of the 
serum bactericidal test in young calves in order to use this test as a selection tool. In short, 
the serum bactericidal test, despite its current limitations, remains a promising predictive 
test for the risk to develop mastitis.
Lactoferrin levels in milk as indicator for lameness and risk of culling
Subsequently, we identified lactoferrin (LF) as a candidate biomarker for lameness and 
involuntary culling using a contemporary proteomics approach with added bioinformatics 
analysis (Chapter 5). The comparison of milk samples from high and low disease resistant 
cows revealed 13 candidate biomarkers. These proteins were more abundant in low-
resistant cows than high-resistant cows. We confirmed in a new and larger group of 
high- and low disease resistant cows selected based on disease registration data and milk 
recording data that LF was more abundant in low-resistant cows. LF levels are variable 
between, but also within cows [11] among others due to a short half-life [12]. In addition, 
LF levels are dependent on the stage of lactation, milk production, age and SCC and are 
associated with mastitis [13-16]. We also observed an association between individual farm 
and LF levels, which might be caused by the different environments and infection status 
on farms. Correction for age, days in milk, production and farm showed that LF levels 
in milk were higher in cows that suffered from lameness. Despite the pleiotropic roles of 
LF, this association was not described in literature before. Since LF is not associated with 
lameness only, but also related to e.g. stage of lactation and mastitis, LF is less suitable 
as biomarker specific for lameness. More importantly, LF levels were higher in cows that 
had clinical manifestations of lameness, meaning that lameness was already detected. 
However, LF had a prognostic value for culling i.e. cows with higher LF levels in milk 
had a higher risk of being culled within the near future. Due to positive associations of LF 
levels in milk with disease in general and age, it is very likely that culling is associated 
with higher LF levels. However, culling of dairy cows is not a good read-out to monitor 
disease resistance [17] since culling is dependent on various factors such health status, 
production and management, and, in addition, has a strong economic incentive [18]. The 
increase of LF levels in milk is associated with mastitis and lameness. Therefore, LF may 
be a biomarker for health problems in dairy cows instead of disease resistance. LF levels 
in milk are relatively easy to measure using a commercially available ELISA test, but 
implementation of LF as biomarker for health problems requires regular monitoring of 
LF levels in milk with correction for factors such as milk production. Based on our data, 
a clear cut-off value for LF levels in milk could not yet be determined, but is required to 
use LF as a biomarker in milk.
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Innate and adaptive immunity: role of B-1 cells and Natural Antibodies in cows
According to the prevailing dogma, also cows have an innate and adaptive immune system 
with separate mediators and functions. The innate immune system consists of cells such 
as neutrophils and macrophages, the complement system, cytokines and anti-microbial 
components, including lactoferrin. Together they can act in a fast way and are able to 
clear most invading microbes [19]. When the innate immune system is unable to solve 
a microbial attack, the adaptive immune system is activated. The adaptive immune 
system mainly consists of SpAbs produced by activated B-2 cells and T-cells (T-helper, 
T-regulatory and cytotoxic T-cells) (Annex 1 and 2). They act in an antigen-specific manner 
and develop immunological memory. B-1 cells and NAbs have characteristics of both the 
innate and adaptive immune system. They could belong to the adaptive immune system 
like the conventional B-2 cells and SpAbs, however, B-1 cells and NAbs also have clear 
innate-like functions. B-1 cells produce NAbs without prior antigenic stimulation, these 
NAbs are directed to common microbial structures and auto-antigens [20]. Therefore, B-1 
cells and NAbs are often indicated as a link between innate and adaptive immunity [21-
23]. Interestingly, also γδ T-cells act at the borderline of the innate and adaptive immune 
systems and they can constitute up to 60% of the PBMCs in newborn calves [24]. In adult 
cows, γδ T-cells represent about 10 to 20% of the circulating lymphocytes, which is still 
high compared to human and murine γδ T-cells which represent 5 to 10% [25]. Both B-1 
cells and γδ T-cells are innate-like lymphocytes which develop during the first wave of 
immune cell development in the foetus according to the layered immune system theory 
[26]. B-1 cells are subdivided in B1a and B1b cells and γδ T-cells can be subdivided in 
WC1+ and WC1- cells. The more “innate-like” B1a cells and WC1+ γδ T-cells recognise 
a limited repertoire of antigens including self-antigens [22, 27]. B1b cells and WC1- γδ 
T-cells are more “adaptive” cells as they both have a broader repertoire, and in addition, 
B1b cells develop T-cell independent memory and WC1- γδ T-cells undergo clonal 
expansion [27, 28]. B-1 cells and γδ T-cells can both take up antigens and induce CD4+ 
T-cells responses [29-31]. Furthermore, a subset of γδ T-cells express and produce IL-10 
[32], similar to B-1 cells [33]. B-1 cells and γδ T-cells have similar characteristics, but 
also interact with each other e.g. NAb production by B-1 cells can be induced by non-
cognate help of γδ T-cells [34]. Furthermore, γδ T-cells regulate B-1 cell numbers by the 
production of IL-4 [35]. B-1 cells and γδ T-cells share some characteristics and interact 
with each other. Therefore it would be interesting to study the interplay between B-1 cells 
and γδ T-cells in cows.
Natural antibodies as studied by IgM antibodies binding to KLH
NAbs (and SpAbs) are studied in cows by determining antibody binding (preferably IgM) 
to naïve antigens (e.g. KLH), common microbial structures (e.g. LPS) and auto-antigens 
(e.g. PtC). However, during life cows encounter microbes that express e.g. LPS and also 
develop SpAbs to common microbial structures. KLH is a large protein derived from 
haemolymph of the sea mollusc Megathura crenulata, that lives off the Pacific coast [36]. 
In addition, KLH might share some antigens or show cross-reactivity with snails that cows 
encounter while grazing on the pasture. More importantly, KLH is a large and highly 
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glycosylated protein, which is cross-reactive with phosphorylcholine (PC; hydrophilic, 
polar head of PtC) and E. coli-derived LPS (O55:B5) [37]. As NAbs in cows were shown 
to increase with age [8, 38], it is questionable if binding to KLH reflects pure NAb levels 
or rather a combination of NAbs and SpAbs. NAbs (IgM anti-KLH) appear to have a 
protective role in heifers with a good udder health history, but this trend disappeared 
with the inclusion of heifers which suffered from udder health problems or by studying 
multiparous cows [2]. This suggests that IgM antibodies binding to KLH represent a 
combination of NAbs and SpAbs dependent on the antigens the cow encounters during 
life. NAbs can still play a protective role, however, over time they are progressively 
mixed up or even overwhelmed by SpAbs representing “reactive” antibodies as they are 
produced in response to an antigen. The “Resilient Cattle” dataset showed that cows with 
higher milk IgM levels binding to KLH before calving had more health problems after 
calving. This might indicate that cows with higher IgM anti-KLH levels where less able to 
clear pathogens or were more challenged by pathogens and had more IgM SpAbs that can 
also bind to KLH. Chapter 4 of this thesis describes that cows with high levels of serum 
IgM against KLH also show high IgM (and IgG) binding to LPS, LTA, PGN and whole 
bacteria. In addition, cows with high NAb levels also have higher total IgM levels than 
cows with low NAb levels. This supports that IgM binding to KLH might not indicate pure 
NAbs only, but appears to be an indicator for total IgM levels representing a mixture of 
NAbs and SpAbs. 
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Figure 1: Development of IgM anti KLH, PtC and total IgM levels during the first 6 months of life
Left: Serum IgM antibodies binding to KLH and PtC (expressed as OD-value at 450nm) and total IgM levels 
(mg/ml) were determined in 15 calves at 0 (before colostrum), 2, 6, 10, 18 and 26 weeks of age. The graphs show 
average values (black dot) with standard deviations (bars) at each time point. Right: The correlation between the 
average levels of IgM binding to KLH versus IgM binding to PtC at 0, 2, 6, 10, 18 and 26 weeks of age (Pearson 
r = 0.812, p = 0.049). The same for total IgM levels versus IgM binding to PtC (Pearson r = 0.711, p = 0.11) and 
IgM binding to KLH versus total IgM levels (Pearson r = 0.959, p = 0.0025).
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To test the hypothesis that IgM anti KLH is an indicator for total IgM levels, we studied 
the development of IgM against KLH, IgM against PtC and total IgM levels in 15 calves 
before colostrum intake until half a year of age (Figure 1, see also chapter 3). The IgM 
antibodies binding to PtC and total IgM levels are not significantly related (Pearson r = 
0.711, p = 0.11). IgM binding to KLH and IgM binding to PtC are related (Pearson r = 
0.812, p = 0.049), but the strongest correlation is observed between IgM binding to KLH 
and total IgM levels (Pearson r = 0.959, p = 0.0025). This strong correlation is mainly 
caused by the clear bimodal development of total IgM antibodies and IgM antibodies 
binding to KLH in calves representing the uptake and breakdown of maternally derived 
IgM and the endogenous IgM production. Probably, the difference with IgM binding to 
PtC would have been more extreme when the calves were sampled at half a day of age and 
at 4 weeks of age. These time points represent the peak levels of maternally-derived IgM 
and the drop in serum IgM levels between maternally-derived IgM and the initiation of 
endogenous IgM production [39, 40]. 
In summary, the cross-reactivity between KLH and common antigens such as LPS [37] 
and the strong correlation between IgM binding to KLH and total IgM levels imply that 
IgM against KLH better reflect total IgM levels than NAbs. The inability to distinguish 
NAbs and SpAbs binding to KLH hampers to determine the role of true NAbs in disease 
resistance.  
       
Comparison of B-1 cell populations indicated by CD5+\-CD11b+ and IgM++pSYK++
Chapter 2 reviews the literature on B-1 cells in veterinary species and one of the main 
conclusions is that CD5 and CD11b alone are not suitable markers to identify B-1 cells 
in cows. Therefore, other markers described for B-1 cells in other species were used to 
test for their capacity to identify B-1 cells in cows: IgM++pSYK++ (Chapter 3). In mice, a 
proportion of the B-1 cells is shown to express CD5 and/or CD11b, but additional markers 
are required for the exact identification of B-1 cells [41, 42]. B-1 cells in mice are enriched 
in the pleural and peritoneal cavity and represent about 35 - 70% of the CD19+ B-cells, 
while in blood B-1 cells represent only 0.3 - 0.5% of the CD19+ B-cells [43]. Within these 
B-1 cells, the presence between CD5 determines the difference between B1a and B1b 
cells. The ratio of B1a (CD5+CD11b+) and B1b (CD5-CD11b+) cells is approximately 2:1 
[44]. 
In an experiment using seven adult cows, the overlap between the previously used 
CD5+/-CD11b+ markers and our newly defined markers IgM++pSYK++ were assessed in 
blood (Figure 2). About 50% of the IgM++pSYK++ cell population turned out to be CD5+ 
indicating a proportion of B1a and B1b cells of 1:1 (Figure 2a). When using both CD5 
and CD11b, this reveals 42% CD5+CD11b+ B1a cells and 24% CD5-CD11b+ B1b cells, 
resulting in a proportion of approximately 2:1 B1a versus B1b cells (Figure 2b), which 
is similar to mice [44]. Furthermore, this indicates an incomplete (about 66%) overlap 
between the CD5+/-CD11b+ and IgM++pSYK++ B-1 cell populations. The other 34% of the 
B-1 cells identified by IgM++pSYK++ is CD11b-, which might be explained by the loss of 
CD11b by B-1 cells after leaving the peritoneal cavity as shown in mice [45], although this 
is, as yet, speculation. Comparing the CD5+/-CD11b+ and IgM++pSYK++ cell populations 
the other way around reveals that IgM++pSYK++ cells represent only 23% of the B-1 
cells indicated by CD5+/-CD11b+ (Figure 2c). This indicates that the overlap between the 
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previously used (murine) markers to identify bovine B-1 cells and our putative B-1 cells 
in cows is low. One important reason is that we observed much lower percentages of 
putative B-1 cells in blood when using our marker combination as compared to using 
the CD5+/-CD11b+ markers, i.e. 6% versus 35% of PBMCs [46], respectively. In humans 
adults, the CD20+CD27+CD43+ B-1 cell population represents 12.7% of the CD20+ B-cells 
and within this B-1 population the ratio B1a versus B1b cells is 3:1 [47]. In addition, the 
CD20+CD27+CD43+ B-1 cell population represents about 33% of the CD20+CD5+ cell 
population. This suggests a larger overlap using the human and murine markers (33%) 
as compared to our study between bovine and murine (23%) markers. However, CD11b+ 
was unfortunately not included in the comparison between human and murine markers. 
Our results show that identification of B-1 cells by IgM++pSYK++ results in a ratio B1a/
B1b cells comparable to mice, however, the percentage of total bovine B-1 cells is more 
comparable to those in humans.
                                  
                                            
Figure 2: Comparison CD5+/-CD11b- versus IgM++pSYK++ cell populations
B-1 cells were indicated before using CD5 and CD11b and subdivided into B1a CD5+CD11b+ and B1b CD5-
CD11b+ cells. We identified putative B-1 cells using IgM++pSYK++. Figure 2a shows the proportion of CD5+ 
and CD5- cells within the IgM++pSYK++ B-1 population. Figure 2b indicates the overlap between the B-1 cell 
populations as specified by IgM++pSYK++. Figure 2c shows the overlap between the B-1 cell populations as 
A
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specified by CD5+/-CD11b+. (Pictures based on the average percentage of B-1 cells in 7 adult cows.) 
High versus low disease resistant cows
Chapter 5 describes the identification of additional biomarkers for natural disease resis-
tance in cows. The initial division into high and low disease resistant cows was based on 
the opinion of the farmers, which inevitably is not purely objective. Additional features 
of cows, such as production and individual character, might have affected the farmers` 
decision. However, the farmer has daily contact with the cows and will have a total view 
of the herd. Due to inclusion of additional data obtained from disease registration and 
milk recording data, the farmers` bias was reduced in the final selection for high and low 
disease resistant cows. It is questionable if the cows are really “low” disease resistant 
since they are still in production and not already culled. In general, about 80% of the cows 
are culled for health-related reasons [48], emphasising the importance of health status in 
dairy cows. Probably, the comparison between high versus low disease resistant cows 
made in chapter 5 was better defined by high versus moderate disease resistant cows. 
Table 1
Cellular function Proteins involved
Lipid metabolism APOE, SERPING1, APOA4, NCOA6, APOH, APOA1, XDH, CLU, BTN1A1, 
PMP2, CDC42, IDH1, LF, PLIN2, LPL, CFB, FABP4, SERPINA1, FABP3, GC, 
TTR, C3, SPP1, AHSG, CD36, LALBA, SLC34A2, GGT1, AZGP1, HSPA8, 
KNG1, SERPINC1, CD9, B4GALT1, NUCB2, CD14, PSAP, NPC2
Molecular 
transport
APOE, APOA4, APOH, NCOA6, APOA1, XDH, CLU, FOLR2, PMP2, BTN1A1, 
CDC42, IDH1, LF, PLIN2, LPL, CFB, FABP4, FABP3, GC, TTR, C3, SPP1, 
RAB13, AHSG, RAB10, CD36, RAB8A, LALBA, SLC34A2, AZGP1, PIGR, 
FOLR1, HSPA8, KNG1, SERPINC1, ORM1, TF, B4GALT1, CSN2, CD14, NUCB2, 
PSAP, NPC2
Small molecule 
biochemistry
APOE, SERPING1, APOA4, NCOA6, APOH, APOA1, XDH, CLU, FOLR2, 
BTN1A1, PMP2, CDC42, IDH1, LF, PLIN2, LPL, CFB, FABP4, SERPINA1, 
FABP3, GC, TTR, SPP1, C3, LPO, AHSG, CD36, LALBA, SLC34A2, GGT1, 
AZGP1, FOLR1, HSPA8, KNG1, SERPINC1, TF, CD9, B4GALT1, NT5E, PSAP, 
NUCB2, CD14, NPC2
The top three functions of the milk proteins obtained by proteomics were determined using Ingenuity and listed 
in Table 1. The bold abbreviations indicate the proteins that were significantly different between the high and low 
disease resistant dairy cows as identified by proteomics.
To put the proteomics results in a broader perspective, the proteins obtained were analysed 
using the Ingenuity networking software. The milk proteins that are most differentially 
expressed between high and low resistant cows as detected by proteomics, were, based 
on this network analysis, functionally involved in lipid metabolism, molecular transport 
and small molecule biochemistry. This is not surprisingly based on the high metabolic 
activity in the udder [49]. The lipid metabolism is an important issue in dairy farming as 
it is associated with the (negative) energy balance of cows (Figure 3). Under homeostatic 
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conditions, the feed intake of dairy cows meets the energy requirements for the cows` 
maintenance and milk production. However, after calving cows develop a NEB due to 
decreased dry matter intake (DMI) and increased milk production [50]. This energy deficit 
is “solved” by lipid mobilisation from the peripheral tissues [51]. The NEB lasts about 8 
weeks implying a high demand on the bovine metabolism [52]. During the NEB, also the 
lipid metabolism in the udder changes [53, 54]. Milk fat is derived from the diet or body fat 
(mostly long-chain fatty acids ≥ 16 carbons) or locally synthesised by mammary epithelial 
cells (mostly short-chain fatty acids ≤ 16 carbons) [55]. Body fat accounts for less than 
10% of the fatty acids in milk fat, but can increase proportionally with a NEB. We did 
not measure the milk fat composition in high- and low-resistant cows, but found proteins 
involved in lipid metabolism which were significantly more abundant in low-resistant 
cows (p < 0.07). These proteins are xanthine dehydrogenase/oxidase (XDH), butyrophilin 
(BTN1A1), cell division control protein 42 homolog (CDC42), isocitrate dehydrogenase 
[NADP] cytoplasmic (IDH1), lactoferrin (LF), perilipin-2 or adipophilin (PLIN2 or 
ADFP), platelet glycoprotein 4 (CD36), sodium-dependent phosphate transport protein 
2B (SL34A2), gamma-glutamyltransferase 1 (GGT1) and CD9 antigen (CD9). (Table 1). 
CD36 is present on mammary epithelial cells and is involved in uptake and translocation 
of dietary and body fat-derived fatty acids to the udder [56]. Isocitrate dehydrogenase is 
a key enzyme in the de novo fatty acid synthesis in the bovine udder [57]. Butyrophilin, 
adipophilin and xanthine dehydrogenase/oxidase are involved in the formation of lipid 
droplets in milk [58, 59]. The increased abundance of CD36, IDH1, BTN1A1, XDH and 
ADFP in milk from low-resistant cows compared to high-resistant cows suggests increased 
(de novo) lipogenesis in low-resistant cows. This is consistent with increased lipid droplet 
formation by cells in response to oxidative stress [60, 61]. Oxidative stress and weight 
loss are enhanced in the periparturient period due to a higher metabolic rate and lipolysis 
[62]. Furthermore, weight loss by lipolysis increases the levels of plasma NEFAs, which 
repress immune functioning [63]. In vitro studies show that NEFAs increase the levels of 
CD36 mRNA in mammary epithelial cells and is also accompanied by an increase in lipid 
droplet formation [56]. A persistent NEB increases both NEFAs and BHBA, the last one 
is a substrate for de novo fatty acid synthesis [64]. The increase of proteins involved in de 
novo lipogenesis in low-resistant cows might therefore be caused by a failure to maintain 
their energy balance, which is accompanied by e.g. increased oxidative stress. Since the 
cows included in this study passed the transition period, their decreased disease resistance 
might be related to metabolism and oxidative stress levels of the cows [65], suggesting an 
inability to return to homeostasis during their lactation. 
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Figure 3: Energy balance of dairy cows
The energy balance of dairy cows depends on the energy intake by feed intake and energy usage for self-
maintenance and milk production. At peak lactation, the energy intake does not meet the energy usage leading 
to a NEB, which lasts for approximately the first 8 weeks of lactation. Later in lactation the energy balance 
stabilises since the cow needs extra energy for her growing calf during pregnancy.  
Also, the elevated levels of gGT1 and LF in low-resistant cows fit the theory of increased 
oxidative stress in these animals. On the one hand, gGT1 contributes to the antioxidant 
defence mechanism of cells by maintaining the intracellular glutathione levels, while on 
the other hand gGT1 has been shown to induce oxidative stress by the catabolism of 
glutathione [66, 67]. In Rathi cows, serum gGT1 levels were shown to be an indicator 
for (oxidative) stress and metabolic dysfunction e.g. caused by acidosis [68]. LF has anti-
oxidative properties by metal binding, e.g. iron, thereby preventing lipid oxidation [69]. 
gGT1 can be a cause or a result of oxidative stress, however, these data suggest that 
gGT1 and LF are produced in response to oxidative stress to prevent damage.  
The phosphate transporter SLC34A2, better known as NaPi-IIb, is suggested to be a 
mammary gland differentiation marker in cows [70]. In goats is shown that SLC34A2 is 
responsible for the phosphate reuptake into mammary epithelial cells and its expression 
is dependent on the phosphate requirements for ATP synthesis [71]. Interestingly, the 
SLC34A2 expression in the murine intestine is upregulated by metabolic acidosis in order 
to adjust to homeostasis [72]. Unfortunately, SLC34A2 expression was not determined in 
the mammary gland. In cows, metabolic acidosis is accompanied by oxidative stress [73]. 
So, increased SLC34A2 expression due to oxidative stress would fit the theory that low-
resistant cows have metabolic problems and increased oxidative stress levels.   
Based on the Proteomics results and available literature, the difference between the high- 
and low- disease resistant cows appears mostly to be related to the energy balance of the 
cows. The low-resistant cows appear to be unable to reach a stable homeostasis during 
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their lactation making the cows more vulnerable to develop disease. In cows, the energy 
balance, diet and immune system are strongly related [8, 74, 75] and a deficiency in one 
will have consequences for the other two. Naturally, additional factors such as genetics 
and management of the cows will play a role too.
Future recommendations
When studying bovine health and immune system, it is important to realise that dairy 
cows do not represent a “normal” physiological situation, but more that of a well-trained 
athlete [76]. The dairy cows` metabolism is primed at converting feed into milk and 
in early lactation milk production precedes at the expense of the cows` maintenance, 
which is reflected by a NEB [77] (Figure 3). Another important feature is the status of 
immunosuppression around calving [78], which is characterised by e.g. reduced migration 
and killing by neutrophils [79, 80] making the cows vulnerable to bacterial infections. 
Natural immunosuppression occurs due to hormonal changes, among others by an 
increase in glucocorticoids such as cortisol around calving [81]. In addition, cows have 
low serum glucose levels after parturition, which is the main fuel for immune cells [78]. 
After calving, the high energy requirements lead to more ROS production, lipolysis and 
NEB which exaggerate the immunosuppressive status of the cow [65, 78, 82]. So, even 
when a cow has a perfect immune system, she will have a harsh time around calving 
and therefore, not surprisingly, most diseases occur in the periparturient period. It is a 
challenging period for the cow and farmer and requires adequate management. Future 
research into bovine disease resistance and identification and use of biomarkers should 
therefore focus at this period, because there is still room for improvement and substantial 
(economic) gain. It is important to be able to determine the cows at risk before disease 
occurs, which indicates the need for prognostic biomarkers. Interestingly, some cows are 
more vulnerable to develop disease than other cows and investigation of the differences 
between those individual cows would be a good starting point, as we applied in chapter 5. 
We compared the protein presence and abundance in milk samples of only 4 high- and 4 
low-disease resistant cows, but a higher number of cows would be appreciated. During the 
“Resilient Cattle” project a biobank is established consisting of milk and serum samples 
and disease registration and milk recording data. From this biobank, the high- and low-
disease resistant cows could be selected as these cows “proved” their disease resistance 
during the last years. As milk composition can strongly differ due factors such as feed, 
stage of lactation and breed [83], a strict selection of cows is recommended.   
Our study has provided suitable markers for bovine B-1 cell identification thereby 
permitting basic immunological studies into the formation of NAbs, their regulation at 
perinatal age and their potential relation to resilience against infections and predictive 
value for the development of future diseases. Studying B-1 cells in cows is quite a 
challenge due to the lack of commercially available tools. The staining for IgM and 
internal pSYK using flow cytometry discriminates B-1 cells from other cells, but this 
protocol is not easy to implement in routine screening. Therefore the use of B-1 cells as 
a potential biomarker is not achievable at this moment and an easier screening methods 
for B-1 cells are recommended. The use of surface expressed markers to identify 
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bovine B-1 cells would improve the screening of B-1 cells and gives the opportunity to 
determine NAb production by individual B-1 cells. B-1 and B-2 cells could be FACS 
sorted using the current IgM and pSYK markers in order to perform transcriptomics and 
determine unique surface markers for both cell populations. In this way, B-1 cell numbers 
and activity (i.e. NAb production) could be monitored in the periparturient period to 
determine the relation between B-1 cells and disease resistance in dairy cows.  
Lactoferrin levels in milk as biomarker for disease resistance is still an interesting candidate 
due to its relation with mastitis, lameness and subsequent involuntary culling, but also by its 
applicability. We expect a similar relation of LF levels with infectious diseases as SSC has 
with mastitis. SSC are increased with mastitis and, although this is a normal physiological 
reaction to fight against invading microbes, high SSC are not preferred in practice. Also 
LF appears to increase as a physiological reaction to mastitis and (probably) infectious 
forms of lameness. Therefore, it would be worthwhile to implement the detection and 
quantification of LF levels in milk in an automated milking system to gain more knowledge 
on the (circadian) rhythm, basic levels and differences within and between cows in LF 
levels. In addition, by inclusion of disease registration data, the relationship between LF 
levels and the development of disease could be determined more precisely. Deviations in 
milk LF levels could be an early indicator for disease in individual cows.  
We focussed on biomarkers for disease resistance in dairy cows which are already in 
lactation. However, it would be ideal to be able to select high-resistant dairy cows at a 
young age since rearing a calf is costly and prediction of its health development would 
be of great value. Therefore, longitudinal prospective studies are warranted to determine 
biomarkers or factors in young calves that are related to high disease resistant cows. It 
is important to record health and performance of the individual animals with disease 
registration data and milk recording data, but also data on e.g. growth. In the context of 
this thesis, B-1 cell numbers or activity, as reflected by the production of NAbs, could be 
determined at a regular basis in a large group of calves from birth to adulthood. These data 
on B-1 cells and NAbs could then be related to disease resistance in dairy cows as reflected 
by the annotations in the disease registration data.
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In conclusion
 
Determining the role of NAbs in the bovine immune system
We determined that cows with high serum NAb levels, represented by IgM binding to 
KLH, also show a higher binding to common microbial structures (including PtC) and 
whole bacteria. This implies that cows with high NAbs are better in recognising invading 
microbes. However, this hypothesis could not be confirmed in the serum bactericidal test, 
which was based upon antibody-mediated complement killing. It is still possible that cows 
with high NAbs are better at fighting microbes via other routes. Additionally, we showed 
that the serum bactericidal test is a predictive test for the risk of mastitis.
Identification of bovine B-1 cells and their relevance to NAb production
B-1 cells in cows are identified using the markers IgM++pSYK++. This staining results in 
a distinct cell population in calves and cows. Young calves (< 3 weeks) have about 1% of 
B-1 cells (from PBMCs) in blood, while adult cows have about 6% B-1 cells. In young 
calves, the percentage of B-1 cells correlated with the levels of IgM antibodies binding 
to phosphatidylcholine. In contrast, IgM antibodies binding to KLH showed a different 
age-related kinetics.
Identification of alternative biomarkers for disease resistance in bovine milk using 
proteomics
Using Proteomics, several candidate biomarkers were identified in milk that were more 
abundant in low-resistant cows. We confirmed in an independent set of milk samples that 
LF is more abundant in low-disease resistant cows. In addition, LF levels were associated 
with lameness and were predictive for the risk of culling.
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The aim of this thesis was to define and test biomarkers for disease resistance in dairy cows 
and to determine the underlying mechanism in natural disease resistance. The health status 
of the cows is an important issue in dairy farming. Due to the mandatory reduction in the 
use of antibiotics, alternatives are required to prevent the development and expression of 
illness in dairy cows. The identification of biomarkers associated with such disease offers 
the opportunity to adapt the management of cows at risk, and in this way, prevent them 
from developing overt disease. Previously, natural antibodies (NAbs) in serum and milk 
were used as candidate biomarkers for natural disease resistance in cows. In this thesis, we 
continue on the occurrence and mode of action of NAbs and also focus on their source: the 
B-1 cells. We performed a literature study on the identification and function of B-1 cells 
in different species and defined the limitations in the current identification of these cells 
in pigs, sheep and cows (Chapter 2). B-1 cells were described in cows by using widely 
accepted cell surface markers CD5 and CD11b. However, in literature several findings 
suggest that these cell surface markers are not unique markers for B-1 identification. 
The similarities between mice and veterinary animals in foetal B-cell development and 
antibody production, implies that B-1 cells are present in cows. In chapter 3, we carefully 
studied new markers to selectively identify B-1 cells in cows. The combination of B-1 
cell markers IgM++ and pSYK++ (indicator constitutive intracellular signalling) identifies 
a distinct cell population with essential B-1 characteristics such as high CD80 expression. 
In addition, the development of these B-1 cells in calves before colostrum intake and 3 
weeks afterwards shows the same kinetics as the development of NAbs represented by 
IgM antibodies binding to the well-accepted NAb-antigen phosphatidylcholine (PtC). In 
calves up to half a year of age, it is shown that the production of such NAbs increases 
from birth and stabilises from 6 weeks onwards. This implies an endogenous NAb 
production, which follows the same age-related kinetics as can be expected from B-1 cell 
development. In contrast, the development of total IgM antibody levels in calves shows 
a bimodal distribution, which is caused by the uptake and breakdown of maternally-
derived IgM and simultaneous endogenous production of specific and natural IgM. 
Chapter 4 describes the role of such NAbs in bovine immunity. NAbs were represented 
by the binding of IgM to the naïve antigen keyhole limpet hemocyanin (KLH). Cows 
with high serum NAb levels were shown to have more IgM and IgG antibodies binding to 
common microbial structures LPS, LTA and PGN, than cows with low serum NAb levels. 
In addition, they also have more IgM antibodies binding to intact, fixed E. coli and S. 
Typhimurium bacteria. However, the killing of live E. coli and S. Typhimurium bacteria 
via antibody-mediated complement killing does not differ between cows with high and 
low NAb levels. The antibody-mediated complement killing was determined in a newly 
developed serum bactericidal test. Cows that performed less in the bactericidal test were 
more likely to develop mastitis in the future. This association was observed for the killing 
of E. coli and S. Typhimurium and the development of mastitis within the next one year. 
For S. Typhimurium the association was still present for the cases of mastitis occurring 
within four years after testing. Alternative biomarkers for disease resistance in cows were 
defined in chapter 5 by using a contemporary proteomics approach. Milk samples from 
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high and low disease resistant cows were selected from the “Resilient Cattle” (Weerbaar 
Vee) biobank. Comparing the spectrum of milk proteins of high and low disease-resistant 
cows showed potential candidate biomarkers that were elevated in the milk of low-resistant 
cows. Two candidate marker proteins were validated with ELISA in a new and larger 
group of high- and low-resistant cows. Lactoferrin (LF) levels were significantly increased 
in milk of low-resistant cows. In addition, LF levels in milk were associated with clinical 
manifestations of lameness and had a predictive value for subsequent culling.   
In conclusion, we found that also in cows NAbs are produced by B-1 cells that can be 
identified based on the combined expression of cell surface IgM and internal pSYK. In 
addition, the frequency of these B-1 cells after birth follows a similar kinetics as described 
before in mice. These NAbs can be more precisely identified based on their PtC binding 
ability and their functional activity in a bactericidal test. However, the true predictive 
value of B-1 cells and NAbs for the health status and immunocompetence of dairy cattle 
remains to be established. Proteomics turned out to be a useful approach for identifying 
potential new biomarkers for health and disease in milk of cows. Application and further 
development of their predictive capacity is dependent on the availability of robust, sensitive 
and quantitative assays. This project was part of the “Resilient Cattle” project providing 
biological samples and essential data on the health status during respective lactation 
periods of individual dairy cows. The impact of this research now requires translation into 
management tools and principles for the individual farmer impacting on the overall health 
status and economic performance of his herd of dairy cattle.
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De gezondheidsstatus van melkkoeien is een belangrijk speerpunt in de melkveehouderij, 
aangezien ziekte vaak gepaard gaat met pijn en stress voor de koe en hoge kosten en 
vermindert werkplezier voor de veehouder. Vanuit de overheid is bepaald dat het gebruik 
van antibiotica in de dierhouderij sterk verminderd moet worden om antibioticaresistentie 
te voorkomen. Dit vraagt om alternatieve methoden om de gezondheid van melkkoeien op 
peil te houden en legt meer focus op het voorkomen van ziekten in plaats van genezen. In 
het voorkomen van ziekten kunnen (voorspellende) biomarkers een belangrijke rol gaan 
spelen. Een biomarker die aangeeft dat een koe ‘at risk’ is voor het ontwikkelen van ziekte 
stelt de veehouder in staat om met managementmaatregelen (bijv. door het voerregime aan 
te passen) te voorkomen dat de koe daadwerkelijk ziek wordt. Uit eerder onderzoek is een 
kandidaat biomarker voor de weerstand van koeien gekomen: natuurlijke antilichamen 
(NAbs) in serum en melk. NAbs zijn antilichamen die worden gevormd zonder specifieke 
stimulatie door bijvoorbeeld bacteriën of vaccinatie. Ze zijn vaak gericht tegen structuren 
die veel op bacteriën voorkomen en daardoor zijn NAbs belangrijk in de eerste fase 
van een immuunreactie. In deze thesis wordt verder ingegaan op de NAbs door te 
onderzoeken hoe NAbs kunnen bijdragen aan een betere weerstand van melkkoeien en het 
identificeren van de bron van NAbs in koeien: de B-1 cellen. Verder is er in dit onderzoek 
gezocht naar alternatieve biomarkers voor weerstand in melkkoeien.     
Hoofdstuk 2 omvat een review over de (potentiële) markers van B-1 cellen in varkens, 
schapen en koeien en de beperkingen van deze markers voor het identificeren van B-1 
cellen in deze dieren. B-1 cellen zijn gedefinieerd op basis van de markers CD5 en CD11b. 
Deze markers zijn van origine beschreven voor B-1 cellen in de muis, maar inmiddels is 
aangetoond dat deze markers niet specifiek genoeg zijn om puur B-1 cellen in de muis 
te identificeren. In het review wordt bediscussieerd dat deze markers waarschijnlijk ook 
niet geschikt zijn voor het identificeren van B-1 cellen in varkens, schapen en koeien. 
De overeenkomsten in de foetale B-1 cel ontwikkeling en antilichaamproductie tussen 
muis en varkens, schapen en koeien impliceert overigens dat B-1 cellen wel aanwezig 
zijn in deze dieren. In hoofdstuk 3 zijn nieuwe markers getest om B-1 cellen in koeien 
te identificeren. Flow cytometry met de marker combinatie van IgM++ en pSYK++ 
resulteert in een aparte celpopulatie met B-1 karakteristieken, zoals een hoge CD80 
expressie. Verder correleren het percentage van deze B-1 cellen in het bloed van jonge 
kalveren, voor en tot 3 weken na biestinname, met de NAb niveaus (gedefinieerd als 
IgM dat bindt aan phosphatidylcholine (PtC)). In kalveren tot 6 maanden oud nemen de 
NAb niveaus in serum toe tot een leeftijd van ongeveer 6 weken, waarna ze stabiliseren. 
Dit impliceert dat de NAbs door het kalf zelf zijn geproduceerd en niet via de biest zijn 
ontvangen. De ontwikkeling van de totale hoeveelheid IgM in serum vertoont daarentegen 
wel duidelijk 2 pieken; een toename veroorzaakt door opname van maternaal IgM vanuit 
de biest en een tweede piek veroorzaakt door IgM productie (specifiek en natuurlijk 
IgM) door het kalf zelf. De NAb ontwikkeling verloopt volgens dezelfde kinetiek als 
van B-1 cellen verwacht kan worden, zoals eerder aangetoond voor de muis. Hoofdstuk 
4 beschrijft de rol van NAbs in de koe. NAbs zijn hier gedefinieerd als IgM antilichamen 
die binden aan het naïeve antigeen “keyhole limpet hemocyanin” (KLH). Koeien met 
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hoge NAb niveaus in hun serum hebben ook meer IgM en IgG antilichamen die binden 
aan microbiële componenten zoals lipopolysaccharide (LPS), lipoteichoic acid (LTA) en 
peptidoglycanen (PGN), dan koeien met lage NAb niveaus. Verder vertoonden koeien met 
hoge NAb niveaus ook meer IgM binding aan intacte E. coli en S. Typhimurium bacteriën. 
Echter, het doden van E. coli en S. Typhimurium bacteriën via antilichaam-gemedieerde 
complement killing in een bactericide test verschilt niet tussen koeien met hoge of lage 
NAb niveaus. Wel bleek dat de koeien die slecht scoorden in de bactericide test een grotere 
kans hadden op het ontwikkelen van mastitis in de toekomst. Deze associatie tussen de 
bactericide test en mastitis was voorspellend op een termijn van een jaar wanneer E. coli 
bacteriën in de bactericide test werden gebruikt. Voor S. Typhimurium was deze associatie 
voorspellend voor een termijn van zelfs 4 jaar. Hoofdstuk 5 beschrijft de identificatie 
van alternatieve biomarkers voor weerstand tegen ziekten in melkkoeien met behulp 
van proteomics. Melkmonsters van hoog en laag weerbare koeien werden geselecteerd 
uit de “Weerbaar Vee” biobank. Deze monsters werden vergeleken op basis van welke 
eiwitten en hoeveel van deze eiwitten aanwezig waren in melk van hoog versus laag 
weerbare koeien. Potentiele biomarkers bleken in een verhoogde concentratie aanwezig in 
de melk van laag weerbare koeien. Twee potentiele biomarkers werden gevalideerd met 
ELISA in een nieuwe en grotere set melkmonsters. Lactoferrine levels waren significant 
verhoogd in de melk van laag weerbare koeien en bleken geassocieerd te zijn met 
 klauwproblemen en een voorspellende waarde te hebben voor het afvoeren van de koe. 
In conclusie, NAbs in koeien worden geproduceerd door B-1 cellen die gekarakteriseerd 
zijn door (hoge) expressie van IgM en pSYK. Het percentage B-1 cellen in bloed 
correleert met de NAb niveaus in jonge kalveren. NAbs kunnen bepaald worden aan 
de hand van de IgM binding aan PtC. De voorspellende waarde van B-1 cellen voor de 
gezondheidsstatus en weerbaarheid van melkkoeien moet echter nog bepaald worden. 
Proteomics is een geschikte techniek om potentiële biomarkers voor de weerstand van 
melkkoeien te identificeren. Lactoferrine bleek een biomarker voor laag weerbare koeien 
en was geassocieerd met klauwproblemen en een grotere kans op het afvoeren van de 
melkkoe.
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Innate immunity
The innate immune system depends on features like extracellular and intracellular 
pattern recognition receptors (PRR) that recognize general molecular patterns. Different 
types of PRR have been described, identifying microbe-, pathogen- and danger-
associated molecular patterns (abbreviated as MAMP, PAMP and DAMP respectively). 
PRR enhance ligation and phagocytosis of microbes or have signaling ability allowing 
activation of the cell. Ligation of extracellular toll like receptors (TLR) by bacterial 
ligands like lipopolysaccharide (LPS) (binds to TLR4), peptidoglycan (PGN) (TLR2) 
and flagellin (TLR5) results in MyD88-dependent production of inflammatory cytokines 
like interleukin (IL)-1ß, IL-6, IL-8, and partly TNF-α. The expression of TLRs is vast 
as they are found on the cell membranes of innate immune cells (dendritic cells (DC), 
macrophages, natural killer cells), cells of the adaptive immunity (T and B lymphocytes) 
and non immune cells (epithelial and endothelial cells, fibroblasts).  
A complex network of specialized DC subsets is involved in on the one hand inducing acute 
inflammatory responses upon invasion by pathogens, and on the other hand in inducing 
tolerance to harmless dietary and inhaled antigens and commensal microbiota [1]. Since 
DC’s control many T-cell responses they have been useful tools to beneficially manipulate 
the T cell responses to recognize specific antigens (mostly viral or tumor antigens) in 
vitro or in vivo. Direct isolation of DC’s from peripheral blood mononuclear cells results 
in extremely low yields (0.1%). However large amounts of DC’s can be generated from 
peripheral blood mononuclear cells (PBMC), bone marrow cells or monocytes cultured 
in vitro in the presence of GM-CSF and IL-4. Complete activation and differentiation 
of T cells in contact with antigen presenting DCs is determined by expression levels of 
co-stimulatory molecules like CD80 and CD86, and the production of cytokines (TNF-α, 
IL-10, IL-12) and other soluble factors (e.g. retinoic acid).
T-cell immune maturation
In mammals, approximately 40-80% of lymphocytes in the blood account for T-cells. 
The peptide-binding T cell antigen receptor (TCR) complex is an important structure on 
the surface of the T-lymphocyte that contains many different proteins. These proteins 
can function in antigen binding for signal transduction and usually have a cluster of 
differentiation designation (CD). CD3 for example is a signal transducer that acts when 
an antigen binds the TCR and is therefore found on all T cells. CD4 is expressed on the 
surface of T helper cells that, as previously described, recognize processed exogenous 
antigen-derived peptides in combination with major histocompatibility (MHC) class II 
molecules on the surface of APC’s. CD8 is predominantly found on the surface of cytotoxic 
T- cells that recognize processed endogenous antigen-derived peptides in combination 
with MHC class I molecules. In humans, 60 – 70 % of T cells are CD4+CD8- and 30-40 % 
are CD4-CD8+. The remaining 5 – 10% of T cells are said to be double negative.  
Both CD4+ and CD8+ T cells can be differentiated in subpopulations that can be 
distinguished by their cytokine secretion profile [2, 3]. This is best established for CD4+ T 
cells. Upon activation by a processed antigen that is presented by APC’s, the naive CD4+ 
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Th cells begin to produce IL-2 and depending on the cytokines present in the environment, 
they continue to differentiate to designated Th1, Th2 or Th17 cells. Th1 cells express 
transcription factor t-bet, produce IL-2, IFN-g and lymphotoxin and support cell-mediated 
immune responses. Th2 cells express the transcription factor GATA-3, produce IL-4, 
IL-5, IL-9, IL-13 and GM-CSF and support humoral and allergic responses. Th17 cells 
produce IL-17, characterized by the transcription factor RORgT and seem to play a key 
role in many autoimmune diseases. Although Th1 and Th2 cells often work together in 
an immune response, the response can become dominantly Th1 or Th2-like. These Th1 
and Th2 subsets appear to be extremes in cytokine production profiles and within these 
polarized subsets, individual Th cells exhibit differential rather than coordinated cytokine 
gene expression. The Th1 and Th2 subsets appear to cross-regulate each other’s cytokine 
production profiles, mainly through IFN-γ and IL-10. From this concept it was rationalized 
that disturbances in the balance of between these two subsets may result in different 
clinical manifestations. IL-12 is a dominant factor promoting Th1 differentiation, and is 
produced by dendritic cells and macrophages. Moreover, IL-12 induces IFN-γ production 
by T cells and natural killer (NK) cells and IL-18 acts synergistically with IL-12 to induce 
Th1 development. Polarization of Th2 cells is critically dependent on the presence of 
IL-4 produced by Th cells, basophils and mast cells. APC-derived IL-6 has also been 
shown to induce small amounts of IL-4 in developing Th cells. IL-10 and prostaglandin 
E2 (PGE2), both produced by APC inhibit IL-12 production and Th1 priming.  
Within the CD4+ cell population, regulatory T cells expressing the transcription factor 
FOXP3 and the surface protein CD25 (the interleukin-2 (IL-2) receptor a-chain) 
are naturally present. CD4+CD25+FOXP3+ Treg cells have a regulatory function by 
suppressing the activation, proliferation and cytokine production of many immune cells, 
including CD4+ cells CD8+ and APCs. Their dysfunction can result in autoimmune 
disease, immunopathology and allergy. In addition, IL-10 secreting Tr1 cells, and 
transforming growth factor-b (TGF-b) secreting Th3 cells are adaptively regulatory: they 
acquire regulatory functions after specific antigenic stimulation [4]. As mentioned before, 
regulatory T cells have been isolated from in vitro cultures, which appeared to produce 
low levels of IL-2, no IL-4, but high levels of IL-10 and TGF-β. This demonstrates the 
importance of cytokines in regulating and dampening the immune response [5].  
To study effects on the maturation potential of the immune response (e.g. under conditions 
of immune-mediated diseases like allergy or by interaction with environmental factors 
like diet), it is presumed that human DCs generated from peripheral blood monocytes 
(moDCs) in vitro, resemble DC produced in vivo [6]. These DCs have been used to 
determine the attribution of allergenic or dietary proteins for driving the polarization of the 
immune system. Therefore, we propose to first investigate the immunomodulatory effects 
on maturation markers and cytokine profiles of human moDCs stimulated with different 
protein preparations and subsequently use co-cultures of moDC with purified CD4+ T cells 
for their polarizing capabilities in donors.
B cell immune maturation
Before an efficient B cell response is mounted, B cells need to mature either from naïve B 
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cells or pre-activated B cells. Humoral immunity is part of the adaptive immune system 
and involves the production of specific antibody molecules (immunoglobulin’s (Ig)) 
in response to an antigen, which is mediated by B cells. Naive B cells produce IgM, 
but can undergo antibody heavy-chain isotype class switching to IgG, IgE or IgA after 
activation. Activation of B cells and isotype switching requires activation of AID and 
is regulated by activated Th cells expressing CD40 ligand and by cytokines produced 
by the Th cells. IL-4 and IL-13, produced by Th2 cells, mediates isotype switching 
towards IgE.  Th2 cells can also induce IgG4 in humans. IgG4 production is initiated 
by the presence of IL-10 from Treg, which inhibits IgE production [7, 8].   
To be functionally active on mucosal surfaces that are exposed to the external milieu, 
transport over the epithelium is required. Several Fc domain-binding receptors have 
been identified, with different affinities and isotype specificities. IgA is bound by 
the FcαR (CD89), IgE by the high or low affinity FcεR (CD23) and IgG by FcγRI-III 
(CD66, CD32, CD16, respectively) [9, 10]. Monocyte derived DCs may preferentially 
express the low affinity receptor CD32, whereas monocytes also express CD89, some 
of the high affinity receptor CD64 and minor levels of CD16. Expression of CD16 is 
more prominent on neutrophils, which can become activated upon binding of immune 
complexes. It is important to note that not all IgG subclasses are bound by the Fc gamma 
receptors. Mainly IgG1 and IgG3 are bound, which are therefore called cytophilic IgG. 
IgG2 and especially IgG4 are well-known for their relatively tolerogenic features, which 
could be explained by the lack binding of those subclasses by Fc receptors.  
Measurement of immune response maturation  
Maturation of dendritic cells
The mechanism for regulation of innate immunity or the induction of immunomodulation 
by food components is largely unknown. The most widely studied mechanism is the uptake 
of proteins by pinocytosis and presentation of peptides to T helper cells. The majority of 
food proteins is (partly) digested and hence presented as peptides to the innate immune 
system. Alternatively, the exposure to environmental and food-derived potentially toxic 
compounds relies on the interaction with cells of the innate immune system of which 
dendritic cells are prototypical examples. Upon intracellular processing by professional 
APCs, peptides are presented on the MHC II class (signal 1) and co-stimulatory molecules 
can be up regulated (signal 2) next to the induction of cytokine secretion (signal 3). These 
factors together determine if and how the Th cell becomes activated.
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Figure 1.Immature monocyte-derived DC were analyzed directly for surface marker expression and also after 24 
of maturation by stimulation with LPS or a probiotic bacterium. Upper panel: CD86 vs MHC class II expression; 
middle panel: CD86 vs CD11c expression; and lower panel: CD115 vs MHC class II expression. MHC class 
II expression (HLA-DR) and CD86 are markers for mature DC representing antigen presentation capacity and 
co-stimulatory activity, respectively. CD115 is a marker for DC precursor and immature cells. Blue is negative 
control and red represents the 24 hr stimulated culture.
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Activation and maturation status of APC’s is usually determined by flow cytometric 
analysis of expression levels of CD80 and CD86 respectively CD83 and the precursor 
marker CD115. CD80 (B7-1) and CD86 (B70-2) are co-stimulatory molecules expressed 
on APCs and hybridize with CD28 expressed on Th cells. APC dependent activation 
of Th cells finally is mediated by the production of inflammatory cytokines like IL-1ß, 
IL-6 and TNF-α, and the regulatory cytokine IL-10. Expression of these co-stimulatory 
molecules and cytokines can be inhibited by IL-10, resulting in reduced activation 
of Th2 cells. Production of the Th1 skewing cytokine IL-12 is also inhibited by IL-
10. Next to absolute production levels, the ratio between IL-10 and IL-12 is used to 
identify if a stimulus is skewing towards Th1 or Th2. Precise evaluation of the cytokine 
production requires both absolute production levels and cytokine ratios. Tolerance is 
essential to prevent chronic inflammatory diseases or allergy. Key players in tolerance 
induction are T regulatory cells and this is a key feature of mucosal tissue, to prevent 
massive inflammation upon antigen challenges that are non-pathogenic.   
Peripheral blood mononuclear cells (PBMCs) obtained from buffy coats of healthy blood 
donors were isolated by gradient centrifugation on Ficoll-Paque PLUS. Monocytes were 
labeled with MicroBeads conjugated to mouse anti human CD14 monoclonal antibodies, 
and isolated using the MACS. Isolated monocytes were cultured in RPMI to which 
recombinant human GM-CSF and IL-4 were added. On day 6, expression of surface 
markers was analyzed using flow cytometry. Subsequently, these immature DCs were 
stimulated for 1 day with LPS or selected probiotic bacteria to become fully mature DC 
based on maturation marker expression. DCs were stained with antibodies against CD14 
(marker for monocytes and macrophages, but not DC), CD115 (marker for precursors and 
immature DC), HLA-DR (MHC class II), CD11c, CD83, and CD86. These monocyte-
derived dendritic cells (moDC) are characterized by their expression of HLA-DR, CD1a, 
CD11b, CD11c, CD86, CD83, CD115 and CD32 (Figure 1). MoDCs were described to 
constitute the main population of DC present under inflammatory conditions and strongly 
able to capture, process and present antigens in the T-cell area, LPS-treated MoDCs 
displayed a mature DC phenotype as shown by up-regulation of the maturation marker 
CD83 and the co-stimulatory molecule CD86 necessary for antigen presentation to T cells. 
Addition to MoDCs of probiotic bacteria also induced (slightly less profound) maturation 
phenotype [11].
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Figure 2. Binding of monomeric bovine IgG (boIgG) but not boIgM (left panel) purified from cow’s milk to 
human monocyte-derived immature DC (middle panel). Staining is performed by using FITC labeled anti-bovine 
IgG monoclonal antibodies. Pre-incubation of DC with IgG could be completely blocked by the competitive 
inhibition with anti-CD64 (FcgRI) antibodies (right panel). Data from one representative donor of two is shown.
Functional activity of mature dendritic cells
An example of dietary immunomodulation is by consumption of bovine milk, which 
contains IgM, IgG and IgA that can bind to pathogens and allergens that are also 
encountered by humans [12-14]. Milk-derived and purified bovine IgG, IgA, and IgM did 
not bind significantly to freshly isolated human monocytes (data not shown). In contrast, 
bovine IgG, but not IgM, from milk as well as purified immunoglobulins did clearly 
bind to immature monocyte-derived DC (Figure 2, left and middle panel). Incubation 
of DC with IgG could be completely blocked by the competitive inhibition with anti-
CD64 (FcgRI) antibodies (Figure 2, right panel), indicating that the high affinity FcgRI 
is responsible for binding of the monomeric IgG to DC. IgG that formed complexes with 
LPS, resulted in increased binding of bovine IgG to human moDC compared to monomeric 
bovine IgG, suggesting binding of immune complexes (Figure 3, upper panel). There is 
an optimal ratio between antigen and IgG for the formation of immune complexes. This 
binding of bovine IgG could partially be inhibited by blocking monoclonal antibodies 
(mAb) directed at the low affinity FcγRII (CD32), but also by mAb to the high affinity 
FcγRI (CD64) (Figure 3, lower panel). These data suggest that monomeric bovine IgG can 
bind to the high affinity human FcγRI, and that bovine IgG immune complexes could bind 
to the human low affinity FcγRII. Depending on the expression levels of activating and 
inhibitory FcγR, inflammatory or non-inflammatory downstream immune responses may 
be initiated leading to the production of protective IgG antibodies. This may be influenced 
by the type of DC the FcγR is expressed.
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Figure 3. Binding of bovine IgG-LPS immune complexes to human moDCs. IgG was incubated with different 
doses of LPS and subsequently added to moDCs (upper panel). IgG –LPS immune complexes in three 
different ratios were added to moDC in the presence or absence of IgG receptor blocking antibodies (lower 
panel). Unstained and FITC control show background staining, IgG mono is monomeric bovine IgG and IgG 
complex shows bovine IgG pre-incubated with LPS (in three different concentrations) prior to addition to the 
DCs. Blocking of LPS-IgG complexes by anti (a) CD32 and aCD64 was performed with specific monoclonal 
antibodies. 
Polarization of T-cells in allergy
Dendritic cells are professional antigen-presenting cells and are the key players in the 
initial stage of the interaction of e.g. allergens and the immune system that shapes the 
differentiation of naïve T cells. DCs display inherent plasticity and depending on 
their functional state, induce or inhibit T cell responses. The differentiation of naïve 
T cells into committed effector and regulator cells depends on complex interactions 
between the antigen, the antigen-presenting cell, and the milieu of cytokines in the 
immediate environment and expression of cell surface receptors. As described, allergy 
is widely considered a Th2 mediated immune maturation disease with a disturbed 
Th1-Th2 balance resulting in excessive amounts of IgE antibodies [7, 8].  
Typically, systemic T cells are isolated from peripheral blood mononuclear cells (human) 
or spleen and peripheral lymph nodes (mouse) by preparing single cell suspensions 
from these lymphoid organs. Naïve (CD62Lhigh) T cells are purified by magnetic beads 
coupled with anti-CD4 antibodies and using magnetic activated cell sorting (MACS) 
or, alternatively, labeling of the cells by anti-CD4 antibodies coupled to a fluorochrome 
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(e.g. FITC or PE) and using flow cytometric cell sorting (FACS) [4]. Isolated T cells can 
be obtained with relatively high purity (>95%) using both methodologies.  
T cell polarization is obtained by culturing purified CD4+ T-cells in vitro and stimulating 
these cells by anti-CD3 and anti-CD28 monoclonal antibodies. All cells are cultured 
in the presence of IL-2 for maximal proliferation (neutral condition). For maximal 
Th1 development cells are cultured in the presence of IL-12, IFN-γ, and anti-IL-4 
antibodies, while maximal Th2 development is obtained by stimulation in the presence 
of IL-4 and anti-IL-12 and anti-IFN-γ antibodies. Cells are stimulated under Th0-like 
conditions in the presence of monensin for 5 hours if intracellular cytokine staining 
(ICS) analysis will be required, or alternatively, cell supernatants are harvested 48 or 96 
hours after secondary stimulation in the absence of monensin treatment [15].  
Polarized T cells are pelleted and stained for surface molecules in a fluorescent activated 
cell-sorting (FACS) buffer. Following this, cells are fixed in paraformaldehyde and 
permeabilized with saponin. Cells are stained for intracellular cytokines with anti- IL-4-PE 
and anti-IFN-γ-FITC. Unlabeled antibody of the same clones is utilized at 10 times excess 
to set negative gates to control for non-specific staining. Cells are suspended in FACS 
buffer and then 10 000 events in the live cell gate (dead cells excluded by propidium iodine 
staining) will be analyzed on a flow cytometer (Figure 4). The use of propidium iodine 
(PI) staining of fixed and permeabilized cells provides a useful tool for setting the life cell 
inclusion gate for subsequent analysis of intracellular cytokine staining. This method of 
setting of stringent live cell gates is essential, as the use of un-stimulated cells alone does 
not adequately control for changes in auto-fluorescence following activation due to the 
inevitable increase in forward/sideward scatter in the flow cytometric analysis. Due to cell 
fixation and permeabilization, there is an inherent amount of non-specific staining which 
must be controlled for. Typically, the gates are set so that only 1% of cells are positive 
for the cytokine of interest in the labeled/unlabeled negative control. In order to detect 
intracellular cytokines, a Golgi trans- port inhibitor must be used on in vitro stimulated 
cells. This inhibitor affects the release or display of rapidly produced cytokines as well as 
other surface molecules. The concentration range in which the Golgi transport inhibitors 
can be used is relatively small, due to their inherent cytotoxicity. Therefore, cells must 
be activated to rapidly produce cytokines (hence the use of PMA and calcium ionophore) 
within a narrow 2-hour window for brefeldin A and a 5-hour window for monensin.
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Figure 4. Maturation of the Immune Response. Absolute cytokine production of interferon-γ (upper panel) 
and interleukin-4 (middle panel) by T helper cells isolated from healthy control (HC) and allergic individuals, 
as detected by ELISA (detection limit 7.5 pg/ml) under different in vitro polarizing conditions, including Th0, 
Th1 and Th2 conditions. Relative cytokine production of T helper type 1 versus T helper type 2 cells (lower 
panel). Absolute production is converted into a relative percentage by dividing interferon-γ or interleukin IL-4 
production values by the mean IFN-γ or IL-4 concentration following Th1 or Th2 polarization, respectively, of 
CD4+ T cells from healthy control (HC) or allergic individuals.
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Preclinical Relevance
Utilization of the DC maturation analysis and a T cell polarization pulse, followed by 
comparison of relative cytokine production by intracellular cytokine staining under polarized 
conditions allows ex vivo assessment of the DC and T cell polarization state in vivo. Immature 
or semi-mature DC can prime naïve T cell to differentiate into Treg cells rather than effector 
T cells, which enables them to promote tolerance instead of immunity. Ex vivo systems 
have the advantage of their natural origin, however donor viability and high individual 
variation can make analyses and interpretation of results more complex. 
Since strong and clear T cell polarization typically takes place in chronic disease states or 
exposure to (potentially toxic) agents [16], this technique provides an assessment whether the 
current direction of polarization in the DC and T cells are heading towards acute responses, 
on a population basis via relative cytokine production, and on a cell-by-cell basis via ICS. 
Most importantly, the comparison of cytokine production by enzyme-linked immunosorbent 
assay (ELISA) must be made on a relative scale, as outlined since the potency of the key 
Th1 and Th2 cytokines, IFN-γ and IL-4 respectively, may not necessarily be equal. Similar 
relative comparisons have been made during microarray analysis of Th1 and Th2 gene 
transcripts. Additionally, all polarizations must be compared to the results obtained from 
CD4+ T cells isolated from a healthy controls polarized under identical conditions. The 
rationale for this is apparent when looking at the data, because some individuals are naturally 
Th2 biased in their cytokine profile, while others are naturally Th1 biased.  
The addition of ICS to this method most importantly allows for further assessment of 
the T helper population in experimental groups, to determine if a mixed cytokine profile 
detected via ELISA and comparison of relative cytokine production truly represents an 
un-differentiated Th0 response of naive cells, or rather if it is indicative of a heterogeneous 
population of simultaneously differentiating Th1 and Th2 cells. Additionally, it can allow 
for further characterization of the cytokine-producing subsets [17, 18].
Clinical Relevance
Polarization of T helper cells is important in disease models associated with chronic 
immune stimulation, where the outcome depends on the type of immune response induced 
and relative amount of cytokines released. Many diseases such as leprosy, allergy, multiple 
sclerosis, and responses to immunotoxic agents have pathology associated with aberrant 
Th1 and Th2 (and Th17) polarization along with disturbed Treg formation (1,2). The 
importance of T cell polarization in a disease such as leprosy is immediately obvious since 
the infection by Mycobacterium leprae can be resolved by a strong cell mediated Th1 
response, while continued infection is associated with a humoral Th2 response.  
It is hard to determine polarization of T helper subsets during an acute response since 
real distinct populations only arise after chronic exposure to a particular antigen. 
However, many in vivo and in vitro experiments have a limited duration that does not 
reflect more chronic effects. It is therefore paramount to try to determine in which 
direction the cell population is polarizing. For this reason we perform two secondary ex 
vivo stimulations under polarizing conditions in our system, in order to determine how 
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far our stimulated cells can be pushed in each direction, Th1 and Th2. Using purified 
human T cells for analysis in these polarization assays, generally up to four rounds of 
stimulation are used before the final analysis of the polarization state can be performed. 
Moreover, un-polarized Th0 cells can be pushed in any direction in culture by addition 
of exogenous polarizing cytokines in concert with neutralizing antibodies to polarizing 
cytokines in the opposite direction, such as IL-4 and IFN-γ. Resistance to this directional 
polarization, or co-expression of IFN-γ or IL-4 in the supernatant under opposite 
polarizing conditions, however, indicates a shift towards differentiated T helper cell 
populations. Naturally, these analyses need to be performed on highly purified populations 
of CD4+ T cells obtained from circulation or isolated lymphoid organs.  
Several techniques can be used to try to determine the direction of polarization [19]. 
Firstly, quantitative reverse transcription polymerase chain reactions (RT-PCR) can be 
used to determine the number and nature of cytokine mRNA transcripts of stimulated 
cells, and can even be performed on a single cell level. This has certain disadvantages, 
since the actual production and release of cytokines cannot be directly measured and 
many of the cytokines of interest are subject to post-transcription regulatory mechanisms. 
Determination of cytokine production via direct protein detection in supernatant of cultured 
cells can be done by ELISA. ELISA determination is a valuable tool for measuring the 
average overall cytokine response accumulated over time, of a heterogeneous population 
of stimulated cells. However, this method alone is unable to distinguish whether a mixed 
Th0 cytokine pattern is due to the release of diverse cytokines from naive Th0 cells, or 
due to the production of cytokines by heterogeneous subpopulations of Th1 and Th2 
cells. Additionally, this method does not allow determination of which proportion of the 
cells is responsible for this skewing. To work around this limitation and to identify cells 
producing more than one cytokine, an ICS method is used. This method makes it possible 
to concurrently check the presence of different cytokines in each cell. When combined 
with ELISA results, an impression of the proportion of cytokine producing cells, as well as 
the combined cytokine profile of the cell population, can be assessed. This approach gives 
invaluable insight into the direction of T helper cell polarization.
Relevance to Humans
Dendritic cells in their immature and mature state present unique characteristics to 
investigate and to permit the estimation of the immunomodulating effects of food 
compounds. Health of human and animals is strongly related to a proper balance 
of immune functions, which can be directly mediated by diets or exposure to 
environmental and food-derived toxins, also called “immune-modulation”. As cells 
in vivo always work as a network, co-culture systems in in vitro or ex vivo conditions 
may present a step forward to mimic the in vivo situation. Subsequently, co-culture of 
dendritic cells and T-cells are essential to further elucidate such immunomodulatory 
activities of food components and potentially toxic compounds [20].  
Properties of many diseases, particularly systemic autoimmune disease, strongly support 
the involvement of helper T lymphocytes. For example, pathogenic autoantibody responses 
Page | 130
Maturation of the Immune Response
 A1
generally are of high-affinity IgG class, after having undergone affinity maturation, which 
requires helper T cells. The protein antigens to which many autoantibodies are directed 
generally require T cell help. Besides roles as helpers, T cells may directly provoke 
cellular injury during inflammatory phases of the disease process. T cells, and in particular 
CD4+ helper T cells produces effector molecules, called cytokines, upon activation. A 
multiplicity of cytokine abnormalities has been associated with various autoimmune and 
immune-mediated diseases. It is thus becoming common practice to analyze the role of 
helper T cells and the cytokines they produce in studying the immunpathologic basis of 
particular diseases, to aid in the unambiguous diagnosis of the disease, and to provide 
parameters to monitor the efficacy of treatment.
Regulatory Environment
Toxicity to the immune system encompasses a variety of adverse effects. These include 
suppression or enhancement of the immune response. Suppression of the immune 
response can lead to decreased host resistance to infectious agents or tumor cells. 
Enhancing the immune response can exaggerate autoimmune diseases or hypersensitivity. 
Toxic compounds (whether environmentally derived, drugs or food compounds) or toxin-
protein adducts might also be recognized as foreign and stimulate an anti-toxin response. 
Subsequent exposures to the toxin can lead to hypersensitivity (allergic) reactions. Much of 
the science and method development and validation efforts in the past have been focused on 
evaluating drug development candidates for their potential for either immunosuppression 
or contact sensitization. No standard approaches for human pharmaceuticals are currently 
available for testing for respiratory or systemic allergenicity (antigenicity) or drug-specific 
autoimmunity; testing for these endpoints is not currently required in any region. 
In addition, there are no direct guidelines determining the testing of human T cell polarization 
in vivo under neutral or diseased conditions. However, since the methodology of dendritic 
cell maturation analysis and T-cell polarization cultures is now more elaborately employed 
and standardization is proposed to apply this methodology in pharmaceutical and research 
conditions.
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Abstract
Non-inflammatory dendritic cell (DC) subsets play an essential role in preventing massive 
inflammation in mucosal tissues. We investigated whether the mucosa-related factors 
retinoic acid (RA) and transforming growth factor-ß1 (TGF-ß1) can induce such DC 
types. DCs were differentiated from monocytes in the absence or presence TGF-ß1 and 
RA. The phenotype as well as responsiveness to bacterial ligands was studied in detail. 
Compared to monocyte-derived DCs (moDCs), the expression of co-stimulatory molecule 
CD86 and DC maturation marker CD83 were strongly reduced by RA and TGF-ß1. In 
addition, both RA and TGF-ß1 induced DCs showed strongly decreased responsiveness to 
stimulation with the bacterial ligands lipopolysaccharide and peptidoglycan, and produced 
significantly lower levels of the pro-inflammatory cytokines IL-12 and TNF-α compared 
to moDCs, whilst IL-10 production was not significantly reduced. DCs differentiated 
under the influence of RA uniquely expressed markers related to intestinal homing 
(CD103 and integrin ß7). In addition, CCR7, which mediates homing to lymph nodes, 
was expressed by DCs differentiated in the presence of RA, and also to a lesser extent by 
the other DC types. Furthermore, whereas moDCs and TGF-ß1-derived moDCs expressed 
high levels of CD32, RA-derived DCs lacked CD32 expression but expressed high levels 
of CD64, suggesting that RA-DC may primarily respond to soluble proteins, and moDC 
and TGF-ß DCs to immune complexes. The data presented here support the hypothesis 
that the mucosal factors TGF-ß1 and RA, which can also be provided through dietary 
intake of dairy products, result in functionally and phenotypically distinct DC types with 
non-inflammatory properties.
Key words: Dendritic cell, activation, CD103, CCR7, ß7, mucosal factors, diet
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Introduction
A complex network of specialized dendritic cell (DC) subsets is involved in 
inducing acute inflammatory responses upon invasion by pathogens in the one 
hand, and on the other hand in inducing tolerance to harmless dietary and inhaled 
antigens as well as commensal microbiota [1,2]. Knowledge on the role of local 
mucosal and dietary factors that induce these different DC types is still limited.  
Intestinal epithelial cells have been shown to be able to induce tolerogenic DCs expressing 
integrin alpha E (CD103) [3]. Transforming growth factor ß (TGF-ß) and retinoic acid 
(RA) are important factors for conferring a tolerogenic environment in the mucosa 
by inducing regulatory T cells (Treg) and IgA-producing plasma cells [4,5]. Under 
specific conditions, RA is also able to induce more inflammatory CD4 T-cells [6, 7]. 
Intestinal epithelial cells produce TGF-ß1 in steady state and can metabolize dietary 
vitamin A to retinoic acid [Reviewed by 8]. TGF-ß present in breast milk has been 
associated with development of gut homeostasis and prevention of allergy development 
in infants [9]. Several studies have indicated a role for the hematopoietic Fms-related 
tyrosine kinase 3 ligand (Flt3l) for induction of CD103 DCs in mice, but this has not 
been confirmed for human CD103+ DCs [10, 11]. Other reports have demonstrated 
that RA is able to induce CD103 expression on human monocyte derived DCs [3] or 
mouse bone marrow cells [12] but data on responsiveness to bacterial ligands is lacking. 
RA has also been implicated in imprinting T cells to migrate to the intestines [13] 
Both DCs and CD4+ T cells can display tolerogenic properties, which is reflected by 
expression of CD103 by DCs and forkhead box P3 (FoxP3) by Tregs [1, 3, 5].   
DC subsets exert different functional roles in the intestines, as evidenced by altered 
composition of the DC network in disease. Increased numbers of CD11b+ DCs and 
decreased numbers of CD103+ DCs were observed after sensitization with peanut 
allergens in a mouse peanut allergy model [14]. Tolerogenic CD103+ DCs are known 
for their different migratory capacity (homing to mesenteric lymph node; MLN) and 
capacity to induce peripheral tolerance by inducing FoxP3+ CD4+ Tregs [1, 5, 15]. Next 
to decreased numbers of CD103+ DCs, Treg-inducing capacity by CD103 expressing 
DCs was lost in a mouse model of colitis [16]. Those studies in mice provide insight 
in how DC subsets may be involved in the prevention or pregression of disease , but 
the role of DC subsets still needs to be established in the human system [17]. Intestinal 
epithelial cells are also important in the maintenance of intestinal homeostasis as 
intestinal epithelial cells of patients suffering from colitis produce lower levels 
of thymic stromal lymphopoietin (TSLP), TGF-ß1 and aldehyde dehydrogenase 
(ALDH). ALDH is involved in synthesis of RA, and reduced expression of ALDH mat 
explain the altered RA-dependent induction of Tregs in those patients [3, 18].   
Complete activation and differentiation of T cells in contact with antigen-presenting DCs is 
determined by expression levels of costimulatory molecules like CD80 and CD86, and the 
production of  cytokines (TNF-α, IL-10, IL-12) and other soluble factors (e.g. RA). Next to 
induction of Tregs, TGF-ß and the metabolite of Vitamin A, RA, have been shown to play a 
role in the induction of IgA in vitro and mouse models, which is a major contributor to the 
first line of mucosal defense [4, 19, 20]. Vitamin A deficiency is associated with pathological 
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signs in epithelia, which could be restored after supplementation with vitamin A [21], but 
it is not known if the restoration of pathology was mediated by CD103+ DCs.  
The currently established model for in vitro DC studies relies on differentiation of 
monocytes under the influence of GM-CSF and IL-4. In addition to the limitations in 
physiological functionality of differentiating DCs from monocytes in vitro, the conventional 
model generates only one subtype of DC whereas multiple DC subsets are found in vivo. 
As data on the direct effects of RA and TGF-ß1 on the DC phenotype and responses to 
bacterial ligands is limited, the current study aimed to identify how these mucosal factors 
affect DC phenotype and activation upon stimulation with bacterial ligands. Conventional 
monocyte-derived DCs (moDC) were compared to moDCs that were differentiated 
under the additional influence of TGF-ß1 or RA. The expression of DC subtype-specific 
cell surface markers, homing receptors, and IgG receptors was evaluated, as were their 
functional responses to stimulation by Toll-like receptor (TLR) ligands.
Materials and Methods
Peripheral blood mononuclear cells and monocyte isolation
Peripheral blood mononuclear cells (PBMCs) obtained from buffy coats of healthy 
blood donors (Sanquin Blood Bank Nijmegen, The Netherlands) were diluted 1:1 in 
IMDM (Gibco-BRL, Paisley, Scotland) and isolated by gradient centrifugation on Ficoll-
Paque PLUS (Amersham Biosciences, Uppsala, Sweden) for 5 minutes at 200g and 
subsequently for 15 min at 500g (without brake at 20ºC). The PBMCs were harvested 
from the Ficoll layer, gently resuspended in IMDM and washed twice in IMDM.  
Freshly isolated PBMCs were labelled with MicroBeads conjugated to mouse IgG2a 
monoclonal anti-human CD14 antibodies (130-050-201, Myltenyi Biotec,   Bergisch 
Gladbach, Germany) and incubated for 15 minutes at 4ºC, washed with MACS buffer (0.5% 
BSA, 2mM EDTA in PBS, pH 7.2), centrifuged (10 min, 200g) and resuspended in MACS 
buffer. The MACS columns were placed in the quadroMACS (Myltenyi Biotec) and rinsed 
with MACS buffer. Subsequently, the cell suspension was added, the columns were rinsed 
three times with MACS buffer and removed from the quadroMACS; labelled cells were 
collected in a new tube by rinsing with MACS buffer and the supplied plunger.  
Purity of the CD14+ cell population was between 90 and 95%, as determined by flow 
cytometric analysis (FACS Canto II BD Biosciences, San Jose, CA, USA) by labeling the 
cells with mouse IgG2a anti human CD14 APC or an isotype control (clone M5E2, 555399 
or 555576, BD Biosciences).
DC generation and stimulation
Isolated monocytes were cultured in RPMI (Lonza, Basel, Switserland) containing 10% 
standardized FCS (A15-551, PAA laboratories) and 1% pen/strep (Gibco, 15140) at a 
concentration of 1*106 cells/ml. 50 ng/ml recombinant human GM-CSF (Peprotech, 300-03) 
and IL-4 (Peprotech, 200-04) were added and refreshed every second or third day. On day 7, 
expression of cell surface markers was analyzed using flow cytometry (FACS Canto II, BD 
Biosciences). Alternatively, DC subsets were generated by adding 10-5 M all-trans retinoic 
Page | 138
The Mucosal Factors Retinoic Acid
 A2
acid (Sigma Aldrich) or 10 ng/ml recombinant human TGF-ß1 (Peprotech) in addition to Il-4 
and GM-CSF. Like IL-4 and GM-CSF, RA and TGF-ß1 were refreshed every second or third 
day. Also TSLP (50 ng/ml, Peprotech) was tested as factor for CD103 induction.  
After differentiation DCs were stimulated with 10 ng/ml recombinant human IL-1ß 
(Peprotech) or 2 µg/ml of LPS (S. typhimurium, L7261, Sigma, St Louis, USA), PGN (S. 
aureus, tlrl-pgnsa, InvivoGen, Toulouse, France) or flagellin (S. typhimurium, tlrl-stfla, 
InvivoGen). Cell free supernatants were collected and stored at -80oC until analysis. DCs 
were collected and cell surface marker expression was analyzed. 
DC-T cell co-culture
In order to evaluate the functional consequences of RA-induced-expression on CD4+ cells, 
DCs and autologous or allogeneic T-cells (CD14-depleted PBMCs) were co-cultured in 
a 1:10 ration (DC:T cell) [22]. At day 5 of DC differentiation, T-cells were added and 
incubated for another 5 days. Some T-cells were pre-incubated with 10-5 M RA receptor 
antagonist LE136 (Tocris Bioscience, Bristol, UK) and/or during culture 150 ng/ml or 
100ng/ml of monoclonal antibodies to CD3 and CD28 (BD Biosciences) were added. Cells 
were harvested and stained for CD4 and CD127, followed by fixation and permeabilization 
and staining with FoxP3 according to the manufacturer`s descriptions (Treg staining kit 
560131; BD Biosciences). Cells were gated on CD4-positivity, and the percentage of 
FoxP3+CD127- cells were extracted by batch processing using FlowJo.
Cell Surface marker analysis
DCs were stained with antibodies against CD14 (APC-H7, 560270, BD Biosciences), 
CD103 (PE, 550260, BD Biosciences), CX3CR1 (PerCP-eFluor710, 46-6099, 
eBioscience), HLA-DR (APC-eFluor780, 47-9956-41, eBioscience), CD11b (PE-Cy7, 
25-0118, eBioscience), CD11c (V450, 560370, BD Biosciences), CD83 (FITC, 11-0839-
42, eBioscience), CD86 (V450, 560357, BD Biosciences), ß7 chain (APC, 551082, BD 
Biosciences), CCR7 (FITC, 561271, BD Biosciences), CD209 (PerCP-Cy5.5, 558263, BD 
Biosciences), CD16 (PE, 332779, BD Biosciences), CD32 (GTX74628, GeneTex. Irvine, 
USA), CD64 (305015, BioLegend), FcRn (sc-271745, Santa Cruz, California, USA). For 
FcRn, CD32 and CD64 a secondary antibody labeled with FITC was used (goat anti mouse 
IgG/IgM, 555988, BD Biosciences). Of each sample a control sample was analyzed, 
stained with control antibodies (same concentration as positive staining was used) of 
the same host species and isotype, conjugated with the same fluorochrome.  
Cells were incubated at room temperature for 20 minutes in the dark. Subsequently, cells 
were centrifuged, supernatant discarded, 200 µl FACS Buffer (BD Biosciences) added, 
and analyzed for surface marker expression by flow cytometric analysis (10 000 cells were 
analyzed using BD Canto II using DIVA software, BD). Data was batch processed and 
percentages and delta mean fluorescent intensity (MFI) values (surface marker staining – 
isotype control staining) were obtained.
Human cytokine measurements
Human cytokine concentrations (IL-10, IL-12 and TNF-α, 558274, 558283 and 558273 
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respectively, BD Biosciences) in cell culture supernatants were determined using the 
cytometric bead array flex sets (BD Biosciences) and incubations were performed in the 
recommended Protein Master Buffer Kit (BD Biosciences). Briefly, 50 µl supernatant 
was incubated with capture beads diluted in 50 µl Capture Bead Diluent for one hour at 
room temperature in the dark. Next, PE Detection Reagent was diluted in 50 µl Detection 
Reagent Diluent, added and incubated for two hours at room temperature in the dark. 
For the standard curve, the provided lyophilized recombinant cytokines were used 
and assayed together with the samples. After incubation the samples were centrifuged, 
supernatant discarded and 200 µl Wash Buffer was added. The samples were analyzed by 
flow cytometric analysis (FACS Canto II, BD Biosciences).
Statistical analysis
Statistical tests were performed in IBM SPSS Statistics v19. The independent samples 
t-test was used to test mean differences between DC types or treatments. Depending on 
equality of variances between test conditions, the p-value of equal or unequal variances 
assumed was reported.
 
Results
Effects of RA and TGF-ß on DC differentiation
IL-4 and GM-CSF are generally used to generate DCs from monocytes. moDC 
are often used as model DC in studies on intestinal immunomodulation. As the 
intestines contain several DC subsets, of which tolerogenic subsets are crucial for 
maintaining homeostasis, we developed two additional DC subsets using the relevant 
mucosal factors RA and TGF-ß1. These factors were added to the differentiating 
DCs of at least 4 different donors in addition to IL-4 and GM-CSF.   
All three DC subsets expressed HLA-DR and lacked CX3CR1 and CD14 expression (Table 
1). Conventionally differentiated moDCs and TGF-ß1-derived DCs (TGFmoDCs) expressed 
CD1a, but RA-derived DCs (RAmoDCs) did not express CD1a (Table 1).   
All three DC types expressed CD11b and CD11c (fig. 1). Analysis of the MFI of CD11b 
revealed that TGF-ß1-derived DCs and even more so the RA-derived DCs expressed 
reduced levels of CD11b compared to moDC (p = 0.006 and p = 0.001, respectively). 
CD11c expression was also reduced (p = 0.001, p = 0.006, respectively; fig 1). This was 
more prominent for TGF-derived moDCs than for RA-derived moDCs, resulting in a 
significantly reduced CD11b/CD11c ratio for RA-derived moDCs compared to moDCs (p 
= 0.020, data not shown). 
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Figure 1. Surface marker expression by the moDCs differentiated under three different regimes. FACS 
histograms (above) show a representative example of at least 4 donors tested. The grey shaded area is isotype 
control, black dashed line is moDCs (IL-4 and GMCSF only), black line is RAmoDCs and grey long-dashed 
line is TGFmoDCs. Bar graphs (below) are shown indicating the average percentage of cells expressing those 
markers (isotype control values are subtracted) and standard error of 4 different donors. p values shown are based 
on double-sided t tests, performed after log transformation of the data.
As in vivo functionality of CD103+ DCs depends on co-expression of (α4)ß7 to adhere to 
E-cadherin and migrate to the intestine and on CCR7 for homing to the MLN, we assessed 
expression of those cell surface markers on the different DC types. The percentage of 
CCR7-expressing cells doubled under the influence of RA but not under the influence 
of TGF-ß1 (fig 1). The MFI level of CCR7 was significantly higher on RA-derived 
moDC compared to moDCs, but not compared to TGF-derived moDCs. In addition to the 
expression of CD103, the percentage of DCs expressing the integrin ß7 was significantly 
higher for RA compared to moDCs and TGF-ß-differentiated DCs (fig 1). TSLP and Flt3 
ligand (implicated in CD103 induction in mice) did not induce expression of CD103 (data 
not shown).The basal expression data of the three DC subsets are summarized in table 1. 
We conclude that especially RA gave rise to moDCs resembling tolerogenic DCs observed 
in vivo in humans.
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Table 1. Basal expression (%) of cell surface molecules on the three moDC types
moDC RAmoDC TGFmoDC
CD14 – – –
HLA-DR ++ ++ ++
CD1a + – +
CD103 – + –
CX3CR1 – – –
CCR7 +/‐ + +/‐
β7 +/‐ + +/‐
CD11b ++ ++ ++
CD11c ++ ++ ++
CD86 + ‐ ‐
CD83 +/‐ ‐ ‐
FcRn – – –
CD16 – +/– –
CD32 + – +
CD64 ‐ + ‐
 
 
Data was calculated by subtracting isotype percentages and is based on at least 4 different donors, except for 
Fc receptor staining, which is based on 3 donors. – = <5%; ‐ = 5 – 25%; +/ ‐ = 25 – 50%; + = 50 – 90%; ++ 
= >90%.
Figure 2. FcγR expression by the three DC types. Mean MFI and standard errors are shown of 3 different donors.
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Differential expression of Fcγ receptors
Fcγ receptors (FcγR) have different affinities for IgG. Low affinity FcγR (CD16) and high 
affinity FcγR (CD64) can bind to monomeric IgG, whereas low affinity FcγR (CD32) 
binds to immune complexes only [23]. CD32 expression was observed for moDCs and 
TGF-derived moDCs, but not for RA-derived moDCs (fig. 2). CD64nwas expressed by 
all DC types, but its expression wasnhighest on RA-derived moDCs. The FcγR expression 
pattern is similar for moDCs and TGF-derived moDCs, although expression of CD32 and 
CD64 seems to be higher on TGF-derived moDCs. RA-derived moDCs have a different 
FcγR expression profile by expressing low levels of CD16 and high levels of CD64, but 
no CD32. Expression of the neonatal receptor (FcRn) could not be shown on any of the 
DC types.
Bacterial ligands reduce expression level of CD103 on RA-derived DCs
CD103+ DCs are believed to migrate to the MLN upon activation, for which reduction 
of CD103 expression levels may be essential, next to upregulation of CCR7, which is 
responsible for homing to the MLN. To test if this also occurs in these in vitro-generated 
CD103+ DCs, RA-derived DCs were stimulated with several bacterial ligands and changes 
in CD103 expression level were measured after 48 h. Addition of bacterial PGN (TLR 
2/6 ligand) and LPS (TLR4 ligand) significantly reduced expression of CD103 (data not 
shown).
DC subsets vary in expression of CD86 and CD83
The expression of co-stimulatory molecules is essential for complete activation of T cells. 
Unstimulated conventional moDCs were slightly pre-activated as evidenced by increased 
CD83 and CD86 expression, but this was not observed for RAmoDCs or TGFmoDCs. Even 
so, CD83 and CD86 expression increased significantly after stimulation with bacterial 
ligands. The percentage of CD86-expressing cells was reduced in RA- and TGF-derived 
moDCs relative to moDCs (p = 0.013 and p = 0.007, respectively), whereas the MFI of CD86 
was only reduced in RA-derived moDCs (not significant; fig. 3). All CD83-expressing cells 
also expressed CD86. RA- and TGF-β1-derived moDCs  showed a reduced percentage of 
CD83+ cells compared to moDCs (p = 0.002 and 0.004, respectively), whereas the level of 
expression (MFI) was the same. Although the percentage of basal expression of CD86 on 
TGF-β1 and RA-derived moDCs was reduced, the addition of bacterial ligands (3 donors, 
24 h, and 4 donors, 48 h) resulted in a pronounced upregulation of CD86 expression on all 
DC types with the most significant changes induced by exposure to LPS (fig. 3; table 2). 
However, after stimulation with the TLR ligands PGN and LPS, the MFI of CD86 of RA- 
and TGF-derived moDCs was still significantly lower compared to conventional moDCs, 
especially for RA-derived moDCs (fig. 3), indicating a state of non-responsiveness. Also, 
the percentage CD83+CD86+ cells upon activation with bacterial ligands was significantly 
reduced when DCs were differentiated in the presence of TGF-β1 and RA. However, no 
differences in MFI of CD83 were observed. 
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| Figure. 3. Expression of maturation and activation marker CD83 and CD86 by the three DC types. (A) 
Isotype control staining (left column), followed by surface marker staining of non-stimulated (medium, 
shown in the middle) or LPS-stimulated (right column) moDCs (top), RAmoDCs (middle) and TGFmoDCs 
(bottom) are displayed. (B) Mean percentage, MFI and standard error are shown of 4 different donors 
after 48 h of incubation with medium or bacterial ligands. (C) p values of t test between DC subsets after 
activation with bacterial ligands. Statistical differences between DC subtypes are shown (t test). Similar 
results (not shown) were obtained with DCs stimulated for 24 h from 3 independent donors.  
Production of the proinflammatory cytokines TNF-α and IL-12 is reduced in RA and 
TGF-ß1 – derived DCs
After stimulation with the bacterial ligands LPS and PG for 48 hours, cell culture 
supernatants were collected and cytokine production levels (TNF-α, IL-10, IL-12) were 
determined. Production levels of all cytokines were decreased in cultures with DCs 
differentiated in the presence of RA and TGF-ß1 (fig 4). RA and TGF-ß1-derived moDCs, 
showed significantly reduced production of the pro-inflammatory cytokines TNF-α and 
IL-12 compared to moDC (RA: p = 0.017 and p = 0.021 respectively; TGF-ß1: p = 0.013 
and p = 0.017, respectively). TGF-derived moDC did not produce detectable IL-12, and 
strongly reduced amounts of IL-12 were produced by RA-derived moDCs when PGN 
or LPS was added. IL-10 production by RA- and TGF-derived DCs had a tendency to 
reduction upon stimulation with PGN, but this did not reach significance.
0
Figure 4. Cytokine production by the three DC types upon 48 h of incubation with medium or bacterial ligands. 
aean cytokine concentration (pg/ml) and standard error of 4 different donors after 48 h of incubation with 
medium or bacterial ligands. b p values of t tests between DC subsets after activation with bacterial ligands 
(relative cytokine levels). Statistical differences between DC subtypes are shown (t test).
A
B
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Induction of FoxP3 Expression
As CD103+ DCs have been implicated in inducing FoxP3+ Tregs, moDCs and 
RAmoDCs were co-cultured with autologous or allogeneic PBMCs that were depleted of 
monocytes and B cells for 5 days at a ratio of 1:10. Cells were stimulated with suboptimal 
concentrations of monoclonal antibodies to CD3 and CD28 (150 and 100 ng/ml) or 
medium. The cells were harvested and stainedfor CD4 and CD127 (which should be 
absent on Tregs) followed by fixation and permeabilization and staining for FoxP3. The 
percentage of CD127–FoxP3+ CD4+ cells was determined by flow cytometric analysis. 
PBMCs cultured in the presence of allogeneic RAmoDCs and CD3 and CD28-specific 
antibodies showed increased percentage of FoxP3+CD127+ CD4+ cells (fig. 5). This could 
be abrogated when PBMCs were pre-incubated with RA receptor antagonist LE135 (10-5 
M). This increased percentage of FoxP3+CD127– cells was not observed when autologous 
RAmoDCs or autologous or allogeneic moDCs were used.
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Figure 5. Induction of FoxP3 expression by CD4+ T cells. T cells were added at day 5 of differentiation and 
incubated for another 5 days before cells were harvested for FACS staining. (A) CD4+ cells are gated on CD127 
(y-axes) and FoxP3 (x-axes); medium (left), αCD3αCD28 (middle) and αCD3αCD28 plus RA block (LE135) 
and αTGF-β (right) for moDCs (top) and RAmoDCs (bottom) are presented. (B) Mean and standard error of 3 
donors are shown for percentage FoxP3+CD127– CD4 cells. Own = Autologous; Allo = allogeneic. * p < 0.05.
A
B
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Discussion
The generation of moDCs is well established, whilst moDCs do not fully reflect the 
complex network of mucosal DCs found in vivo, that is partly conditioned by local factors 
in the mucosa. In this report we describe two DC subsets that can be induced by the 
mucosal ligands RA and TGF-β1. RA- and TGF-β1-derived DCs were compared to the 
commonly used moDCs that are differentiated with IL-4 and GM-CSF only. Addition of 
RA gave rise to a CD103 and integrin β7-expressing subset that also expressed CCR7 and 
resembles non-inflammatory DCs observed in vivo. Expression of CCR7 was also found 
to be increased on CD11c+CD103+ DCs isolated from human MLN, compared to 
CD11c+CD103– MLN DCs, indicating that our in vitro-generated RA-derived moDCs 
might be a relevant model for CD11c+CD103+CCR7+ DCs found in vivo [3] . DCs 
differentiated under the influence of IL-4 and GM-CSF in the presence or absence of 
TGF-β did not express CD103 and integrin β7. Differentiation in the presence of RA or 
TGF-β1 resulted in reduced responsiveness to bacterial ligands.   
All three regimens used to differentiate peripheral monocytes seem to result in 
differentiation of immature DC types as expression of CD14 was lost and HLA-DR, 
CD11b and CD11c were upregulated. CD103– and CD103+ DCs expressed CD209, but 
CD103+ DCs lacked CD1a. The in vitro-differentiated CD103+ DCs expressed CD11b, but 
at lower levels compared to CD103– moDCs. The cytokine TSLP did not induce expression 
of CD103. Although much progress has been made, the precise factors differentially 
inducing CD11c+CD103+ and CD11lo CD103– DCs have not been revealed to date [24]. 
Even though functional consequences of different expression levels of CD11b and CD11c 
by DCs are not understood well, CD11b may correlate with more inflammatory DC 
subsets, whereas CD11c might be more expressed on tolerogenic CD103+ subsets in vivo 
[25]. None of the moDCs generated, neither basally, nor after addition of bacterial ligands, 
expressed CX3CR1. CX3CR1 expression could also not be induced by differentiation of 
DCs in the presence of IL-1β. This might be explained by the finding that HLA-DR-
positive colonic cells that expressed CX3CR1 also expressed CD14, which suggests that 
CX3CR1 expression in humans might be limited to macrophages and is lacking on DCs 
[26].   
Compared to moDCs, differentiation using additional RA and TGF-β1 resulted in reduced 
expression of CD86 and CD83, and reduced production of cytokines, indicating that these 
cells may have tolerogenic properties, which was confirmed by their reduced activation by 
TLR ligands. Those findings are similar to data obtained after co-culturing moDCs with 
CaCo-2 cells for 24 h [3,27].     
CD103+ DCs are believed to migrate to the lymph node upon activation in a CCR7-
dependent manner [28]. CD103+ DCs present in the MLN express CCR7 [3, 24], which 
was also found in a significant proportion of RA-derived moDCs. Expression of ALDH 
does not depend on TLR-signaling [29], which is in line with our finding that expression 
of CD103 was downregulated after stimulation with bacterial ligands. It can be envisaged 
that CCR7-dependent migration is more efficient when expression of CD103 is reduced 
upon activation. An effect of the downregulation of CD103 expression upon stimulation 
with bacterial ligands may be that CD103+ DCs lose their non-inflammatory properties 
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[16]. The functional relevance of CCR7 expression by RAmoDCs is not clear yet. CCR7 
expression by CD103+ DCs may allow induction of peripheral tolerance, or enhance 
inflammation as CCR7-expressing DCs were observed in the colon of Crohn’s disease 
patients, which were absent in healthy individuals [30].  
Another interesting difference observed between the three DC types was the level of 
expression of FcγR on the cell membrane. Addition of TGF-β1 during differentiation 
resulted in a similar pattern of FcγR expression as on moDCs (CD32hi, CD16lo, CD32lo) 
but expression levels of low affinity CD32 and high affinity FcγR CD64 were increased. 
RA, however, resulted in a lack of CD32 expression and relatively high expression of 
CD64. This may imply that moDCs and TGF-derived moDCs have a higher capacity to 
bind to immune complexes, including bacteria, whereas RA-derived moDCs may be 
specialized in binding soluble antigens (e.g. dietary proteins). Immune complex binding 
(e.g. bacteria) by moDCs may preferentially result in the activation of T cells, whereas 
those complexes bound by non-inflammatory TGF-derived DCs may result in tolerance to 
those bacteria. It has been established that ligation of CD64 by antigen-IgG complexes 
could result in activation of T cells by DCs [31]. As RA-derived DCs show non-
inflammatory characteristics, ligation of CD64 on RA-derived DCs (CD103+) may result 
in induction of oral tolerance as those cells migrate to the MLN and induce Tregs in vivo. 
Currently, data describing FcγR expression of DC subsets is limited. As IL-4 downregulates 
FcγR expression, it is worthwhile evaluating the effect of RA and TGF-β1 on FcγR 
expression in the absence of IL-4 [32].   
Like CD103+ DCs found in vivo, the RA-differentiated DCs described here could induce 
increased percentages of FoxP3+ in allogeneic CD4+ cells under the influence of suboptimal 
doses of anti-CD3 and anti-CD28 monoclonal antibodies (fig. 5). This increased expression 
was not observed when T cells were co-cultured with conventional moDCs, and could be 
abrogated by blocking TGF-β and RA simultaneously (fig. 5). It was previously shown 
that the RA- and TGF-β-dependent induction of FoxP3 expression by CD4+ T cells is 
abrogated when IL-15 is also present, and RA even enhances IFN-y production by CD4+ T 
cells in the presence of RA [6]. The different levels of cytokines produced by the DC types 
may result in differential skewing of T helper cells, as was observed for the induction of 
Th2 cells by DCs conditioned by epithelial cells [33]. The absence of production of Th1 
inducing IL-12 by TGF-derived DCs may promote the development of Th2 cells, especially 
since IL-10 expression was largely maintained [34, 35]. Recently, DCs have been identified 
as important players in induction of mucosally produced IgA. CD103+ DCs are a candidate 
IgA-inducing DC subset [12] as these cells are able to produce the major IgA switch factor 
TGF-β, and RA which induces IgA plasma cell homing to the intestines [3, 4]. For synthesis 
of RA, humans depend on dietary intake of RA precursors. These precursors are present in 
several dietary ingredients, including a number of vegetables like carrot (β-carotene) and 
cow’s milk. Induction of peripheral antigen-specific FoxP3+ Tregs may indirectly depend 
on dietary intake of RA. Also, TGF-β is present in physiologically relevant amounts 
(several nanograms per mililiter) in cow’s milk. The bioactive form of TGF-β1 found in 
milk is largely conserved and TGF-β2 is identical to human TGF-β, and, interestingly, 
TGF-β bioactivity is induced by acidic conditions in the stomach rather than inhibited 
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[36]. Also, bovine IL-10 is cross-reactive with the human IL-10R, though IL-10 is mainly 
present in colostrum and lacking in the majority of commercially available dairy products 
[37]. Presence of IL-10 during terminal differentiation into immature DCs gives rise to 
DCs with increased capacity to induce type 1 regulatory T cells [38, 39] . Tus, several 
mucosal and dietary factors may contribute to a noninflammatory intestinal milieu.  
In conclusion, the RA- and TGF-β1-differentiated DCs described here induce distinct 
mucosal DC subsets, including CD103+ DCs. The phenotype of CD103+ DCs resembles 
the CD103+ DCs described in in vivo studies, and can advance widely used DC-type in 
vitro models with a different functional response to bacterial ligands. However, it still 
needs to be further established to what extent those CD103+ moDCs resemble the 
functionality of CD103+ DCs in vivo. Importantly, the expression of homing markers and 
FcγR differed between the DC types, suggesting different functional roles in intestinal 
immunity. Induction of these non-inflammatory DC types may very well be modulated by 
the dietary intake of vitamin A and TGF-β.
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